Home | MyCME | All CME | Blog | Psychlopedia

CME Activity Archive

CME Activities From Our Journals

Online CME Activities

+Effective Management Approaches for Psychosis in Patients With Parkinson Disease [Series Home Page]

+JCP CME Activities [Series Home Page]

Sakurai et al

JCP CME

Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial

Hitoshi Sakurai, Takefumi Suzuki, Robert R. Bies, Bruce G. Pollock, Masaru Mimura, Shitij Kapur, and Hiroyuki Uchida

Activity | Published: 10/26/2016 | Keywords: schizophrenia, None, None, None, None, None

When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out whether increasing the dose provides any greater benefit than waiting longer for patients to respond to the lower dose.

Cox et al

JCP CME

The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes

Elizabeth Q. Cox, Nathaniel A. Sowa, Samantha E. Meltzer-Brody, and Bradley N. Gaynes

Activity | Published: 9/14/2016 | Keywords: depression, None, None, None, None, None

Perinatal depression is common and can have serious implications for both the mother and child. However, the authors of this review found that over 90% of women with antenatal or postpartum depression receive inadequate treatment. Read this CME activity so that your patients won't go undiagnosed and untreated.

Wilkinson et al

JCP CME

A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications

Samuel T. Wilkinson, Rajiv Radhakrishnan, and Deepak Cyril D’Souza

Activity | Published: 8/24/2016 | Keywords: Alzheimer's, PTSD, neurology, None, None, None

Marijuana has been approved in many US states to treat a number of psychiatric conditions, including posttraumatic stress disorder, agitation in Alzheimer’s disease, and Tourette’s disorder. But what is the strength of evidence for the efficacy of marijuana and other cannabinoids for these psychiatric indications? Learn more by reading this CME journal article.

Wilens et al

JCP CME

Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders

Timothy Wilens, Courtney Zulauf, MaryKate Martelon, Nicholas R. Morrison, Andrew Simon, Nicholas W. Carrellas, Amy Yule, and Rayce Anselmo

Activity | Published: 7/27/2016 | Keywords: substance use disorders, ADHD, None, None, None, None

Nonmedical use of prescription stimulants among college students is a growing public health problem. How can clinicians reduce stimulant misuse? Read this journal CME article to learn about the problem and what you can do about it.

Saha et al

JCP CME

Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States

Tulshi D. Saha, Bradley T. Kerridge, Risë B. Goldstein, S. Patricia Chou, Haitao Zhang, Jeesun Jung, Roger P. Pickering, W. June Ruan, Sharon M. Smith, Boji Huang, Deborah S. Hasin, and Bridget F. Grant

Activity | Published: 6/22/2016 | Keywords: substance use disorders, None, None, None, None, None

Although opioid analgesics are important components of treatment for chronic pain, prescriptions for opioid analgesics---as well as harms from their use---have skyrocketed during the last decade. Do you systematically screen patients for nonmedical prescription opioid use and educate them about the risks? Read this journal CME article for more information.

Fontanella et al

JCP CME

Benzodiazepine Use and Risk of Mortality Among Patients With Schizophrenia: A Retrospective Longitudinal Study

Cynthia A. Fontanella, John V. Campo, Gary S. Phillips, Danielle L. Hiance-Steelesmith, Helen Anne Sweeney, Kwok Tam, Douglas Lehrer, Robert Klein, and Mark Hurst

Activity | Published: 5/25/2016 | Keywords: schizophrenia, None, None, None, None, None

Do you prescribe benzodiazepines to your patients with schizophrenia? Learn more about the risk-benefit profile of this strategy by reading this journal CME study. The findings on mortality risk may surprise you.

Gotlib et al

JCP CME

Guideline Adherence for Mentally Ill Reproductive-Aged Women on Treatment With Valproic Acid: A Retrospective Chart Review

Dorothy Gotlib, Elizabeth Perelstein, Jacob Kurlander, Kara Zivin, Michelle Riba, and Maria Muzik

Activity | Published: 4/27/2016 | Keywords: bipolar disorder, None, None, None, None, None

Treating reproductive-aged female patients with valproic acid comes with serious teratogenic risks. Read this journal CME article to explore data on safety and clinical strategies.

Mota et al

JCP CME

Late-Life Exacerbation of PTSD Symptoms in US Veterans: Results From the National Health and Resilience in Veterans Study

Natalie Mota, Jack Tsai, Paul D. Kirwin, Ilan Harpaz-Rotem, John H. Krystal, Steven M. Southwick, and Robert H. Pietrzak

Activity | Published: 3/23/2016 | Keywords: PTSD, None, None, None, None, None

Do you see patients who are older military veterans? Did you know that some experience exacerbated posttraumatic stress disorder (PTSD) symptoms, possibly decades after their trauma? Read this journal CME activity to find out about the prevalence and determinants of PTSD exacerbations in older age.

Simon et al

JCP CME

Risk of Suicide Attempt and Suicide Death Following Completion of the Patient Health Questionnaire Depression Module in Community Practice

Gregory E. Simon, Karen J. Coleman, Rebecca C. Rossom, Arne Beck, Malia Oliver, Eric Johnson, Ursula Whiteside, Belinda Operskalski, Robert B. Penfold, Susan M. Shortreed, and Carolyn Rutter

Activity | Published: 2/24/2016 | Keywords: depression, None, None, None, None, None

When your patients complete the Patient Health Questionnaire, they are asked about the frequency of suicidal thoughts. For patients who indicate suicidal ideation, how long does their suicide risk last? How does clinical intervention change the risk? To learn more, read this journal CME study.

Lee et al

JCP CME

Antidepressant Treatment and Risk of Dementia: A Population-Based, Retrospective Case-Control Study

Cynthia Wei-Sheng Lee, Cheng-Li Lin, Fung-Chang Sung, Ji-An Liang, and Chia-Hung Kao

Activity | Published: 1/27/2016 | Keywords: depression, dementia, None, None, None, None

Previous studies have demonstrated that depression may be a risk factor for dementia. Does the risk of dementia change when people take antidepressants? Learn more about research findings in this journal CME study, which compared the histories of antidepressant use in patients with and without dementia.

Baer et al

JCP CME

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

Lee Baer, Madhukar H. Trivedi, Ilana Huz, A. John Rush, Stephen R. Wisniewski, and Maurizio Fava

Activity | Published: 12/23/2015 | Keywords: depression, obsessive-compulsive disorder, None, None, None, None

When you treat patients for major depressive disorder, do you screen them for obsessive-compulsive symptoms? Read this journal CME activity based on STAR*D data to learn more about how obsessions and compulsions affect depression remission and how you can identify them.

Olfson et al

JCP CME

Antipsychotic Treatment of Adults in the United States

Mark Olfson, Marissa King, and Michael Schoenbaum

Activity | Published: 10/21/2015 | Keywords: dementia, depression, None, None, None, None

When you prescribe antipsychotic agents, do you record a diagnosis of mental illness? Do you prescribe them long-term for patients with dementia? Read this journal CME activity to find out about prescription trends.

Wilkinson et al

JCP CME

Marijuana Use Is Associated With Worse Outcomes in Symptom Severity and Violent Behavior in Patients With Posttraumatic Stress Disorder

Samuel T. Wilkinson, Elina Stefanovics, Robert A. Rosenheck

Activity | Published: 9/23/2015 | Keywords: PTSD, None, None, None, None, None

Despite the lack of randomized controlled trials of marijuana in the treatment of PTSD, some US states have legalized this treatment strategy. Review this journal CME article to find out more about potential outcomes of this treatment.

Sullivan et al

JCP CME

Influence of Schizophrenia Diagnosis on Providers’ Practice Decisions

Greer Sullivan, Dinesh Mittal, Christina M. Reaves, Tiffany F. Haynes, Xiaotong Han, Snigdha Mukherjee, Scott Morris, Laura Marsh, and Patrick W. Corrigan

Activity | Published: 8/26/2015 | Keywords: schizophrenia, medical conditions, None, None, None, None

Do clinicians resemble the general public in terms of negatively viewing persons with mental illness? Read this journal CME activity to learn whether a diagnosis of schizophrenia in a case vignette influences providers’ clinical expectations and referral practices. Then, examine whether your own perspectives on the abilities and competence of high-functioning patients with schizophrenia are more negative than warranted.

Hoertel et al

JCP CME

Childhood Maltreatment and Risk of Suicide Attempt: A Nationally Representative Study

Nicolas Hoertel, Silvia Franco, Melanie M. Wall, Maria A. Oquendo, Shuai Wang, Frédéric Limosin, and Carlos Blanco

Activity | Published: 7/15/2015 | Keywords: personality disorders, depression, anxiety, substance use disorders, None, None

Which types of childhood maltreatment are associated with greater risk of suicide attempt in adulthood? Are child abuse or neglect associated with an earlier age at first suicide attempt? Do psychopathology and sociodemographic characteristics affect the association between childhood maltreatment and suicide attempt? Explore answers to these questions in this CME journal article.

Faedda et al

JCP CME

Precursors of Bipolar Disorders: A Systematic Literature Review of Prospective Studies

Gianni L. Faedda, Ciro Marangoni, Giulia Serra, Paola Salvatore, Gabriele Sani, Gustavo H. Vázquez, Leonardo Tondo, Paolo Girardi, Ross J. Baldessarini, and Athanasios Koukopoulos

Activity | Published: 5/21/2015 | Keywords: bipolar disorder, None, None, None, None, None

Do you know which signs and symptoms have been identified as precursors of bipolar disorder? Read this CME journal article to learn about precursors that may arise years before syndromal onset, often with significant morbidity and disability.

Han et al

JCP CME

Prevalence and Correlates of Past 12-Month Suicide Attempt Among Adults With Past-Year Suicidal Ideation in the United States

Beth Han, Wilson M. Compton, Joseph Gfroerer, and Richard McKeon

Activity | Published: 3/15/2015 | Keywords: mental illness, depression, substance use disorders, None, None, None

While not everyone with suicidal ideation progresses to a plan and an attempt, does everyone who attempts suicide first make a plan? Does the absence of a major depressive episode imply the absence of risk for a suicide attempt? How does substance use affect risk? To learn more, read this CME journal article describing results from a Substance Abuse and Mental Health Services Administration survey.

Goldstein et al

JCP CME

Excessive and Premature New-Onset Cardiovascular Disease Among Adults With Bipolar Disorder in the United States NESARC Cohort

Benjamin I. Goldstein, Ayal Schaffer, Shuai Wang, and Carlos Blanco

Activity | Published: 2/15/2015 | Keywords: bipolar depression, depression, medical conditions, None, None, None

Do you integrate cardiovascular health into the assessment, monitoring, and treatment of people with bipolar disorder? Read this CME activity to learn about the risk for new-onset cardiovascular disease among patients with bipolar disorder compared with those with major depression and controls. The findings of this 3-year study, which controlled for age and risk factors such as smoking, obesity, and hypertension, may surprise you.

Frankland et al

JCP CME

Comparing the Phenomenology of Depressive Episodes in Bipolar I and II Disorder and Major Depressive Disorder Within Bipolar Disorder Pedigrees

Andrew Frankland, Ester Cerrillo, Dusan Hadzi-Pavlovic, Gloria Roberts, Adam Wright, Colleen K. Loo, Michael Breakspear, and Philip B. Mitchell

Activity | Published: 1/15/2015 | Keywords: bipolar depression, depression, None, None, None, None

How often do you diagnose patients with major depressive disorder only to later realize they have bipolar disorder? Using a method called the Probabilistic Approach to Bipolar Depression may help you with this challenging differential diagnosis. Read this CME journal article about identifying differences in depressive presentations between bipolar disorder and MDD.

Wisco et al

JCP CME

Posttraumatic Stress Disorder in the US Veteran Population: Results From the National Health and Resilience in Veterans Study

Blair E. Wisco, Brian P. Marx, Erika J. Wolf, Mark W. Miller, Steven M. Southwick, and Robert H. Pietrzak

Activity | Published: 12/15/2014 | Keywords: PTSD, None, None, None, None, None

When you assess veterans' trauma histories, do you include both combat- and noncombat-related traumas? Both types are common in veterans. The prevalence of PTSD in US veterans is slightly higher than that of the general US adult population, and veterans with PTSD have higher rates of other psychiatric disorders and suicidal behaviors than veterans without PTSD. Read this CME journal article to learn what types of interventions may benefit veterans with PTSD.

Smith et al

JCP CME

Depression and Multimorbidity: A Cross-Sectional Study of 1,751,841 Patients in Primary Care

Daniel J. Smith, Helen Court, Gary McLean, Daniel Martin, Julie Langan Martin, Bruce Guthrie, Jane Gunn, and Stewart W. Mercer

Activity | Published: 11/15/2014 | Keywords: depression, medical conditions, None, None, None, None

How do you help your patients receive coordinated medical and psychiatric care? A study of nearly 144,000 people with depression reports that 68% have at least 1 comorbid physical health condition. Read this journal CME article to see why health care systems must be structured to manage multiple conditions concurrently rather than to use a single-disease approach.

Godin et al

JCP CME

Metabolic Syndrome in a French Cohort of Patients With Bipolar Disorder: Results From the FACE-BD Cohort

Ophélia Godin, Bruno Etain, Chantal Henry, Thierry Bougerol, Philippe Courtet, Leroux Mayliss, Christine Passerieux, Jean-Michel Azorin, Jean-Pierre Kahn, Sebastien Gard, Dominique Costagliola, and Marion Leboyer for the FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators

Activity | Published: 10/15/2014 | Keywords: bipolar disorder, medical conditions, None, None, None, None

Nearly 1 in 5 of your patients with bipolar disorder may have metabolic syndrome (MetS), and 16% to 36% may have components of it. Do you regularly assess patients for these abnormalities? Read this journal CME activity to learn about MetS risk factors and the need for integrated psychiatric and primary care for these patients.

Madsen et al

JCP CME

Postdeployment Suicidal Ideations and Trajectories of Posttraumatic Stress Disorder in Danish Soldiers: A 3-Year Follow-Up of the USPER Study

Trine Madsen, Karen-Inge Karstoft, Mette Bertelsen, and Søren Bo Andersen

Activity | Published: 9/15/2014 | Keywords: PTSD, None, None, None, None, None

Could the course of illness of posttraumatic stress disorder (PTSD) affect suicidal ideation among veterans? Read this CME activity from The Journal of Clinical Psychiatry to find out how rates of suicidal ideation differed among veterans with varying trajectories of PTSD over more than 2 and a half years.

Mittal et al

JCP CME

Demographic, Economic, and Clinical Correlates of Depression Treatment Response in an Underserved Primary Care Population

Dinesh Mittal, Lakshminarayana Chekuri, Liya Lu, and John C. Fortney

Activity | Published: 8/15/2014 | Keywords: depression, None, None, None, None, None

Can you predict your patients' depression treatment response using demographic, clinical, and socioeconomic variables? Read this CME activity from The Journal of Clinical Psychiatry to learn the results of a study of response to collaborative care for depression in federally qualified health centers.

Hackman et al

JCP CME

Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment: Detection of High Rates of Opioid Prescribing to a Dual Diagnosis Population

Daniel T. Hackman, Marion S. Greene, Taya J. Fernandes, Ashley M. Brown, Eric R. Wright, and R. Andrew Chambers

Activity | Published: 7/15/2014 | Keywords: substance use disorders, None, None, None, None, None

How can you help to diminish the epidemic of prescription drug abuse, which is disproportionately affecting those with mental illness? In this CME article from The Journal of Clinical Psychiatry, learn why prescription drug monitoring program databases are powerful tools to recognize high frequencies of patient exposure to prescribed opioids and other drugs that are frequently abused.

Clinebell et al

JCP CME

Guidelines for Preventing Common Medical Complications of Catatonia: Case Report and Literature Review

Kimberly Clinebell, Pierre N. Azzam, Priya Gopalan, and Roger Haskett

Activity | Published: 6/15/2014 | Keywords: medical conditions, mental illness, bipolar disorder, schizophrenia, None, None

Catatonia places patients at risk for a wide range of medical complications ranging from mildly painful to potentially fatal. Read this CME case and literature review to learn about preventing and managing deep vein thrombosis and pulmonary embolism, pressure ulcers, muscular contractures, and nutritional deficiencies in inpatients with catatonia.

Gaynes et al

JCP CME

Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis

Bradley N. Gaynes, Stacey W. Lloyd, Linda Lux, Gerald Gartlehner, Richard A. Hansen, Shannon Brode, Daniel E. Jonas, Tammeka Swinson Evans, Meera Viswanathan, and Kathleen N. Lohr

Activity | Published: 5/15/2014 | Keywords: depression, None, None, None, None, None

When your patients' major depressive disorder has not remitted after 2 antidepressant trials of adequate dose and duration, do you consider repetitive transcranial magnetic stimulation (rTMS)? Read this CME activity from The Journal of Clinical Psychiatry for a review of available studies on the use of rTMS in patients with treatment-resistant depression.

Sara et al

JCP CME

The Impact of Cannabis and Stimulant Disorders on Diagnostic Stability in Psychosis

Grant E. Sara, Philip M. Burgess, Gin S. Malhi, Harvey A. Whiteford, and Wayne C. Hall

Activity | Published: 4/15/2014 | Keywords: schizophrenia, substance use disorders, None, None, None, None

Nearly half of initial diagnoses of drug-induced psychosis are later revised to schizophrenia. In this journal CME article, find out how cannabis and stimulants affect diagnostic stability in patients with psychosis.

Simhandl et al

JCP CME

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

Christian Simhandl, Barbara König, and Benedikt L. Amann

Activity | Published: 3/15/2014 | Keywords: bipolar disorder, None, None, None, None, None

Two-thirds of patients with bipolar disorder relapsed during a 4-year, naturalistic follow-up. Explore this and other findings in this CME article.

Kredentser et al

JCP CME

Cause and Rate of Death in People With Schizophrenia Across the Lifespan: A Population-Based Study in Manitoba, Canada

Maia S. Kredentser, Patricia J. Martens, Harvey M. Chochinov, and Heather J. Prior

Activity | Published: 2/15/2014 | Keywords: schizophrenia, medical conditions, None, None, None, None

Do you screen your patients with schizophrenia for suicidal ideation and medical illnesses? Although suicide is a frequent cause of death, lung and other cancers, respiratory illness, and circulatory illness are also more likely to cause death in patients with schizophrenia than in those without. Read this journal CME study to examine changes in mortality risk over the lifespan.

Chi-Shin Wu et al

JCP CME

Long-Term Antidepressant Use and the Risk of Type 2 Diabetes Mellitus: A Population-Based, Nested Case-Control Study in Taiwan

Chi-Shin Wu, Susan Shur-Fen Gau, and Mei-Shu Lai

Activity | Published: 1/15/2014 | Keywords: depression, anxiety, None, None, None, None

Could your patients who use antidepressants long-term have an increased risk of developing diabetes? Does age or type of antidepressant influence risk? Find out in this CME article.

Rosen et al

JCP CME

Do Benzodiazepines Reduce the Effectiveness of Exposure Therapy for Posttraumatic Stress Disorder?

Craig S. Rosen, Mark A. Greenbaum, Paula P. Schnurr, Tyson H. Holmes, Penny L. Brennan, and Matthew J. Friedman

Activity | Published: 12/15/2013 | Keywords: PTSD, anxiety, None, None, None, None

Benzodiazepines are often prescribed to PTSD patients for disturbed sleep or other anxiety disorders. Do they reduce the efficacy of exposure therapy? Find out in this CME article.

Sin and Norman

JCP CME

Psychoeducational Interventions for Family Members of People With Schizophrenia: A Mixed-Method Systematic Review

Jacqueline Sin and Ian Norman

Activity | Published: 12/15/2013 | Keywords: schizophrenia, None, None, None, None, None

When you provide psychoeducation for family members of your patients with schizophrenia, when do you provide it and what format do you use? Read this CME activity in The Journal of Clinical Psychiatry to learn about elements of psychoeducational interventions that have earned participants' satisfaction.

Cohen et al

JCP CME

Posttraumatic Stress Disorder and Cognitive Function: Findings From the Mind Your Heart Study

Beth E. Cohen, MD, MAS (Chair), et al

Activity | Published: 11/15/2013 | Keywords: PTSD, depression, dementia, None, None, None

Read this journal CME study to discover associations between PTSD and cognitive function so that you can help patients minimize modifiable risk factors.

Zimmerman et al

JCP CME

Distinguishing Bipolar II Depression From Major Depressive Disorder With Comorbid Borderline Personality Disorder: Demographic, Clinical, and Family History Differences

Mark Zimmerman, Jennifer H. Martinez, Theresa A. Morgan, Diane Young, Iwona Chelminski, and Kristy Dalrymple

Activity | Published: 9/15/2013 | Keywords: bipolar depression, personality disorders, depression, bipolar disorder, None, None

Distinguishing between bipolar II depression and MDD with comorbid borderline personality disorder is challenging. Learn about differential variables.

Yoon et al

JCP CME

Impact of the Number of Parents With Alcohol Use Disorder on Alcohol Use Disorder in Offspring: A Population-Based Study

Gihyun Yoon, Joseph Westermeyer, Michael A. Kuskowski, and Laura Nesheim

Activity | Published: 8/15/2013 | Keywords: substance use disorders, None, None, None, None, None

New! Learn about the role of parental alcohol use disorder (AUD) as a risk factor for AUD in offspring.

Salvatore, et al

JCP CME

Predicting Diagnostic Change Among First-Episode Patients Diagnosed With DSM-IV Major Depression With Psychotic Features

Paola Salvatore, Ross J. Baldessarini, Hari-Mandir K. Khalsa, Mario Amore, Cristina Di Vittorio, Gabriella Ferraro, Carlo Maggini, and Mauricio Tohen

Activity | Published: 7/15/2013 | Keywords: depression, bipolar depression, bipolar disorder, None, None, None

Discover how to accurately diagnose depression with psychotic features.

Nielsen et al

JCP CME

Termination of Clozapine Treatment Due to Medical Reasons: When Is It Warranted and How Can It Be Avoided?

Jimmi Nielsen, Christoph U. Correll, Peter Manu, and John M. Kane

Activity | Published: 6/15/2013 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Learn how to manage adverse effects and discover when to stop clozapine treatment.

Withers et al

JCP CME

Is Depression With Atypical Features Associated With Trauma History?

Amy C. Withers, Jenna M. Tarasoff, and Jonathan W. Stewart

Activity | Published: 5/15/2013 | Keywords: atypical depression, PTSD, None, None, None, None

In this journal article, learn about the link between atypical depression and trauma history, which may be more complex than prior research has outlined.

Eisen et al

JCP CME

Five-Year Course of Obsessive-Compulsive Disorder: Predictors of Remission and Relapse

Jane L. Eisen, Nicholas J. Sibrava, Christina L. Boisseau, Maria C. Mancebo, Robert L. Stout, Anthony Pinto, and Steven A. Rasmussen

Activity | Published: 3/15/2013 | Keywords: obsessive-compulsive disorder, None, None, None, None, None

What types of primary obsessions are associated with a better or worse course of obsessive-compulsive disorder? Find out in this CME activity from The Journal of Clinical Psychiatry, and learn why early detection and treating to remission are so critical.

Goldberg et al

JCP CME

Clinician-Rated Versus Self-Rated Screening for Bipolar Disorder Among Inpatients With Mood Symptoms and Substance Misuse

Joseph F. Goldberg, Amir Garakani, and Sigurd H. Ackerman

Activity | Published: 12/15/2012 | Keywords: bipolar disorder, substance use disorders, bipolar mania, None, None, None

Clinician-Rated Versus Self-Rated Screening for Bipolar Disorder Among Inpatients With Mood Symptoms and Substance Misuse

Black et al

JCP CME

Marital Status, Childhood Maltreatment, and Family Dysfunction: A Controlled Study of Pathological Gambling

Donald W. Black, Martha C. Shaw, Brett A. McCormick, and Jeff Allen

Activity | Published: 10/15/2012 | Keywords: pathological gambling, None, None, None, None, None

Marital Status, Childhood Maltreatment, and Family Dysfunction: A Controlled Study of Pathological Gambling

Batelaan et al

JCP CME

Panic Attacks as a Dimension of Psychopathology: Evidence for Associations With Onset and Course of Mental Disorders and Level of Functioning

Neeltje M. Batelaan, Didi Rhebergen, Ron de Graaf, Jan Spijker, Aartjan T. F. Beekman, and Brenda W. J. H. Penninx

Activity | Published: 9/15/2012 | Keywords: anxiety, panic disorder, depression, substance use disorders, None, None

Panic Attacks as a Dimension of Psychopathology: Evidence for Associations With Onset and Course of Mental Disorders and Level of Functioning

Orriols et al

JCP CME

Risk of Injurious Road Traffic Crash After Prescription of Antidepressants

Ludivine Orriols, Raphaëlle Queinec, Pierre Philip, Blandine Gadegbeku, Bernard Delorme, Nicholas Moore, Samy Suissa, and Emmanuel Lagarde for the CESIR Research Group

Activity | Published: 8/15/2012 | Keywords: depression, None, None, None, None, None

Risk of Injurious Road Traffic Crash After Prescription of Antidepressants

Biederman et al

JCP CME

Adult Outcome of Attention-Deficit/Hyperactivity Disorder: A Controlled 16-Year Follow-Up Study

Joseph Biederman, Carter R. Petty, K. Yvonne Woodworth, Alexandra Lomedico, Laran L. Hyder, and Stephen V. Faraone

Activity | Published: 7/15/2012 | Keywords: ADHD, None, None, None, None, None

Adult Outcome of Attention-Deficit/Hyperactivity Disorder: A Controlled 16-Year Follow-Up Study

Parikh et al

JCP CME

A Randomized Controlled Trial of Psychoeducation or Cognitive-Behavioral Therapy in Bipolar Disorder: A Canadian Network for Mood and Anxiety Treatments (CANMAT) Study

Sagar V. Parikh, Ari Zaretsky, Serge Beaulieu, Lakshmi N. Yatham, L. Trevor Young, Irene Patelis-Siotis, Glenda M. MacQueen, Anthony Levitt, Tamara Arenovich, Pablo Cervantes, Vytas Velyvis, Sidney H. Kennedy, and David L. Streiner

Activity | Published: 6/15/2012 | Keywords: bipolar disorder, None, None, None, None, None

A Randomized Controlled Trial of Psychoeducation or Cognitive-Behavioral Therapy in Bipolar Disorder: A Canadian Network for Mood and Anxiety Treatments (CANMAT) Study

Ira D. Glick, MD

JCP CME

Managing Psychiatric Issues in Elite Athletes

Ira D. Glick, Mark A. Stillman, Claudia L. Reardon, and Eva C. Ritvo

Activity | Published: 5/15/2012 | Keywords: depression, substance use disorders, eating disorders, mental illness, None, None

Managing Psychiatric Issues in Elite Athletes

Nicholas Myles, MBBS

JCP CME

Tobacco Use Before, At, and After First-Episode Psychosis: A Systematic Meta-Analysis

Nicholas Myles, Hannah D. Newall, Jackie Curtis, Olav Nielssen, David Shiers, and Matthew Large

Activity | Published: 4/15/2012 | Keywords: schizophrenia, substance use disorders, None, None, None, None

Tobacco Use Before, At, and After First-Episode Psychosis: A Systematic Meta-Analysis

Norifusa Sawada, MD

JCP CME

How Successful Are Physicians in Eliciting the Truth From Their Patients? A Large-Scale Internet Survey From Patients’ Perspectives

Norifusa Sawada, Hiroyuki Uchida, Koichiro Watanabe, Toshiaki Kikuchi, Takefumi Suzuki, Haruo Kashima, and Masaru Mimura

Activity | Published: 3/15/2012 | Keywords: depression, None, None, None, None, None

How Successful Are Physicians in Eliciting the Truth From Their Patients? A Large-Scale Internet Survey From Patients’ Perspectives

Sara Germans, MD, PhD

JCP CME

Results of the Search for Personality Disorder Screening Tools: Clinical Implications

Sara Germans, Guus L. Van Heck, and Paul P. G. Hodiamont

Activity | Published: 2/15/2012 | Keywords: personality disorders, None, None, None, None, None

Results of the Search for Personality Disorder Screening Tools: Clinical Implications

Giovanni B. Cassano, MD

JCP CME

The Role of Psychomotor Activation in Discriminating Unipolar From Bipolar Disorders: A Classification-Tree Analysis

Giovanni B. Cassano, Paola Rucci, Antonella Benvenuti, Mario Miniati, Simona Calugi, Luca Maggi, Stephano Pini, David J. Kupfer, Mario Maj, Andrea Fagiolini, and Ellen Frank

Activity | Published: 1/15/2012 | Keywords: bipolar disorder, depression, None, None, None, None

The Role of Psychomotor Activation in Discriminating Unipolar From Bipolar Disorders: A Classification-Tree Analysis

Roberto Nuevo, PhD

JCP CME

Increased Risk of Diabetes Mellitus Among Persons With Psychotic Symptoms: Results From the WHO World Health Survey

Roberto Nuevo, Somnath Chatterji, David Fraguas, Emese Verdes, Nirmala Naidoo, Celso Arango, and José Luis Ayuso-Mateos

Activity | Published: 12/15/2011 | Keywords: medical conditions, schizophrenia, None, None, None, None

Increased Risk of Diabetes Mellitus Among Persons With Psychotic Symptoms: Results From the WHO World Health Survey

Rudolf Uher, PhD

JCP CME

Early and Delayed Onset of Response to Antidepressants in Individual Trajectories of Change During Treatment of Major Depression: A Secondary Analysis of Data From the Genome-Based Therapeutic Drugs for Depression (GENDEP) Study

Rudolf Uher, Ole Mors, Marcella Rietschel, Aleksandra Rajewska-Rager, Ana Petrovic, Astrid Zobel, Neven Henigsberg, Julien Mendlewicz, Katherine J. Aitchison, Anne Farmer, and Peter McGuffin

Activity | Published: 11/15/2011 | Keywords: depression, None, None, None, None, None

Early and Delayed Onset of Response to Antidepressants in Individual Trajectories of Change During Treatment of Major Depression: A Secondary Analysis of Data From the Genome-Based Therapeutic Drugs for Depression (GENDEP) Study

Antonio J. Polo, PhD

JCP CME

The Prevalence and Comorbidity of Social Anxiety Disorder Among United States Latinos: A Retrospective Analysis of Data From 2 National Surveys

Antonio J. Polo, Margarita Alegría, Chih-Nan Chen, and Carlos Blanco

Activity | Published: 8/15/2011 | Keywords: anxiety, social anxiety disorder, None, None, None, None

The Prevalence and Comorbidity of Social Anxiety Disorder Among United States Latinos: A Retrospective Analysis of Data From 2 National Surveys

Isabelle Chaudieu, PhD

JCP CME

Late-Life Health Consequences of Exposure to Trauma in a General Elderly Population: The Mediating Role of Reexperiencing Posttraumatic Symptoms / Efficacy of Antipsychotic Drugs Against Hostility in the European First-Episode Schizophrenia Trial (EUFEST)

Isabelle Chaudieu, Joanna Norton, Karen Ritchie, Philippe Birmes, Guillaume Vaiva, and Marie-Laure Ancelin / Jan Volavka, Pal Czobor, Eske M. Derks, Istvan Bitter, Jan Libiger, René S. Kahn, and W. Wolfgang Fleischhacker for the EUFEST Study Group

Activity | Published: 7/15/2011 | Keywords: medical conditions, PTSD, None, None, None, None

Late-Life Health Consequences of Exposure to Trauma in a General Elderly Population: The Mediating Role of Reexperiencing Posttraumatic Symptoms / Efficacy of Antipsychotic Drugs Against Hostility in the European First-Episode Schizophrenia Trial (EUFEST)

Roland M. Jones, MB, ChB, MSc, MRCPsych

JCP CME

Alcohol Use Disorders in Schizophrenia: A National Cohort Study of 12,653 Patients/The Epidemiology of the Proposed DSM-5 Hoarding Disorder: Exploration of the Acquisition Specifier, Associated Features, and Distress

Roland M. Jones, Paul Lichtenstein, Martin Grann, Niklas Långström, and Seena Fazel / Kiara R. Timpano, Cornelia Exner, Heide Glaesmer, Winfried Rief, Aparna Keshaviah, Elmar Brähler, and Sabine Wilhelm

Activity | Published: 6/15/2011 | Keywords: substance use disorders, schizophrenia, None, None, None, None

Alcohol Use Disorders in Schizophrenia: A National Cohort Study of 12,653 Patients / The Epidemiology of the Proposed DSM-5 Hoarding Disorder: Exploration of the Acquisition Specifier, Associated Features, and Distress

Akinori Nakata, PhD

JCP CME

Work Hours, Sleep Sufficiency, and Prevalence of Depression Among Full-Time Employees: A Community-Based Cross-Sectional Study / Emotion Dysregulation and Negative Affect: Association With Psychiatric Symptoms

Akinori Nakata / Bekh Bradley, Jared A. DeFife, Clifford Guarnaccia, Justine Phifer, Negar Fani, Kerry J. Ressler, and Drew Westen

Activity | Published: 5/15/2011 | Keywords: depression, None, None, None, None, None

Work Hours, Sleep Sufficiency, and Prevalence of Depression Among Full-Time Employees: A Community-Based Cross-Sectional Study / Emotion Dysregulation and Negative Affect: Association With Psychiatric Symptoms

Jiska Cohen-Mansfield, PhD, ABPP

JCP CME

The Impact of Stimuli on Affect in Persons With Dementia / Efficacy of Antidepressants for Dysthymia: A Meta-Analysis of Placebo-Controlled Randomized Trials

Jiska Cohen-Mansfield, Marcia S. Marx, Khin Thein, and Maha Dakheel-Ali / Yeciel Levkovitz, Enrico Tedeschini, and George I. Papakostas

Activity | Published: 4/15/2011 | Keywords: dementia, depression, None, None, None, None

T

JCP CME

Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions / Patient-Level Predictors and Clinical Correlates of Duration of Untreated Psychosis Among Hospitalized First-Episode Patients

Kee-Lee Chou, Corey S. Mackenzie, Kun Liang, and Jitender Sareen / Michael T. Compton, Tynessa L. Gordon, Sandra M. Goulding, Michelle L. Esterberg, Tandrea Carter, Amy S. Leiner, Paul S. Weiss, Benjamin G. Druss, Elaine F. Walker, and Nadine J. Kaslow

Activity | Published: 2/15/2011 | Keywords: anxiety, depression, substance use disorders, schizophrenia, None, None

JCP CME

Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms / The Epidemiology of Chronic Major Depressive Disorder and Dysthymic Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Chittaranjan Andrade, Surya Sandarsh, Kumar B. Chethan, Koregala S. Nagesh / Carlos Blanco, Mayumi Okuda, John C. Markowitz, Shang-Min Liu, Bridget F. Grant, Deborah S. Hasin

Activity | Published: 12/15/2010 | Keywords: depression, substance use disorders, None, None, None, None

JCP CME

Patient Preferences for Obsessive-Compulsive Disorder Treatment / Nocturnal Sleep Disturbances as a Predictor of Suicide Attempts Among Psychiatric Outpatients: A Clinical, Epidemiologic, Prospective Study

Sapana R. Patel and Helen Blair Simpson / Shirley X. Li, Siu P. Lam, Mandy W. M. Yu, Jihui Zhang, and Yun K. Wing

Activity | Published: 11/15/2010 | Keywords: obsessive-compulsive disorder, insomnia, None, None, None, None

JCP CME

Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis / Use of Clinical Markers to Identify Metabolic Syndrome in Antipsychotic-Treated Patients

Alessandro Serretti and Laura Mandelli / Hua Jin, Jonathan Meyer, Sunder Mudaliar, Robert Henry, Srikrishna Khandrika, Danielle K. Glorioso, Helena Kraemer, and Dilip Jeste

Activity | Published: 10/15/2010 | Keywords: medical conditions, None, None, None, None, None

JCP CME

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder / Comorbidity of Generalized Anxiety Disorder and Substance Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Robert M. Post, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Paul E. Keck Jr, Susan L. McElroy, Gabriele S. Leverich, David A. Luckenbaugh, Michael Rowe, Scott Pizzarello, Ralph W. Kupka, Heinz Grunze, and Willem A. Nolen / Analucía A. Alegría, Deborah S. Hasin, Edward V. Nunes, Shang-Min Liu, Carrie Davies, Bridget F. Grant, and Carlos Blanco

Activity | Published: 9/15/2010 | Keywords: bipolar disorder, generalized anxiety disorder, substance use disorders, None, None, None

JCP CME

Prediction of Recurrence in Recurrent Depression: A 5.5-Year Prospective Study / A 2-Year Prospective Follow-Up Study of the Course of Obsessive-Compulsive Disorder

Mascha C. ten Doesschate, Claudi L. H. Bockting, Maarten W. J. Koeter, and Aart H. Schene for the DELTA Study Group / Jane L. Eisen, Anthony Pinto, Maria C. Mancebo, Ingrid R. Dyck, Maria E. Orlando, and Steven A. Rasmussen

Activity | Published: 8/15/2010 | Keywords: depression, obsessive-compulsive disorder, None, None, None, None

JCP CME

Early-Onset Bipolar Disorder and Treatment Delay Are Risk Factors for Poor Outcome in Adulthood / Increased Risk for Suicidal Behavior in Comorbid Bipolar Disorder and Alcohol Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Robert M. Post, Gabriele S. Leverich, Ralph W. Kupka, Paul E. Keck Jr, Susan L. McElroy, Lori L. Altshuler, Mark A. Frye, David A. Luckenbaugh, Michael Rowe, Heinz Grunze, Trisha Suppes, and Willem A. Nolen / Maria A. Oquendo, Dianne Currier, Shang-Min Liu, Deborah S. Hasin, Bridget F. Grant, and Carlos Blanco

Activity | Published: 7/15/2010 | Keywords: bipolar disorder, substance use disorders, None, None, None, None

JCP CME

Strategies in Treatment of Suicidality: Identification of Common and Treatment-Specific Interventions in Empirically Supported Treatment Manual / The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission

Igor Weinberg, Elsa Ronningstam, Mark J. Goldblatt, Mark Schechter, Joan Wheelis, and John T. Maltsberger / Lisa P. Henry, G. Paul Amminger, Meredith G. Harris, Hok Pan Yuen, Susy M. Harrigan, Amy L. Prosser, Orli S. Schwartz, Simone E. Farrelly, Helen Herrman, Henry J. Jackson, and Patrick D. McGorry

Activity | Published: 6/15/2010 | Keywords: depression, schizophrenia, None, None, None, None

JCP CME

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial / A Randomized Trial of Cognitive-Behavioral Therapy or Selective Serotonin Reuptake Inhibitor or Both Combined for Panic Disorder With or Without Agoraphobia: Treatment Results Through 1-Year Follow-Up

Wijnand Laan, Diederick E. Grobbee, Jean-Paul Selten, Cobi J. Heijnen, René S. Kahn, and Huibert Burger / Franske J. van Apeldoorn, Marieke E. Timmerman, Peter Paul A. Mersch, Wiljo J. P. J. van Hout, Sako Visser, Richard van Dyck, and Johan A. den Boer

Activity | Published: 5/15/2010 | Keywords: schizophrenia, None, panic disorder, None, None, None

JCP CME

Antidepressant Discontinuation in Bipolar Depression: A Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Randomized Clinical Trial of Long-Term Effectiveness and Safety / Underrecognition of Clinically Significant Side Effects in Depressed Outpatients

S. Nassir Ghaemi, Michael M. Ostacher, Rif S. El-Mallakh, David Borrelli, Claudia F. Baldassano, Mary E. Kelley, Megan M. Filkowski, John Hennen, Gary Sachs, Frederick K. Goodwin, and Ross J. Baldessarini / Mark Zimmerman, Janine N. Galione, Naureen Attiullah, Michael Friedman, Cristina Toba, Daniela A. Boerescu, and Moataz Ragheb

Activity | Published: 4/15/2010 | Keywords: bipolar depression, depression, None, None, None, None

JCP CME

Treatment of Cannabis Use Among People With Psychotic or Depressive Disorders: A Systematic Review / Sharing and Selling of Prescription Medications in a College Student Sample

Amanda L. Baker, Leanne Hides, and Dan I. Lubman / Laura M. Garnier, Amelia M. Arria, Kimberly M. Caldeira, Kathryn B. Vincent, Kevin E. O'Grady, and Eric D. Wish

Activity | Published: 3/15/2010 | Keywords: substance use disorders, None, None, None, None, None

JCP CME

A Randomized Controlled Trial Comparing the Memory Effects of Continuation Electroconvulsive Therapy Versus Continuation Pharmacotherapy: Results From the Consortium for Research in ECT (CORE) Study / Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report

Glenn E. Smith, Keith G. Rasmussen Jr, C. Munro Cullum, M. Donna Felmlee-Devine, Georgios Petrides, Teresa A. Rummans, Mustafa M. Husain, Martina Mueller, Hilary J. Bernstein, Rebecca G. Knapp, M. Kevin O'Connor, Max Fink, Shirlene Sampson, Samuel H. Bailine, and Charles H. Kellner, for the CORE Investigators / Roy H. Perlis, Michael J. Ostacher, David J. Miklowitz, Jordan W. Smoller, Ellen B. Dennehy, Colleen Cowperthwait, Andrew A. Nierenberg, Michael E. Thase, and Gary S. Sachs

Activity | Published: 2/15/2010 | Keywords: bipolar disorder, depression, None, None, None, None

JCP CME

The Prevalence of Personality Disorders in Hypochondriasis / Bipolar Symptoms in Adult Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study of 510 Clinically Diagnosed Patients and 417 Population-Based Controls

Reiko Sakai, Yvonne Nestoriuc, Nyryan V. Nolido, and Arthur J. Barsky / Anne Halmøy, Helene Halleland, Margaretha Dramsdahl, Per Bergsholm, Ole Bernt Fasmer, and Jan Haavik

Activity | Published: 1/15/2010 | Keywords: personality disorders, ADHD, bipolar disorder, None, None, None

JCP CME

Long-Term Effects of Preventive Cognitive Therapy in Recurrent Depression: A 5.5-Year Follow-Up Study / Current Prescription Patterns and Safety Profile of Irreversible Monoamine Oxidase Inhibitors: A Population-Based Cohort Study of Older Adults

Claudi L. H. Bockting, Philip Spinhoven, Luuk F. Wouters, Maarten W. J. Koeter, Aart H. Schene, for the DELTA Study Group / Kenneth I. Shulman, Hadas D. Fischer, Nathan Herrmann, Cindy Yan Huo, Geoffrey M. Anderson, and Paula A. Rochon

Activity | Published: 12/15/2009 | Keywords: depression, atypical depression, bipolar depression, None, None, None

JCP CME

Exploratory Data Mining Analysis Identifying Subgroups of Patients With Depression Who Are at High Risk for Suicide / Presenting ADHD Symptoms, Subtypes, and Comorbid Disorders in Clinically Referred Adults With ADHD

Mark A. Ilgen, Karen Downing, Kara Zivin, Katherine J. Hoggatt, H. Myra Kim, Dara Ganoczy, Karen L. Austin, John F. McCarthy, Jignesh M. Patel, and Marcia Valenstein / Timothy E. Wilens, Joseph Biederman, Stephen V. Faraone, MaryKate Martelon, Diana Westerberg, and Thomas J. Spencer

Activity | Published: 11/15/2009 | Keywords: None, None, None, None, None, None

JCP CME

All-Cause Mortality Associated With Atypical and Conventional Antipsychotics Among Nursing Home Residents With Dementia: A Retrospective Cohort Study / Prevalence and Burden of General Medical Conditions Among Adults With Bipolar I Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Rosa Liperoti, Graziano Onder, Francesco Landi, Kate L. Lapane, Vincent Mor, Roberto Bernabei, and Giovanni Gambassi / Brian E. Perron, Matthew O. Howard, Jenna K. Nienhuis, Mark S. Bauer, Amanda Toler Woodward, and Amy M. Kilbourne

Activity | Published: 10/15/2009 | Keywords: Alzheimer's, bipolar disorder, None, None, None, None

JCP CME

Relations Among Psychopathology, Substance Use, and Physical Pain Experiences in Methadone-Maintained Patients / Three-Year Follow-Up of Syndromal Antisocial Behavior in Adults: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions

Declan T. Barry, Mark Beitel, Brian Garnet, Dipa Joshi, Andrew Rosenblum, and Richard S. Schottenfeld / Risë B. Goldstein and Bridget F. Grant

Activity | Published: 9/15/2009 | Keywords: substance use disorders, None, personality disorders, None, None, None

JCP CME

Sleep in Depression and Anxiety Disorders: A Population-Based Study of Elderly Persons

Julia F. van den Berg, Hendrika J. Luijendijk, Joke H. M. Tulen, Albert Hofman, Arie Knuistingh Neven, and Henning Tiemeier

Activity | Published: 8/15/2009 | Keywords: sleep disorders, anxiety, depression, None, None, None

JCP CME

The Importance of Childhood Trauma and Childhood Life Events for Chronicity of Depression in Adults

Jenneke E. Wiersma, Jacqueline G. F. M. Hovens, Patricia van Oppen, Erik J. Giltay, Digna J. F. van Schaik, Aartjan T. F. Beekman, and Brenda W. J. H. Penninx

Activity | Published: 7/15/2009 | Keywords: depression, None, None, None, None, None

George S. Alexopoulos, MD (Chair)

JCP CME

A Roadmap to Key Pharmacologic Principles in Using Antipsychotics in the Treatment of Older Patients

George S. Alexopoulos, MD (Chair), et al

Activity | Published: 1/15/2009 | Keywords: None, None, None, None, None, None

NEW! Review treatment principles for elderly patients gleaned from trial data, practice guidelines, and expert opinion in this Academic Highlights.

Karen D. Wagner, MD, PhD (Chair)

JCP CME

Are Psychological and Pharmacologic Interventions Equally Effective in the Treatment of Adult Depressive Disorders? A Meta-Analysis of Comparative Studies / Overdiagnosis of Bipolar Disorder Among Substance Use Disorder Inpatients With Mood Instability / Academic Highlights: An Update on Depression in Children and Adolescents

Pim Cuijpers, Annemieke van Straten, Patricia van Oppen, and Gerhard Andersson / Joseph F. Goldberg, Jessica L. Garno, Ann M. Callahan, Denise L. Kearns, Barry Kerner, and Sigurd H. Ackerman / Karen D. Wagner, MD, PhD (Chair), et al.

Activity | Published: 11/15/2008 | Keywords: None, None, None, None, None, None

Read this Academic Highlights to update your understanding of the risk factors and epidemiology of pediatric depression and suicide and learn how to better diagnose and treat your young patients.

Eric Hollander, MD (Chair)

JCP CME

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression / Obsessive-Compulsive Disorder: Strategies for Optimal Treatment

Siegfried Kasper, MD (Chair), et al / Eric Hollander, MD (Chair), et al

Activity | Published: 10/15/2008 | Keywords: None, None, None, None, None, None

Update your understanding of the etiology and neurobiology of OCD, and discover psychosocial and pharmacologic treatment strategies to improve your patients' quality of life.

Michael R. Liebowitz, MD (Chair)

JCP CME

Parasomnia Among Psychiatric Outpatients: A Clinical, Epidemiologic, Cross-Sectional Study / Academic Highlights: Easing the Burden of Social Anxiety Disorder

Siu P. Lam, Samson Y. Y. Fong, Crover K. W. Ho, Mandy W. M. Yu, and Yun K. Wing / Michael R. Liebowitz, MD (Chair), et al.

Activity | Published: 9/15/2008 | Keywords: social anxiety disorder, anxiety, sleep disorders, None, None, None

Read this Academic Highlights to understand the presentation and comorbidities of SAD and discover appropriate treatment modalities for your patients with this common condition.

JCP CME

Trauma and Posttraumatic Stress Disorder in the Elderly: Findings From a German Community Study / Long-Term Stability of Cognitive Impairment in Bipolar Disorder: A 2-Year Follow-Up Study of Lithium-Treated Euthymic Bipolar Patients

Carsten Spitzer, Sven Barnow, Henry Völzke, Ulrich John, Harald J. Freyberger, and Hans Joergen Grabe / Maria Mur, Maria J. Portella, Anabel Martínez-Arán, Josep Pifarré, and Eduard Vieta

Activity | Published: 5/15/2008 | Keywords: PTSD, anxiety, bipolar disorder, None, None, None

JCP CME

Use of Cocaine by Heavy Drinkers Increases Vulnerability to Developing Alcohol Dependence: A 4-Year Follow-Up Study / Familial Transmission of Suicidal Behavior: Factors Mediating the Relationship Between Childhood Abuse and Offspring Suicide Attempts

Gabriel Rubio, Jorge Manzanares, Mónica Jiménez, Roberto Rodríguez-Jiménez, Isabel Martínez, Miguel M. Iribarren, Miguel A. Jiménez-Arriero, Guillermo Ponce, and Tomás Palomo / Beth S. Brodsky, J. John Mann, Barbara Stanley, Adrienne Tin, Maria Oquendo, Boris Birmaher, Laurence Greenhill, David Kolko, Jamie Zelazny, Ainsley Keller Burke, Nadine M. Melhem, and David Brent

Activity | Published: 4/15/2008 | Keywords: substance use disorders, None, None, None, None, None

JCP CME

Metabolic Syndrome Predisposes to Depressive Symptoms: A Population-Based 7-Year Follow-Up Study / Gender Differences in 2 Clinical Trials of Adults With Attention-Deficit

Hannu Koponen, Jari Jokelainen, Sirkka Keinänen-Kiukaanniemi, Esko Kumpusalo, Mauno Vanhala / Reid J. Robison, Frederick W. Reimherr, Barrie K. Marchant, Stephen V. Faraone, Lenard A. Adler, Scott A. West

Activity | Published: 2/15/2008 | Keywords: ADHD, None, None, None, None, None

Charles L. Bowden, MD (Chair)

JCP CME

Long-Term Maintenance Therapy for Major Depressive Disorder With rTMS/Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates/Focus on Bipolar Disorder Treatment

John P. O’Reardon, Kate H. Blumner, Andrew D. Peshek, Rocio Romero Pradilla, and Pilar Cristancho Pimiento/Francesco Benedetti, Barbara Barbini, Mara Cigala Fulgosi, Cristina Colombo, Sara Dallaspezia, Adriana Pontiggia, and Enrico Smeraldi/Charles L. Bowden, MD (Chair) et al.

Activity | Published: 12/15/2005 | Keywords: depression, bipolar disorder, bipolar depression, None, None, None

Due to the frequency and severity of bipolar depression and acute mania, effective pharmacologic and psychosocial management for both presentations is critical. Learn about these management strategies and more in this Academic Highlights.

Martin B. Keller, MD (Chair)

JCP CME

Sequential Treatment of Mood and Anxiety Disorders / Variables Associated With Alcohol, Drug, and Daily Smoking Cessation / Untangling Depression and Anxiety: Clinical Challenges

Giovanni A. Fava, Chiara Ruini, and Chiara Rafanelli/Norifumi Tsuno, Alain Besset, and Karen Ritchie/Martin B. Keller, MD (Chair) et al.

Activity | Published: 11/15/2005 | Keywords: depression, anxiety, substance use disorders, None, None, None

In this section of the Journal, you can update your understanding of the neurobiology of depression and anxiety and learn about the presentation, diagnosis, and treatment of these disorders to optimize your patients’ outcomes.

JCP CME

Prevalence and Features of Intermittent Explosive Disorder in a Clinical Setting/Sleep and Depression

Emil F. Coccaro, Michael A. Posternak, and Mark Zimmerman/Norifumi Tsuno, Alain Besset, and Karen Ritchie

Activity | Published: 10/15/2005 | Keywords: intermittent explosive disorder, depression, sleep disorders, None, None, None

JCP CME

Complicated Grief and Its Correlates in Patients With Bipolar Disorder/Differences Between Minimally Depressed Patients Who Do and Do Not Consider Themselves to Be in Remission

Naomi M. Simon, Mark H. Pollack, Diana Fischmann, Carol A. Perlman, Anna C. Muriel, Cynthia W. Moore, Andrew A. Nierenberg, and M. Katherine Shear/Mark Zimmerman, Joseph B. McGlinchey, Michael A. Posternak, Michael Friedman, Daniela Boerescu, and Naureen Attiullah

Activity | Published: 9/15/2005 | Keywords: bipolar disorder, depression, None, None, None, None

JCP CME

Clinical and Demographic Features of Atypical Depression in Outpatients With Major Depressive Disorder: Preliminary Findings From STAR*D/Posttraumatic Stress Disorder Among Israeli Ex-Prisoners of War 18 and 30 Years After Release

Jon S. Novick, Jonathan W. Stewart, Stephen R. Wisniewski, Ian A. Cook, Radmila Manev, Andrew A. Nierenberg, Jerrold F. Rosenbaum, Kathy Shores-Wilson, G. K. Balasubramani, Melanie M. Biggs, Sid Zisook, and A. John Rush, for the STAR*D Investigators/Zahava Solomon and Rachel Dekel

Activity | Published: 8/15/2005 | Keywords: depression, atypical depression, PTSD, anxiety, None, None

JCP CME

The Clinical Domains of Psychosomatic Medicine/Severe Obsessive-Compulsive Disorder With and Without Comorbid Hair Pulling: Comparison and Clinical Implications

Giovanni A. Fava and Nicoletta Sonino/S. Evelyn Stewart, Michael A. Jenike, and Nancy J. Keuthen

Activity | Published: 7/15/2005 | Keywords: obsessive-compulsive disorder, None, None, None, None, None

JCP CME

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?/Prevalence and Predictors of Parenting Outcomes in a Cohort of Mothers With Schizophrenia Admitted for Joint Mother and Baby Psychiatric Care in England

Roger D. Weiss, Michael J. Ostacher, Michael W. Otto, Joseph R. Calabrese, Mark Fossey, Stephen R. Wisniewski, Charles L. Bowden, Andrew A. Nierenberg, Mark H. Pollack, Ihsan M. Salloum, Naomi M. Simon, Michael E. Thase, and Gary S. Sachs, for STEP-BD Investigators/Kathryn M. Abel, Roger T. Webb, Margaret P. Salmon, Ming W. Wan, and Louis Appleby

Activity | Published: 6/15/2005 | Keywords: substance use disorders, bipolar disorder, schizophrenia, None, None, None

JCP CME

Comorbidity of DSM-IV Pathological Gambling and Other Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions/Risk Factors for Completed Suicide in Schizophrenia

Nancy M. Petry, Frederick S. Stinson, and Bridget F. Grant/Chian-Jue Kuo, Shang-Ying Tsai, Chun-Hsuan Lo, Ying-Ping Wang, and Chiao-Chicy Chen

Activity | Published: 5/15/2005 | Keywords: pathological gambling, substance use disorders, schizophrenia, None, None, None

JCP CME

Female Reproductive Cycle and Obsessive-Compulsive Disorder/Pregnancy Outcome of Women Using Atypical Antipsychotic Drugs: A Prospective Comparative Study

Javier Labad, José Manuel Menchón, Pino Alonso, Cinto Segalàs, Susana Jiménez, and Julio Vallejo/Kate McKenna, Gideon Koren, Maria Tetelbaum, Lynda Wilton, Saad Shakir, Orna Diav-Citrin, Andrea Levinson, Robert B. Zipursky, and Adrienne Einarson

Activity | Published: 4/15/2005 | Keywords: obsessive-compulsive disorder, schizophrenia, bipolar disorder, None, None, None

JCP CME

Substance Use Disorders in Individuals With Body Dysmorphic Disorder/Bipolar Disorder With Comorbid Cluster B Personality Disorder Features: Impact on Suicidality

Jon E. Grant, William Menard, Maria E. Pagano, Christina Fay, and Katharine A. Phillips/Jessica L. Garno, Joseph F. Goldberg, Paul Michael Ramirez, and Barry A. Ritzler

Activity | Published: 3/15/2005 | Keywords: substance use disorders, bipolar disorder, body dysmorphic disorder, personality disorders, None, None

JCP CME

Prevalence and Clinical Correlates of Irritability in Major Depressive Disorder: A Preliminary Report From the Sequenced Treatment Alternatives to Relieve Depression Study/Medical Morbidity and Mortality in Schizophrenia Guidelines for Psychiatrists

Roy H. Perlis, Renerio Fraguas, Maurizio Fava, Madhukar H. Trivedi, James F. Luther, Stephen R. Wisniewski, and John A. Rush/Donald C. Goff, Corinne Cather, A. Eden Evins, David C. Henderson, Oliver Freudenreich, Paul M. Copeland, Michael Bierer, Kenneth Duckworth, and Frank M. Sacks

Activity | Published: 2/15/2005 | Keywords: depression, schizophrenia, medical conditions, None, None, None

JCP CME

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

John M. Kane, Anissa Abi-Dargham, Stephen R. Marder, Peter J. Weiden, and Henry A. Nasrallah

Activity | Published: 1/15/2005 | Keywords: schizophrenia, None, None, None, None, None

JCP CME

Effects of Psychiatric Disorders and Psychotropic Medications on Prolactin and Bone Metabolism/Clinical Characteristics of Depressive Symptoms in Children and Adolescents With Major Depressive Disorder

Madhusmita Misra, George I. Papakostas, and Anne Klibanski/Ozgur Yorbik, Boris Birmaher, David Axelson, Douglas E. Williamson, and Neal D. Ryan

Activity | Published: 12/15/2004 | Keywords: depression, medical conditions, None, None, None, None

JCP CME

Impact of Depressive Symptoms Compared With Manic Symptoms in Bipolar Disorder: Results of a U.S. Community-Based Sample/Academic Highlights: Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion

Joseph R. Calabrese, Robert M. A. Hirschfeld, Mark A. Frye, and Michael L. Reed/Jerrold F. Rosenbaum, Charles P. O'Brien, Michael W. Otto, Mark H. Pollack, Peter P. Roy-Byrne, and Samantha A. Stewart

Activity | Published: 11/15/2004 | Keywords: schizophrenia, bipolar disorder, anxiety, None, None, None

JCP CME

Risk Factors for Premenstrual Dysphoric Disorder in a Community Sample of Young Women: The Role of Traumatic Events and Posttraumatic Stress Disorder/On the Threshold of Disorder: A Study of the Impact of the DSM-IV Clinical Significance Criterion on Diagnosing Depressive and Anxiety Disorders in Clinical Pracitice

Axel Perkonigg, Kimberly A. Yonkers, Hildegard Pfister, Roselind Lieb, and Hans-Ulrich Wittchen/Mark Zimmerman, Iwona Chelminski, and Diane Young

Activity | Published: 10/15/2004 | Keywords: premenstrual dysphoric disorder, PTSD, anxiety, depression, None, None

JCP CME

Breastfeeding During Maternal Antidepressant Treatment With Serotonin Reuptake Inhibitors: Infant Exposure, Clinical Symptoms, and Cytochrome P450 Genotypes/Academic Highlights: Enhancing Treatment Response in Depression

Jan Oystein Berle, Vidar M. Steen, Trond Oskar Aamo, Harald Breilid, Kolbjørn Zahlsen, and Olav Spigset/Philip T. Ninan, Maurizio Fava, and Kerry J. Ressler

Activity | Published: 9/15/2004 | Keywords: depression, None, None, None, None, None

JCP CME

Major Depressive Disorder and Borderline Personality Disorder Revisited: Longitudinal Interactions/Impact of Comorbid Anxiety Disorders on Outcome in a Cohort of Patients With Bipolar Disorder

John G. Gunderson, Leslie C. Morey, Robert L. Stout, Andrew E. Skodol, M. Tracie Shea, Thomas H. McGlashan, Mary C. Zanarini, Carlos M. Grilo, Charles A. Sanislow, Shirley Yen, Maria T. Daversa, and Donna S. Bender/Khrista R. Boylan, Peter J. Bieling, Michael Marriott, Helen Begin, L. Trevor Young, and Glenda M. MacQueen

Activity | Published: 8/15/2004 | Keywords: depression, personality disorders, anxiety, bipolar disorder, None, None

JCP CME

Prevalence, Correlates, and Disability of Personality Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions/Alcohol Use Disorder Comorbidity in Eating Disorders: A Multicenter Study/Academic Highlights: Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders

Bridget F. Grant, Deborah S. Hasin, Frederick S. Stinson, Deborah A. Dawson, S. Patricia Chou, W. June Ruan, and Roger P. Pickering/Cynthia M. Bulik, Kelly L. Klump, Laura Thornton, Allan S. Kaplan, Bernie Devlin, Manfred M. Fichter, Katherine A. Halmi, Michael Strober, D. Blake Woodside, Scott Crow, James E. Mitchell, Alessandro Rotondo, Mauro Mauri, Giovanni B. Cassano, Pamela K. Keel, Wade H. Berrettini, and Walter H. Kaye/Thomas Roth, Karl Doghramji, Paul Doghramji, Jonathan R. L. Schwartz, and James K. Walsh

Activity | Published: 7/15/2004 | Keywords: personality disorders, substance use disorders, sleep disorders, None, None, None

JCP CME

Lifetime and 1-Month Prevalence Rates of Intermittent Explosive Disorder in a Community Sample/Academic Highlights: Depression and Physical Symptoms: The Mind-Body Connection

Emil F. Coccaro, Catherine A. Schmidt, Jack F. Samuels, and Gerald Nestadt/Alan F. Schatzberg, Bruce A. Arnow, Vivien K. Burt, Pedro L. Delgado, Ruta M. Nonacs, and Maurice M. Ohayon

Activity | Published: 6/15/2004 | Keywords: intermittent explosive disorder, depression, medical conditions, None, None, None

JCP CME

What Characteristics of Primary Anxiety Disorders Predict Subsequent Major Depressive Disorder?/Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional

Antje Bittner, Renee D. Goodwin, Hans-Ulrich Wittchen, Katja Beesdo, Michael Höfler, and Roselind Lieb/Susan L. McElroy, Renu Kotwal, Shishuka Malhotra, Erik B. Nelson, Paul E. Keck, Jr., and Charles B. Nemeroff

Activity | Published: 5/15/2004 | Keywords: anxiety, depression, None, None, None, None

JCP CME

Speed of Response and Remission in Major Depressive Disorder With Acute Electroconvulsive Therapy (ECT): A Consortium for Research in ECT (CORE) Report/Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia

Mustafa M. Husain, A. John Rush, Max Fink, Rebecca Knapp, Georgios Petrides, Teresa Rummans, Melanie M. Biggs, Kevin O'Connor, Keith Rasmussen, Marc Litle, Wenle Zhao, Hilary J. Bernstein, Glenn Smith, Martina Mueller, Shawn M. McClintock, Samuel H. Bailine, and Charles H. Kellner/Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Jeffrey A. Lieberman, Leslie Citrome, Brian Sheitman, Joseph P. McEvoy, Thomas B. Cooper, and Miranda Chakos

Activity | Published: 4/15/2004 | Keywords: depression, schizophrenia, None, None, None, None

JCP CME

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction/Psychopathology of Seasonal Affective Disorder Patients in Comparison With Major Depression Patients Who Have Attempted Suicide

A. Eden Evins, Corinne Cather, Nancy A. Rigotti, Oliver Freudenreich, David C. Henderson, Casey M. Olm-Shipman, and Donald C. Goff/Baba P. G. Pendse, Gunnar Engström, and Lil Träskman-Bendz

Activity | Published: 3/15/2004 | Keywords: schizophrenia, seasonal affective disorder, depression, None, None, None

JCP CME

Depressive Disorders Are Related to Nicotine Dependence in the Population But Do Not Necessarily Hamper Smoking Cessation/Academic Highlights: Emerging Therapeutic Strategies in Alzheimer’s Disease

Ulrich John, Christian Meyer, Hans-Jürgen Rumpf, and Ulfert Hapke/George T. Grossberg, Jody Corey-Bloom, Gary W. Small, and Pierre N. Tariot

Activity | Published: 2/15/2004 | Keywords: depression, substance use disorders, Alzheimer's, None, None, None

JCP CME

Impact of Age at Onset and Duration of Illness on the Expression of Comorbidities in Obsessive-Compulsive Disorder/Academic Highlights: Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics

Juliana B. Diniz, Maria C. Rosario-Campos, Roseli G. Shavitt, Mariana Curi, Ana G. Hounie, Sergio A. Brotto, and Euripedes C. Miguel/John M. Kane, Robert R. Conley, Samuel J. Keith, Henry A. Nasrallah, and Martin Turner

Activity | Published: 1/15/2004 | Keywords: obsessive-compulsive disorder, schizophrenia, None, None, None, None

JCP CME

Improving Adherence to Antidepressants: A Systematic Review of Interventions/Bipolar Disorder, Obesity, and Pharmacotherapy-Associated Weight Gain

Anton C. M. Vergouwen, Abraham Bakker, Wayne J. Katon, Theo J. Verheij, and Frank Koerselman/Paul E. Keck, Jr., and Susan L. McElroy

Activity | Published: 12/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and Without Obsessive-Compulsive Disorder: Schizophrenic and OC Symptoms in Schizophrenia/Partial Compliance and Patient Consequences in Schizophrenia: Our Patients Can Do Better

Michael Poyurovsky, Victoria Kriss, Gregory Weisman, Sarit Faragian, Rena Kurs, Michael Schneidman, Camil Fuchs, Abraham Weizman, and Ronit Weizman/Samuel J. Keith and John M. Kane

Activity | Published: 11/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Feeling Unreal: A Depersonalization Disorder Update of 117 Cases/Aerobic Endurance Exercise Improves Executive Functions in Depressed Patients/Academic Highlights: Reducing the Risk for Suicide in Schizophrenia and Affective Disorders

Daphne Simeon, Margaret Knutelska, Dorothy Nelson, and Orna Guralnik/Sabine Kubesch, Volker Bretschneider, Roland Freudenmann, Niels Weidenhammer, Manfred Lehmann, Manfred Spitzer, and Georg Gron/Herbert Y. Meltzer and Ross J. Baldessarini

Activity | Published: 9/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Pharmacotherapy of Paraphilias With Long-Acting Agonists of Luteinizing Hormone–Releasing Hormone: A Systematic Review

Peer Briken, Andreas Hill, and Wolfgang Berner

Activity | Published: 8/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Do Antidepressants Induce Rapid Cycling? A Gender-Specific Association/Mental Disorder and Serious Violence: The Victims

Aysegul Yildiz and Gary S. Sachs/Ingrid Johnston and Pamela J. Taylor

Activity | Published: 7/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Conventional Antipsychotic Prescription in Unipolar Depression, II: Withdrawing Conventional Antipsychotics in Unipolar, Nonpsychotic Patients/Morbidity in 258 Bipolar Outpatients Followed for 1 Year With Daily Prospective Ratings on the NIMH Life Chart Method

Ann M. Mortimer, Maria Martin, Jason A. Wheeler Vega, and Philip J. Tyson/Robert M. Post, Kirk D. Denicoff, Gabriele S. Leverich, Lori L. Altshuler, Mark A. Frye, Trisha M. Suppes, A. John Rush, Paul E. Keck, Jr., Susan L. McElroy, David A. Luckenbaugh, Chad Pollio, Ralph Kupka, and Willem A. Nolen

Activity | Published: 6/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Factors Associated With Suicide Attempts in 648 Patients With Bipolar Disorder in the Stanley Foundation Bipolar Network/Residual Symptoms in Depression: Can Treatment Be Symptom-Specific?

Gabriele S. Leverich, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Paul E. Keck, Jr., Susan L. McElroy, Kirk D. Denicoff, Gabriela Obrocea, Willem A. Nolen, Ralph Kupka, Jorg Walden, Heinz Grunze, Sara Perez, David A. Luckenbaugh, and Robert M. Post/Matthew Menza, Humberto Marin, and Rachel Sokol Opper

Activity | Published: 5/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

How Long Should Patients With Psychotic Depression Stay on the Antipsychotic Medication?/Remission, Residual Symptoms, and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice

Anthony J. Rothschild and Suzanne E. Duval/Brian J. Cuffel, Francisca Azocar, Molly Tomlin, Shelly F. Greenfield, Alisa B. Busch, and Thomas W. Croghan

Activity | Published: 4/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Evaluation of Sexual Changes After Stroke/Anxiety Disorders in 318 Bipolar Patients: Prevalence and Impact on Illness Severity and Response to Mood Stabilizer/Academic Highlights: Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder

Salvatore Giaquinto, Sandro Buzzelli, Luciano Di Francesco, and Giuseppe Nolfe/Chantal Henry, Donatienne Van den Bulke, Frank Bellivier, Bruno Etain, Frederic Rouillon, and Marion Leboyer/Joseph Biederman, Christopher J. Kratochvil, Thomas J. Spencer, and Janet Wozniak

Activity | Published: 3/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression?/Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem?

Giovanni A. Fava/Gen Kanayama, Geoffrey H. Cohane, Roger D. Weiss, and Harrison G. Pope, Jr.

Activity | Published: 2/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Antidepressants and Driver Impairment: Empirical Evidence From a Standard On-the-Road Test/Randomized Controlled Trial of Different Models of Care for Nursing Home Residents With Dementia Complicated by Depression or Psychosis

Johannes G. Ramaekers/Henry Brodaty, Brian M. Draper, Joanne Millar, Lee-Fay Low, David Lie, Simone Sharah, and Helen Paton

Activity | Published: 1/15/2003 | Keywords: None, None, None, None, None, None

JCP CME

Predictors of Noncompliance in Patients With Schizophrenia/Obsessive-Compulsive-Bipolar Comorbidity: A Systematic Exploration of Clinical Features and Treatment Outcome

Diana O. Perkins/Giulio Perugi, Cristina Toni, Franco Frare, Maria Chiara Travierso, Elie Hantouche, and Hagop S. Akiskal

Activity | Published: 12/15/2002 | Keywords: None, None, None, None, None, None

+PCC CME Activities [Series Home Page]

Penders et al

PCC CME

Bright Light Therapy as Augmentation of Pharmacotherapy for Treatment of Depression: A Systematic Review and Meta-Analysis

Thomas M. Penders, Cornel N. Stanciu, Alexander M. Schoemann, Phillip T. Ninan, Richard Bloch, and Sy A. Saeed

Activity | Published: 10/20/2016 | Keywords: depression, None, None, None, None, None

When your patients' depressive episodes have not fully remitted with antidepressant therapy, do you consider augmenting with bright light therapy? This treatment modality is accepted for seasonal depression, but a meta-analysis suggests that its efficacy extends to nonseasonal episodes as well. Learn more in this journal CME activity.

Weidman et al

PCC CME

At a Loss for Words

David A. Weidman, Anna D. Burke, Garret H. Riggs, Helle Brand, Jacquelynn N. Copeland, and William J. Burke

Activity | Published: 8/18/2016 | Keywords: Alzheimer's, dementia, neurology, None, None, None

Read this CME case to meet a 70-year-old patient who has experienced speech changes that have gradually progressed for 4 years. She has had problems with word-finding, mispronunciations, mild stuttering, and made-up words, and, in the past year, she's begun having functional impairments. Follow along with colleagues through diagnosis and treatment steps.

Flynn et al

PCC CME

Student Evaluation of the Yellow Ribbon Suicide Prevention Program in Midwest Schools

Alexandra Flynn, Rosalee Zackula, Nicole M. Klaus, Liz McGinness, Susan Carr, and Matthew Macaluso

Activity | Published: 6/30/2016 | Keywords: mental illness, None, None, None, None, None

Did you know that suicide is the second leading cause of death in adolescents? The US Surgeon General recommends implementing school programs to address adolescent distress, provide crisis intervention, and incorporate peer support for seeking help. Read this CME journal article about the results of a school-based suicide prevention program. Then, investigate school programs in your area, and screen young patients for suicidality.

Weinreb et al

PCC CME

Managing Depression Among Homeless Mothers: Pilot Testing an Adapted Collaborative Care Intervention

Linda Weinreb, Carole C. Upshur, Debbian Fletcher-Blake, George Reed, and Christine Frisard

Activity | Published: 4/21/2016 | Keywords: depression, None, None, None, None, None

Homeless mothers have high rates of mental and physical health problems and often have had multiple traumatic experiences. Although depression is common, most homeless mothers do not receive treatment for it. Therefore, targeting this population for depression screening in primary care settings, including shelter-based clinics, has the potential to more readily engage these women in treatment for depression and their other medical and mental health issues. Read this CME article to learn more.

Burke et al

PCC CME

Movements and Memory

Anna D. Burke, Garret H. Riggs, David A. Weidman, Helle Brand, and William J. Burke

Activity | Published: 2/25/2016 | Keywords: dementia, None, None, None, None, None

Follow along as Mr A, an 82-year-old man with cognitive impairment, is evaluated and treated. His symptoms include getting lost while driving, forgetting conversations and events, and having disturbed sleep. Mr A also has mild tremors in his hands and some dizziness. What are the best diagnosis and treatments for Mr A?

Chakravorty et al

PCC CME

Sleep Duration and Insomnia Symptoms as Risk Factors for Suicidal Ideation in a Nationally Representative Sample

Subhajit Chakravorty, H.Y. Katy Siu, Linden Lalley-Chareczko, Gregory K. Brown, James C. Findley, Michael L. Perlis, and Michael A. Grandner

Activity | Published: 12/31/2015 | Keywords: sleep disorders, depression, None, None, None, None

Do you screen for depressive disorder and suicidal ideation in patients complaining of insomnia and abnormal sleep duration? Read this journal CME article to learn about recent research on this topic.

Czech et al

PCC CME

Association Between Specific Depression Symptoms and Glycemic Control Among Patients With Comorbid Type 2 Diabetes and Provisional Depression

Stephanie J. Czech, Susan M. Orsillo, Paul A. Pirraglia, Thomas M. English, and Alexa J. Connell

Activity | Published: 10/15/2015 | Keywords: depression, medical conditions, insomnia, None, None, None

Do you treat patients with type 2 diabetes who also have depression? Did you know that assessing and managing sleep problems might improve glycemic control in these patients? Read this journal CME article for more information.

Madan et al

PCC CME

Reducing Adverse Polypharmacy in Patients With Borderline Personality Disorder: An Empirical Case Study

Alok Madan, John M. Oldham, Sylvia Gonzalez, and J. Christopher Fowler

Activity | Published: 7/30/2015 | Keywords: personality disorders, medical conditions, None, None, None, None

How can outcomes be improved in patients with borderline personality disorder? Have you considered that reducing polypharmacy could help? Read this CME journal case study to follow a patient's symptoms and well-being as her medication regimen is simplified from admission to discharge and afterwards.

Flynn et al

PCC CME

Wernicke’s Encephalopathy: Increasing Clinician Awareness of This Serious, Enigmatic, Yet Treatable Disease

Alexandra Flynn, Matthew Macaluso, Inna D’Empaire, and Megan M. Troutman

Activity | Published: 5/21/2015 | Keywords: medical conditions, mental illness, substance use disorders, None, None, None

Permanent brain damage, long-term institutionalization, and death can result from undiagnosed and untreated Wernicke’s encephalopathy. Too many cases are not diagnosed until autopsy. Do you know which patients are at risk? Read this journal CME article to review the clinical diagnosis and effective treatment for this medical emergency.

Harward et al

PCC CME

Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort

Jonathan L. Harward, Valerie B. Clinard, Michael R. Jiroutek, Beverly H. Lingerfeldt, and Andrew J. Muzyk

Activity | Published: 4/15/2015 | Keywords: insomnia, sleep disorders, None, None, None, None

Did you know that recommended dosing levels for zolpidem were lowered in 2013 due to risk of next-day driving impairment in up to 1 of 3 women and 1 of 4 men? Data from one pharmacy chain show that only 16% of new precriptions matched the lower dosing recommendations. Read this journal CME article to find out how you can improve patient and public safety.

Nynas et al

PCC CME

Depression and Anxiety Following Early Pregnancy Loss: Recommendations for Primary Care Providers

Johnna Nynas, Puneet Narang, Murali K. Kolikonda, and Steven Lippmann

Activity | Published: 2/15/2015 | Keywords: depression, anxiety, medical conditions, None, None, None

How do you address psychological concerns in your patients who have experienced a miscarriage? Emotional distress usually follows early pregnancy loss. This reaction tends to improve over time, but women should be screened for depression and anxiety in case a formal evaluation and treatment are warranted. Read this journal CME activity to learn more.

Shahla Mohsenin and Vahid Mohsenin

PCC CME

Diagnosis and Management of Sleep Disorders in Posttraumatic Stress Disorder: A Review of the Literature

Shahla Mohsenin, MD, and Vahid Mohsenin, MD

Activity | Published: 12/15/2014 | Keywords: PTSD, sleep disorders, None, None, None, None

How well are sleep problems being managed in your patients with PTSD? Insomnia, nightmares, sleep apnea, and sleep movement disorders are common in these patients. Read this journal CME activity to learn about diagnosing and managing these conditions so that you can better help your patients with PTSD.

Shane J. McInerney and Sidney H. Kennedy

PCC CME

Review of Evidence for Use of Antidepressants in Bipolar Depression

Shane J. McInerney, MB, MSc, MRCPsych, and Sidney H. Kennedy, MD, FRCPC

Activity | Published: 10/15/2014 | Keywords: bipolar depression, None, None, None, None, None

Antidepressants are used in up to 50% of patients with bipolar depression. Do you prescribe them for your patients? Read this brief review to find out whether antidepressants work in bipolar depression and whether any benefits exceed risks, such as induction of (hypo)mania and rapid cycling.

Blasco-Fontecilla et al

PCC CME

A Cross-Sectional Study of Major Repeaters: A Distinct Phenotype of Suicidal Behavior

Hilario Blasco-Fontecilla, MD, PhD; Isabelle Jaussent, PhD; Emilie Olié, MD, PhD; Severine Béziat, MSc; Sebastien Guillaume, MD, Paula Artieda-Urrutia, Enrique Baca-Garcia, Jose de Leon, and Philippe Courtet

Activity | Published: 8/15/2014 | Keywords: substance use disorders, eating disorders, depression, None, None, None

Can people become addicted to suicidal behavior? Do individuals who attempt suicide 5 times or more represent a distinct phenotype among those with suicidal behavior? Read this journal CME article to learn more about the demographic and clinical characteristics of patients who repeatedly attempt suicide.

Ionescu et al

PCC CME

Pharmacologic Treatment of Dimensional Anxious Depression: A Review

Dawn F. Ionescu, Mark J. Niciu, Erica M. Richards, and Carlos A. Zarate, Jr

Activity | Published: 6/15/2014 | Keywords: depression, anxiety, None, None, None, None

Did you know that anxious symptoms affect about half of patients with depression? To note the effects of anxiety within depression, the DSM-5 added an “anxious distress” specifier to the diagnosis of major depressive disorder. In this CME activity from The Primary Care Companion, read about the outcomes and side effect burden associated with anxious depression.

Hu et al

PCC CME

Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care

Jia Hu, Rodrigo Mansur, and Roger S. McIntyre

Activity | Published: 4/15/2014 | Keywords: bipolar depression, bipolar disorder, bipolar mania, None, None, None

Unlike the DSM-IV-TR, the DSM-5 allows patients with subsyndromal mixed symptoms to receive a diagnostic specifier for mixed features, which may reduce the frequent misdiagnosis of bipolar disorder and improve treatment. Read about the diagnostic changes and the implications for treatment in this Primary Care Companion journal CME article.

Das et al

PCC CME

Out of Sight, Out of Mind: The Case of a 62-Year-Old Man With Visual Complaints and Cognitive Decline

Saurav Das, Adam S. Fleisher, Roy Yaari, James D. Seward, Anna D. Burke, Helle Brand, and Pierre N. Tariot

Activity | Published: 2/15/2014 | Keywords: Alzheimer's, dementia, depression, medical conditions, None, None

Have any patients come to you with vision problems that their eye doctors can't solve? Read this Primary Care Companion interactive case report to learn about how these symptoms may be indicative of a variant of Alzheimer's disease or a precursor. Diagnostic tests and potential treatments are discussed.

Burke et al

PCC CME

Hypersexuality in Dementia

Anna D. Burke, Roy Yaari, Pierre N. Tariot, Adam S. Fleisher, Geri R. Hall, and Helle Brand

Activity | Published: 10/15/2013 | Keywords: dementia, None, None, None, None, None

Have you tried treating hypersexuality in patients with dementia? Although up to a fifth of patients with dementia have sexually disinhibited behaviors, no approved treatments are available. Read this case study to get treatment ideas from experts at the Banner Alzheimer's Institute.

Yaari et al

PCC CME

Preserving Independence

Roy Yaari, Anna D. Burke, Helle Brand, James D. Seward, and Pierre N. Tariot

Activity | Published: 8/15/2013 | Keywords: Alzheimer's, dementia, depression, insomnia, None, None

Participate in this CME case study to diagnose and manage Ms A, an 84-year-old woman whose cognitive changes began about 1 year ago.

Yaari et al

PCC CME

A Rapid Turn of Events: Sudden Physical and Cognitive Decline

Roy Yaari, Susy Favaro, Anna D. Burke, Helle Brand, Adam S. Fleisher, James D. Seward, Jan Dougherty, and Pierre N. Tariot

Activity | Published: 6/15/2013 | Keywords: dementia, None, None, None, None, None

Explore the appropriate workup, differential diagnosis, and care for a rapidly progressive dementia in a 57-year-old man.

Yaari et al

PCC CME

As Time Goes By

Roy Yaari, Geri Hall, Helle Brand, Jan Dougherty, Adam S. Fleisher, James D. Seward, and Pierre N. Tariot

Activity | Published: 4/15/2013 | Keywords: Alzheimer's, dementia, depression, None, None, None

Have the spouses of your patients with dementia asked you about driving safety? Do you have patients who refuse to accept a diagnosis of Alzheimer's disease? Has agitation in your patients with dementia caused their caregivers to call you in distress? Read the case of Ms A to learn strategies for managing patients with Alzheimer's disease as it progresses over time. Both medication and caregiver education can help.

Burke et al

PCC CME

The Threat of Behavioral Changes in Dementia

Anna D. Burke, Roy Yaari, Pierre N. Tariot, Geri R. Hall, Jan Dougherty, Helle Brand, and Adam S. Fleisher

Activity | Published: 2/15/2013 | Keywords: dementia, None, None, None, None, None

When Mr A, a 68-year-old man, presents to Banner Alzheimer’s Institute, his wife says symptoms of short-term memory loss began 3 years ago and gradually worsened. Mr A has poor insight and states that the things he forgets are things that he does not want to remember. Mr A displays irritability as well as verbal aggression toward his spouse. Mr A’s wife also reports “tactless” behaviors and loss of empathy toward others. What is causing his symptoms?

Yaari et al

PCC CME

Delayed Cognitive Impairment After a Hypoxic Event

Roy Yaari, Helle Brand, James D. Seward, Anna D. Burke, Adam S. Fleisher, and Pierre N. Tariot

Activity | Published: 12/15/2012 | Keywords: Alzheimer's, bipolar disorder, dementia, substance use disorders, None, None

Delayed Cognitive Impairment After a Hypoxic Event

Burke et al

PCC CME

A Wolf in Sheep’s Clothing: When Behaviors Imply Dementia

Anna D. Burke, Roy Yaari, Geri Hall, Helle Brand, Pierre Tariot, Adam Fleisher, and Jan Dougherty

Activity | Published: 10/15/2012 | Keywords: dementia, None, None, None, None, None

A Wolf in Sheep’s Clothing: When Behaviors Imply Dementia

Yaari et al

PCC CME

A Tale of Two Amyloid Positron Emission Tomography Scans in Patients With Mild Cognitive Impairment

Roy Yaari, Adam S. Fleisher, James D. Seward, Anna D. Burke, Helle Brand, and Pierre N. Tariot

Activity | Published: 8/15/2012 | Keywords: Alzheimer's, dementia, None, None, None, None

A Tale of Two Amyloid Positron Emission Tomography Scans in Patients With Mild Cognitive Impairment

Burke et al

PCC CME

The Shadow People: A Glimpse Into Dementia With Lewy Bodies

Anna D. Burke, Roy Yaari, Pierre N. Tariot, Jan Dougherty, Adam S. Fleisher, and Helle Brand

Activity | Published: 6/15/2012 | Keywords: dementia, None, None, None, None, None

The Shadow People: A Glimpse Into Dementia With Lewy Bodies

Roy Yaari, MD

PCC CME

Falling Down

Roy Yaari, Helle Brand, Jan Dougherty, Anna D. Burke, Adam S. Fleisher, James D. Seward, and Pierre N. Tariot

Activity | Published: 4/15/2012 | Keywords: Alzheimer's, dementia, medical conditions, sleep disorders, None, None

Falling Down

Roy Yaari, MD, MAS

PCC CME

Alone in the Home

Roy Yaari, Geri R. Hall, Helle Brand, James D. Seward, Anna D. Burke, Adam S. Fleisher, Jan Dougherty, and Pierre N. Tariot

Activity | Published: 2/15/2012 | Keywords: Alzheimer's, dementia, None, None, None, None

Alone in the Home

Anna D. Burke, MD

PCC CME

Psychological Masquerade

Anna D. Burke, Roy Yaari, Helle Brand, James D. Seward, Adam S. Fleisher, Jan Dougherty, and Pierre N. Tariot

Activity | Published: 12/15/2011 | Keywords: Alzheimer's, dementia, depression, None, None, None

Psychological Masquerade

Roy Yaari, MD, MAS

PCC CME

When Laughing Is No Joking Matter

Roy Yaari, Helle Brand, James D. Seward, Anna D. Burke, Adam S. Fleisher, Jan Dougherty, and Pierre N. Tariot

Activity | Published: 10/15/2011 | Keywords: Alzheimer's, dementia, None, None, None, None

When Laughing Is No Joking Matter

Anna D. Burke, MD

PCC CME

Mild Cognitive Impairment: Diagnosis and Treatment Dilemmas

Anna D. Burke, Roy Yaari, Adam S. Fleisher, Helle Brand, Jan Dougherty, James D. Seward, and Pierre N. Tariot

Activity | Published: 8/15/2011 | Keywords: dementia, None, None, None, None, None

Mild Cognitive Impairment: Diagnosis and Treatment Dilemmas

Roy Yaari, MD, MAS

PCC CME

When Is It Dementia?

Roy Yaari, Adam S. Fleisher, Anna D. Burke, Helle Brand, Jan Dougherty, James D. Seward, Pierre N. Tariot

Activity | Published: 6/15/2011 | Keywords: dementia, None, None, None, None, None

When Is It Dementia?

Roy Yaari, MD, MAS

PCC CME

Why Does Mommy Forget?

Roy Yaari, Adam S. Fleisher, Anna D. Burke, Helle Brand, Jan Dougherty, James D. Seward, Pierre N. Tariot

Activity | Published: 4/15/2011 | Keywords: Alzheimer's, dementia, depression, anxiety, None, None

Why Does Mommy Forget?

Shan Xing, et al

PCC CME

Failure to Fill Electronically Prescribed Antidepressant Medications: A Retrospective Study

Shan Xing, Bethany A. DiPaula, Helen Y. Lee, and Catherine E. Cooke

Activity | Published: 1/15/2011 | Keywords: depression, None, None, None, None, None

PCC CME

The Impact of Anxiety, Depression, and Suicidality on Quality of Life and Functional Status of Patients With Congestive Heart Failure and Hypertension: An Observational Cross-Sectional Study

Gianluca Serafini, Maurizio Pompili, Marco Innamorati, Giulia Iacorossi, Ilaria Cuomo, Mariarosaria Della Vista, David Lester, Luciano De Biase, Paolo Girardi, and Roberto Tatarelli

Activity | Published: 12/15/2010 | Keywords: anxiety, depression, medical conditions, None, None, None

PCC CME

Perceived Reasons for and Consequences of Substance Abuse Among Patients With Psychosis

Sahoo Saddichha, Ravi Prakash, Baxi N. P. Sinha, and Christoday R. J. Khess

Activity | Published: 9/15/2010 | Keywords: substance use disorders, bipolar disorder, schizophrenia, None, None, None

PCC CME

Added Burden of Mental Disorders on Health Status Among Patients With Chronic Obstructive Pulmonary Disease

Bradford Felker, Kristen R. Bush, Ofer Harel, Jane B. Shofer, Molly M. Shores, and David H. Au

Activity | Published: 8/15/2010 | Keywords: anxiety, depression, medical conditions, None, None, None

PCC CME

Evaluation of Guideline-Concordant Care for Bipolar Disorder Among Privately Insured Youth

Sara E. Evans-Lacko, Susan dosReis, Elizabeth A. Kastelic, Cristiane S. Paula, and Donald M. Steinwachs

Activity | Published: 6/15/2010 | Keywords: bipolar disorder, None, None, None, None, None

PCC CME

Prevalence and Correlates of Clinically Significant Depressive Symptoms in an Urban Hospital Emergency Department

Matthew J. Mimiaga, William M. Reichmann, Steven A. Safren, Elena Losina, Christian Arbelaez, and Rochelle P. Walensky

Activity | Published: 4/15/2010 | Keywords: depression, None, None, None, None, None

PCC CME

Why Treat Insomnia?

Sara E. Matteson-Rusby, Wilfred R. Pigeon, Phillip Gehrman, and Michael L. Perlis

Activity | Published: 2/15/2010 | Keywords: insomnia, None, None, None, None, None

PCC CME

Time-Invariant and Time-Varying Predictors of Depression Symptoms in Primary Care Patients

Lisa A. Uebelacker, Risa B. Weisberg, David R. Strong, Marcia Smith, and Ivan W. Miller

Activity | Published: 12/15/2009 | Keywords: depression, None, None, None, None, None

PCC CME

Augmentation Effect of Repetitive Transcranial Magnetic Stimulation Over the Orbitofrontal Cortex in Drug-Resistant Obsessive-Compulsive Disorder Patients: A Controlled Investigation

Chiara Ruffini, Marco Locatelli, Adelio Lucca, Francesco Benedetti, Chiara Insacco, and Enrico Smeraldi

Activity | Published: 11/15/2009 | Keywords: obsessive-compulsive disorder, None, None, None, None, None

PCC CME

Recognition and Treatment of Depression and Anxiety Symptoms in Heart Failure

Jeffrey A. Cully, Daniel E. Jimenez, Tracey A. Ledoux, and Anita Deswal

Activity | Published: 6/15/2009 | Keywords: anxiety, depression, medical conditions, None, None, None

PCC CME

Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Schizotypal Personality Disorder: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions

Attila J. Pulay, Frederick S. Stinson, Deborah A. Dawson, Risë B. Goldstein, S. Patricia Chou, Boji Huang, Tulshi D. Saha, Sharon M. Smith, Roger P. Pickering, W. June Ruan, Deborah S. Hasin, and Bridget F. Grant

Activity | Published: 4/15/2009 | Keywords: personality disorders, None, None, None, None, None

PCC CME

The Relationship Between Borderline Personality Symptomatology and Somatic Preoccupation Among Internal Medicine Outpatients

Randy A. Sansone, M.D., Nighat A. Tahir, M.D., Victoria R. Buckner, D.O., and Michael W. Wiederman, Ph.D.

Activity | Published: 8/15/2008 | Keywords: personality disorders, None, None, None, None, None

Robert L. Findling, MD

PCC CME

Commentary: Diagnosing and Managing Complicated ADHD

Robert L. Findling, MD (Chair), et al.

Activity | Published: 6/15/2008 | Keywords: ADHD, None, None, None, None, None

Maurizio Fava, MD (Chair)

PCC CME

Identifying and Managing Depression in the Medical Patient

Maurizio Fava, MD (Chair) et al.

Activity | Published: 12/15/2005 | Keywords: depression, medical conditions, None, None, None, None

Read this Academic Highlights to find out about the prevalence and impact of depression in patients with medical illnesses, and learn how to effectively identify, treat, and monitor this comorbidity.

Roundy et al.

PCC CME

Are Anxiety and Depression Addressed in Primary Care Patients With Chronic Obstructive Pulmonary Disease? A Chart Review

Kent Roundy, Jeffrey A. Cull,y Melinda A. Stanley, Connie Veazey, Julianne Souchek, Nelda P. Wray, Mark E. Kunik

Activity | Published: 10/15/2005 | Keywords: depression, anxiety, medical conditions, None, None, None

Ramaswamy et al.

PCC CME

A Primary Care Perspective of Posttraumatic Stress Disorder for the Department of Veterans Affairs

Sriram Ramaswamy, Vishal Madaan, Faiz Qadri, Christopher J. Heaney, Terry C. North, Prasad R. Padala, Syed P. Sattar, Frederick Petty

Activity | Published: 8/15/2005 | Keywords: PTSD, anxiety, None, None, None, None

Lato, et al

PCC CME

The Relation Between Body Fat Distribution and Cardiovascular Risk Factors in Patients With Schizophrenia: A Cross-Sectional Pilot Study

Martha M. Lato, M. Beatriz Currier, Oscar Villaver, deMercedes Gonzalez-Blanco

Activity | Published: 6/15/2005 | Keywords: schizophrenia, medical conditions, None, None, None, None

Benson, et al

PCC CME

Screening for Early Alzheimer’s Disease: Is There Still a Role for the Mini-Mental State Examination?

Aaron D. Benson, BS; Melissa J. Slavin, PhD; Thanh-Thu Tran, BS; Jeffrey R. Petrella, MD; and P. Murali Doraiswamy, MD

Activity | Published: 4/15/2005 | Keywords: Alzheimer's, dementia, None, None, None, None

Rosenbaum, et al

PCC CME

Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders

Jerrold F. Rosenbaum, MD; Charles P. O’Brien, MD, PhD; Michael W. Otto, PhD; Mark H. Pollack, MD; Peter P. Roy-Byrne, MD; Samantha A. Stewart, MD

Activity | Published: 2/15/2005 | Keywords: None, None, None, None, None, None

PCC CME

Enhancement of Treatment Response in Depression in the Primary Care Setting.

Activity | Published: 12/15/2004 | Keywords: depression, None, None, None, None, None

Roth et al

PCC CME

Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders in the Primary Care Setting

Thomas Roth, Karl Doghramji, Paul Doghramji, Jonathan R.L. Schwartz, James K. Walsh

Activity | Published: 10/15/2004 | Keywords: sleep disorders, None, None, None, None, None

PCC CME

Recognizing and Treating the Physical Symptoms of Depression in Primary Care

Alan F. Schatzberg, Bruce A. Arnow, Vivien K. Burt, Pedro L. Delgado, Ruta M. Nonacs, Maurice M. Ohayon

Activity | Published: 8/15/2004 | Keywords: None, None, None, None, None, None

Craft and Perna

PCC CME

The Benefits of Exercise for the Clinically Depressed

Lynette L. Craft and Frank M. Perna

Activity | Published: 6/15/2004 | Keywords: depression, None, None, None, None, None

Culpepper et al

PCC CME

Suicidality as a Possible Side Effect of Antidepressant Treatment

Larry Culpepper, Jonathan R. T. Davidson, Allen J. Dietrich, Wayne K. Goodman, Kurt Kroenke, Thomas L. Schwenk

Activity | Published: 5/15/2004 | Keywords: depression, None, None, None, None, None

PCC CME

Emerging Therapeutic Strategies for Treating Alzheimer’s Disease in Primary Care

Activity | Published: 12/15/2003 | Keywords: None, None, None, None, None, None

Rushing et al

PCC CME

Bulimia Nervosa: A Primary Care Review

Jona M. Rushing, Laura E. Jones, Caroline P. Carney

Activity | Published: 12/15/2003 | Keywords: None, None, None, None, None, None

Carrigan and Lynch

PCC CME

Managing Suicide Attempts: Guidelines for the Primary Care Physician

Catherine Goertemiller Carrigan and Denis J. Lynch

Activity | Published: 10/15/2003 | Keywords: None, None, None, None, None, None

Gill and Dansky

PCC CME

Use of an Electronic Medical Record to Facilitate Screening for Depression in Primary Care

James M. Gill, and Bonnie S. Dansky

Activity | Published: 6/15/2003 | Keywords: None, None, None, None, None, None

Donna B. Greenberg

PCC CME

Preventing Delirium at the End of Life: Lessons From Recent Research

Donna B. Greenberg

Activity | Published: 4/15/2003 | Keywords: None, None, None, None, None, None

Freeman and Sondheimer

PCC CME

Premenstrual Dysphoric Disorder: Recognition and Treatment

Ellen W. Freeman and Steven J. Sondheimer

Activity | Published: 4/15/2003 | Keywords: None, None, None, None, None, None

+Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder [Series Home Page]

+Parkinson Disease: Current Trends in Treatment and Unmet Needs [Series Home Page]

+Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice [Series Home Page]

+Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management [Series Home Page]

+Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan? [Series Home Page]

+What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options [Series Home Page]

+Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach [Series Home Page]

+Emerging Treatment Strategies for Patients With Tardive Dyskinesia [Series Home Page]

+Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics? [Series Home Page]

Diana O. Perkins

Brief Report

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

Diana O. Perkins, MD, MPH

Activity | Published: 9/28/2017 | Keywords: schizophrenia, None, None, None, None, None

Do you consider long-acting injectable (LAI) antipsychotics when selecting among treatments for schizophrenia? Take part in this CME activity to review the evidence for LAIs vs oral medications and to learn which patients may benefit most from this treatment option. Plus, discover the pharmacokinetic properties of LAIs and barriers to their use.

+Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission [Series Home Page]

+Challenges in the Recognition and Treatment of Binge-Eating Disorder [Series Home Page]

+Recognition and Treatment of Pediatric Bipolar Disorder [Series Home Page]

Robert L. Findling (Chair) et al

Journal Supplement

Recognition and Treatment of Pediatric Bipolar Disorder

Robert L. Findling, MD, MBA (Chair), et al

Activity | Published: 8/31/2016 | Keywords: bipolar disorder, bipolar mania, bipolar depression, None, None, None

Do you find the diagnosis and treatment of pediatric bipolar disorder challenging? Read this CME supplement to learn about the phenomenology and differential diagnosis of bipolar disorders in children and adolescents as well as evidence-based pharmacologic and psychotherapeutic interventions. With effective treatment and the support of their families, young patients with bipolar disorder can learn to manage the illness and become independent, healthy adults.

+Improving the Care and Management of Patients With Inadequate Response to Depression Treatment [Series Home Page]

Michael E. Thase

Case & Comment

Managing Medical Comorbidities in Patients With Depression to Improve Overall Prognosis

Michael E. Thase, MD

Activity | Published: 7/7/2016 | Keywords: depression, medical conditions, None, None, None, None

What additional precautions should be taken when a patient presents with symptoms of depression as well as medical comorbidities? Consider the options as you review this new Case and Comment activity about Tony, a 64-year-old man whose treatment-resistant depression is more difficult to manage due to medical conditions.

George I. Papakostas

Case & Comment

Identifying Patients Who Need a Change in Depression Treatment and Implementing That Change

George I. Papakostas, MD

Activity | Published: 6/20/2016 | Keywords: depression, None, None, None, None, None

What steps should be taken when you are presented with a patient who has been previously treated by a primary care provider but has been unresponsive to treatment? Gain insight into the challenges of treatment-resistant depression by exploring this new Case and Comment activity focused on Robert, a 55-year-old accountant.

Roger S. McIntyre

Case & Comment

Implementing Appropriate Treatment Strategies for Varying Types of Depression

Roger S. McIntyre, MD, FRCPC

Activity | Published: 5/11/2016 | Keywords: depression, bipolar disorder, anxiety, None, None, None

What steps should be taken when your patient does not respond adequately to antidepressant medication and has symptoms that may indicate the presence of several diagnoses? Review this Case and Comment activity to analyze the case of Melissa, an architect whose treatment-resistant depression may be masking other diagnoses.

Bradley Gaynes

Case & Comment

Recognizing and Assessing Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

Bradley Gaynes, MD, MPH

Activity | Published: 4/5/2016 | Keywords: depression, None, None, None, None, None

What should you do when your patients do not respond adequately to antidepressant therapy? Review this new Case and Comment activity to learn more about Alice's depressive episode and how you can help your patients like Alice achieve remission.

Bradley Gaynes (Chair), et al

Journal Supplement

Improving the Care and Management of Patients With Inadequate Response to Depression Treatment

Bradley Gaynes, MD, MPH (Chair), et al

Activity | Published: 1/27/2016 | Keywords: depression, None, None, None, None, None

With only about one-third of patients with depression responding to their initial treatment trial, clinicians face the challenge of managing patients with poor response or treatment-resistant depression. In this Supplement, learn to identify difficult-to-treat types of depression, to select evidence-based treatments, to adjust treatment in a timely manner, and to coordinate care of comorbid conditions to improve patient outcomes.

+Enhancing Approaches to the Identification and Management of Pseudobulbar Affect [Series Home Page]

David W. Crumpacker

Brief Report

Enhancing Approaches to the Identification and Management of Pseudobulbar Affect

David W. Crumpacker, MD

Activity | Published: 7/7/2016 | Keywords: medical conditions, depression, None, None, None, None

Pseudobulbar affect has been unrecognized and untreated for too long. Engage in this activity and watch its brief videos to learn about this embarrassing, socially limiting condition so you can better help your patients.

+Achieving Remission and Recovery in Depression With Anxiety [Series Home Page]

Andrew Cutler

Brief Report

The Role of Insomnia in Depression and Anxiety: Its Impact on Functioning, Treatment, and Outcomes

Andrew J. Cutler, MD

Activity | Published: 4/19/2016 | Keywords: depression, insomnia, anxiety, neurology, None, None

The case of 42-year-old Mrs C illustrates the common combination of anxious depression and sleep problems. In this activity, learn about the relationship between these disorders and find effective strategies to treat insomnia with depression and anxiety.

David Sheehan

Brief Report

Importance of Restoring Function in Patients With Major Depressive Disorder

David V. Sheehan, MD, MBA

Activity | Published: 3/19/2016 | Keywords: depression, None, None, None, None, None

Restoring function in areas like home, work, and relationships is an important treatment goal for patients with depression. Here, find practical rating scales to monitor areas of functioning and discover specific interventions to target these impairments.

Larry Culpepper

Brief Report

Impact of Anxious Symptoms and Comorbid Anxiety Disorders on Functional Impairment in Depressed Patients

Larry Culpepper, MD, MPH

Activity | Published: 2/22/2016 | Keywords: depression, anxiety, None, None, None, None

Explore this activity to understand the relationship between, and impact of, depression and anxiety, and discover strategies to assess and treat both depressive and anxious symptoms in your patients.

+Measuring and Managing Cognitive Impairment in Schizophrenia [Series Home Page]

S. Charles Schulz (Chair), et al

Journal Supplement

Measuring and Managing Cognitive Impairment in Schizophrenia

S. Charles Schulz, MD (Chair), et al

Activity | Published: 2/24/2016 | Keywords: schizophrenia, None, None, None, None, None

Cognitive impairment is present in almost all patients with schizophrenia, yet it often receives less clinical attention than positive and negative symptoms. Read this supplement to help identify, monitor, and manage these symptoms in your patients.

+Sleep Disorders in the Psychiatric Setting [Series Home Page]

Krystal and Sorscher

Webcast

Recognizing and Managing Insomnia in Primary Care and Specialty Settings

Andrew D. Krystal, MD, MS (chair), and Adam J. Sorscher, MD

Activity | Published: 2/1/2016 | Keywords: insomnia, None, None, None, None, None

Watch this webcast to see two patient cases with different sleep difficulties. Listen as the faculty discuss these cases and give evaluation tools and treatment strategies that will help you manage patients with sleep problems in your own practice.

+Strategies to Improve Outcomes for Primary Care Patients With Major Depressive Disorder [Series Home Page]

Rakesh Jain et al

PCC CME

Improving Outcomes for Primary Care Patients With Depression

Rakesh Jain, MD, MPH (Chair), et al

Activity | Published: 11/11/2015 | Keywords: depression, None, None, None, None, None

How do you assess symptom resolution, treatment adherence, and tolerability in your patients with depression? Follow the 3 patient cases in this CME newsletter to learn how measurement-based care can help you monitor treatment, improve adherence and patient outcomes, and recognize and treat residual symptoms.

C. Brendan Montano

Brief Report

Tactics to Improve Adherence in Depressed Primary Care Patients

C. Brendan Montano, MD

Activity | Published: 9/30/2015 | Keywords: depression, None, None, None, None, None

Do your patients with depression have trouble with medication adherence? Follow as Mr K, a 28-year-old patient, stops adhering to his antidepressant due to adverse effects, and learn techniques for questioning your patients, collecting their information, and providing them with clear instructions to improve adherence.

W. Clay Jackson

Brief Report

The Benefits of Measurement-Based Care for Primary Care Patients With Depression

W. Clay Jackson, MD, DipTh

Activity | Published: 8/31/2015 | Keywords: depression, None, None, None, None, None

What treatment strategies do you consider for your patients who fail to respond to initial antidepressant treatment? Read the case of Mrs C to see how measurement-based care helps confirm her diagnosis, track symptom response, and assess her sense of well-being and to learn strategies for treating suboptimal response.

Rakesh Jain, MD, MPH

Brief Report

The Identification and Resolution of Residual Symptoms in Depressed Primary Care Patients

Rakesh Jain, MD, MPH

Activity | Published: 7/31/2015 | Keywords: depression, None, None, None, None, None

Like many patients being treated for depression, 86-year-old Mrs J does not recognize the residual symptoms she is experiencing. Follow her case as her psychiatrist uses several tools including rating scales and collateral information to identify her continuing symptoms and then considers different treatment strategies based on her age and symptoms.

Rakesh Jain et al

Podcast

Resolving Residual Symptoms in Primary Care Patients With Depression

Rakesh Jain, MD, MPH (chair), et al

Activity | Published: 4/15/2015 | Keywords: depression, sleep disorders, None, None, None, None

In this CME podcast, listen to experts discuss the case of Mrs J, an elderly woman with a history of depression. She has reported insomnia and has requested a benzodiazepine to help her sleep. Although she claims that her depressed mood is well controlled, her husband reports differently. The experts review her treatment options, taking into account both her symptoms and her age.

Rakesh Jain et al

Podcast

Improving Adherence in Primary Care Patients With Depression

Rakesh Jain, MD, MPH (chair), et al

Activity | Published: 4/15/2015 | Keywords: depression, bipolar depression, None, None, None, None

In this CME podcast, listen to experts discuss the case of Mr K, a health 28-year-old man who has never needed medical care previously. He has recently lost his job and developed a major depressive episode that has complicated features. The experts review his objective screening and monitoring instrument results as well as possible steps to take that will help alleviate Mr K’s problematic symptoms.

Rakesh Jain et al

Podcast

Saving Time With Measurement-Based Care for Depression in Primary Care

Rakesh Jain, MD, MPH (chair), et al

Activity | Published: 4/15/2015 | Keywords: depression, None, None, None, None, None

In this CME podcast, listen to experts discuss the case of Mrs C, a 38-year-old married woman with depression who does not respond to initial antidepressant treatment. Next-step strategies for identifying the cause of nonresponse and tips for how to best monitor patients are discussed.

+Recognizing and Treating Excessive Daytime Sleepiness and Narcolepsy [Series Home Page]

Thomas Roth (Chair) et al

JCP CME

Managing Excessive Daytime Sleepiness

Thomas Roth, PhD (Chair), and Russell P. Rosenberg, PhD

Activity | Published: 11/25/2015 | Keywords: narcolepsy, sleep disorders, None, None, None, None

Your patients' safety may be at risk if they have unrecognized excessive daytime sleepiness (EDS). Read this Commentary to learn how to assess EDS, to recognize any underlying conditions, and to select appropriate behavioral and pharmacologic strategies to treat both EDS and associated conditions.

Russell Rosenberg

Brief Report

Clinical Assessment of Excessive Daytime Sleepiness in the Diagnosis of Sleep Disorders

Russell P. Rosenberg, PhD

Activity | Published: 8/5/2015 | Keywords: narcolepsy, sleep disorders, None, None, None, None

Physicians who are not sleep specialists often feel they lack knowledge about sleep disorders. Read this Psychlopedia activity to familiarize yourself with disorders associated with excessive daytime sleepiness and the assessment methods used to diagnose these disorders.

Russell Rosenberg

Brief Report

Recommended Treatment Strategies for Patients With Excessive Daytime Sleepiness

Russell P. Rosenberg, PhD

Activity | Published: 8/13/2015 | Keywords: narcolepsy, sleep disorders, None, None, None, None

Given the prevalence of sleep disorders, too few sleep specialists are available. Therefore, other health care providers, especially primary care clinicians, need to know about the diagnosis of sleep disorders and the therapeutic options available to treat them. Read this Psychlopedia activity to increase your ability to select appropriate treatment strategies for sleep disorders.

Thomas Roth, PhD

Brief Report

The Effect of Comorbid Psychiatric and Medical Illnesses on Sleep Disorder Treatment

Thomas Roth, PhD

Activity | Published: 7/31/2015 | Keywords: narcolepsy, sleep disorders, None, None, None, None

Unrecognized conditions may be contributing to symptoms of daytime sleepiness and/or fatigue in your patients with sleep disorders. Learn about psychiatric, neurologic, and medical conditions that frequently coexist with sleep disorders and discover treatment strategies, both pharmacologic and nonpharmacologic, to improve patient outcomes.

Thomas Roth, PhD

Brief Report

Effects of Excessive Daytime Sleepiness and Fatigue on Overall Health and Cognitive Function

Thomas Roth, PhD

Activity | Published: 7/31/2015 | Keywords: narcolepsy, sleep disorders, None, None, None, None

Excessive daytime sleepiness (EDS) and fatigue can lead to accidents or unemployment if left unrecognized and untreated in your patients. In this Psychlopedia activity, discover patient-report scales and objective measures to screen for these symptoms and learn to recognize common disorders that may cause or contribute to EDS/fatigue.

+Complicated Major Depressive Disorder [Series Home Page]

Maurizio Fava

Brief Report

Switching Treatments for Complicated Depression

Maurizio Fava, MD

Activity | Published: 3/9/2009 | Keywords: depression, None, None, None, None, None

Less than a third of patients treated with a first-line antidepressant for depression will achieve remission. Read this new J Clin Psychlopedia section to review switching strategies to help your patients with resistant depression who have achieved no response or only partial response to treatment.

Maurizio Fava, MD

Brief Report

Augmentation and Combination Strategies for Complicated Depression

Maurizio Fava, MD

Activity | Published: 3/15/2009 | Keywords: depression, None, None, None, None, None

In this J Clin Psychlopedia activity, review safe and effective augmentation and combination treatment strategies for treatment-resistant depression.

Michael E. Thase, MD

Brief Report

Newer Medications for Complicated Depression

Michael E. Thase, MD

Activity | Published: 3/15/2009 | Keywords: depression, None, None, None, None, None

Many of your patients with major depression probably receive only moderate relief from currently available antidepressant pharmacotherapies. Read this new J Clin Psychlopedia activity to learn about the future of antidepressant treatment.

Michael E. Thase, MD

Brief Report

Treating Major Depression: Antidepressant Algorithms

Michael E. Thase, MD

Activity | Published: 3/15/2009 | Keywords: depression, None, None, None, None, None

Engage in this interactive activity to learn how treatment algorithms can help you successfully treat patients with complicated major depression.

+What Psychiatric Nurses Need to Know About Bipolar Disorder [Series Home Page]

Joanne Iennaco and Julie Carbray

Game Case

Engaging Patients in Long-Term Management of Bipolar Disorder

Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN, and Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Activity | Published: 10/21/2015 | Keywords: bipolar disorder, None, None, None, None, None

What strategies do you use to get patients with bipolar disorder to participate in their illness management? Play this game-based activity to see if you can help a long-term patient with bipolar disorder learn the importance of adhering to treatment, tracking mood states, and making important lifestyle changes.

Joanne Iennaco and Julie Carbray

Game Case

Communicating With Colleagues and Patients About Acute Bipolar Disorder

Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN, and Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Activity | Published: 9/16/2015 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

Play your way to CME credit! This game-based activity lets you test your knowledge of assessment tools, treatment response, and patient education as you help 24-year-old Kate recover from her latest bipolar episode.

Julie Carbray and Joanne Iennaco

Game Case

Recognizing Signs and Symptoms of Bipolar Disorder

Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, and Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN

Activity | Published: 8/31/2015 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

This activity lets you earn CME credit and learn the signs and symptoms of bipolar disorder—while playing games! You’ll follow the case of David, a 20-year-old college student while uncovering rating scales and diagnostic criteria that can help with patient assessment.

+Using Mechanism of Action to Choose Medications for Treatment-Resistant Depression [Series Home Page]

Thomas Schwartz

Case & Comment

Why Is Mechanism of Action Important in Antidepressant Treatment?

Thomas L. Schwartz, MD

Activity | Published: 10/5/2015 | Keywords: depression, None, None, None, None, None

How do you handle patients who do not respond adequately to SSRI treatment? Explore this new Case and Comment to compare Maria's response to different antidepressant medications and learn more about how to effectively choose a therapeutic strategy for your patients.

Michael E. Thase

Case & Comment

How Does Understanding Mechanism of Action Help Clinicians Personalize Antidepressant Treatment Choices?

Michael E. Thase, MD

Activity | Published: 9/17/2015 | Keywords: depression, bipolar depression, None, None, None, None

Patients may experience a symptom profile that changes over time, such as a patient who first appears to have unipolar depression but later exhibits signs of mania or hypomania. Here, follow the case of Adam, a 30-year-old man, who is experiencing a recurrence of depression, and track his response through several antidepressant trials.

Michael E. Thase

Case & Comment

What Are the Mechanisms of Action of Current Antidepressant Treatments?

Michael E. Thase, MD

Activity | Published: 8/20/2015 | Keywords: depression, None, None, None, None, None

Therapeutic effects of antidepressants may vary greatly from patient to patient, with some patients failing to respond after several treatment trials. In this Case and Comment activity, follow the treatment steps taken for a 62-year-old surgeon with a treatment-resistant depressive episode.

Michael E. Thase, MD (Chair), et al

JCP CME

Choosing Medications for Treatment-Resistant Depression Based on Mechanism of Action

Michael E. Thase, MD (Chair), and Thomas L. Schwartz, MD

Activity | Published: 6/24/2015 | Keywords: depression, None, None, None, None, None

What can you do for your patients with depression who show partial response or no response to treatment? Follow a discussion by expert faculty about how altering levels of dopamine, norepinephrine, and serotonin in the brain may theoretically target specific depressive symptoms and how the mechanisms of action of different antidepressant classes are associated with therapeutic benefits and adverse effects.

Michael E. Thase and Thomas L. Schwartz

Webcast

Using Mechanism of Action to Choose Medications for Treatment-Resistant Depression

Michael E. Thase, MD (chair), and Thomas L. Schwartz, MD

Activity | Published: 3/15/2015 | Keywords: depression, None, None, None, None, None

Do you know how antidepressant classes can complement each other through different mechanism of action? Watch this webcast to learn the mechanism of action of various antidepressant classes and how to apply that knowledge to your patients with depression.

+Barriers to Remission in Major Depressive Disorder: Residual Symptoms, Functional Impairment, and Medication Mechanism of Action [Series Home Page]

Pierre Blier

Brief Report

Neurobiology of Depression and Mechanism of Action of Depression Treatments

Pierre Blier, MD, PhD

Activity | Published: 10/19/2015 | Keywords: depression, None, None, None, None, None

Antidepressants, including SSRIs, may alleviate depressive symptoms but leave residual symptoms. In this activity, discover the mechanism of action of antidepressants and adjunctive agents and how to choose effective strategies to target specific symptoms or block/activate specific receptors for broader therapeutic benefits.

Larry Culpepper

Brief Report

Functional Impairment and Improvement in Depression

Larry Culpepper, MD, MPH

Activity | Published: 8/12/2015 | Keywords: depression, None, None, None, None, None

Unresolved symptoms of depression can cause functional impairment and negatively affect patients' work performance, home life, and relationships. In this Psychlopedia activity, learn how to assess functional impairments using validated rating scales and to address contributors to functional impairment.

Andrew A. Nierenberg, MD

Brief Report

Residual Symptoms in Depression: Prevalence and Impact

Andrew A. Nierenberg, MD

Activity | Published: 6/30/2015 | Keywords: depression, None, None, None, None, None

While mood symptoms may remit in your patients with depression, lack of motivation and negative affect may keep patients from achieving full recovery. Here, learn how these residual symptoms hinder your patients' function and discover tools to assess quality of life and positive affect.

+Criminal Forensic Psychiatry [Series Home Page]

Scott Freeman

Brief Report

Criminal Forensic Psychiatry: A Primer for Psychiatrists

Scott A. Freeman, MD

Activity | Published: 9/17/2015 | Keywords: mental illness, None, None, None, None, None

How is mental illness assessed and treated within the judicial system? Many mentally ill people spend time in correctional settings, and psychiatrists are involved in their evaluation and treatment. Participate in this Psychlopedia activity to find out about competency to stand trial and the insanity defense.

+Cognition in the Depressed Patient [Series Home Page]

George I. Papakostas, MD

Brief Report

Components of Cognitive Functioning and Their Measurement

George I. Papakostas, MD

Activity | Published: 4/15/2015 | Keywords: depression, None, None, None, None, None

Do you regularly assess cognition in your patients with depression? Read this Psychlopedia activity to learn about validated scales for assessing cognition in MDD in clinical trials and in practice.

George I. Papakostas and Larry Culpepper

JCP CME

Understanding and Managing Cognition in the Depressed Patient

George I. Papakostas, MD (Chair), and Larry Culpepper, MD, MPH

Activity | Published: 4/9/2015 | Keywords: depression, None, None, None, None, None

Patients with MDD may experience cognitive dysfunctions that make recovery difficult or incomplete. Read this new Academic Highlights to learn to understand and identify problems with cognition in depressed patients, and to learn new antidepressant therapies that improve all areas of cognition.

George I. Papakostas

Brief Report

Antidepressants and Their Effect on Cognition in Major Depressive Disorder

George I. Papakostas, MD (Chair)

Activity | Published: 4/15/2015 | Keywords: depression, None, None, None, None, None

Do you consider cognitive symptoms when selecting a medication for major depressive disorder? Discover how to use cognitive scales to evaluate patient symptoms and needs, and understand the effects of various antidepressant medications on cognition.

Larry Culpepper

Brief Report

Impact of Untreated Major Depressive Disorder on Cognition and Daily Function

Larry Culpepper, MD, MPH

Activity | Published: 1/15/2015 | Keywords: depression, None, None, None, None, None

Cognitive symptoms may be present before your patients experience a first depressive episode and linger between episodes and even after remission of mood symptoms. Read this new Psychlopedia activity to learn which cognitive symptoms will likely affect your patients with MDD, when these symptoms may occur, and how they may hinder patients at home, work, or school.

Larry Culpepper

Brief Report

Neuroanatomy and Physiology of Cognition

Larry Culpepper, MD, MPH

Activity | Published: 4/15/2015 | Keywords: depression, None, None, None, None, None

New research on brain networks provides insight into cognitive deficits prevalent in patients with depression. Explore this Psychlopedia activity to discover how disrupted connections and functions in various brain networks and regions contribute to cognitive symptoms and how new treatments are needed for these symptoms.

+Understanding and Coping With Binge Eating Disorder: The Patient’s Perspective [Series Home Page]

Susan L. McElroy, MD (chair), and Anna I. Guerdjikova, PhD, LISW, CCRC

Webcast

Understanding and Coping With Binge Eating Disorder: The Patient’s Perspective

Susan L. McElroy, MD (chair), and Anna I. Guerdjikova, PhD, LISW, CCRC

Activity | Published: 6/4/2015 | Keywords: eating disorders, depression, None, None, None, None

Patients with BED will likely seek treatment for another problem like depression or weight loss rather than admit their eating behaviors. Watch this webcast to learn how to assess for and diagnose BED in patients with comorbid conditions and to understand the current pharmacologic and nonpharmacologic treatment options available for patients with this condition.

+Overcoming Challenges in the Diagnosis and Management of ADHD in African American Adults [Series Home Page]

Rostain et al

JCP CME

Culturally Competent Strategies for Assessing and Treating ADHD in African American Adults

Anthony L. Rostain, MD (Chair), et al

Activity | Published: 5/21/2015 | Keywords: ADHD, None, None, None, None, None

African American adults may not recognize their symptoms of ADHD because they have developed coping strategies. Explore this Commentary to learn about the prevalence of and assessment tools for ADHD in African American adults and to choose an individualized approach to treatment that is sensitive to your patients' background and current needs.

Rostain et al

JCP CME

Cultural Background and Barriers to Mental Health Care for African American Adults

Anthony L. Rostain, MD (Chair), et al

Activity | Published: 3/15/2015 | Keywords: ADHD, None, None, None, None, None

Over one-third of African American adults may not receive treatment for serious mental illnesses. Read this new Commentary to discover how the history of psychiatry and African Americans may contribute to attitudes of fear and mistrust regarding diagnosis and treatment and how these and other barriers to care may be addressed to improve the mental health care of your African American patients.

Anthony L. Rostain

Brief Report

Health Care–Seeking Behaviors of African American ADHD Patients and Their Families: Overcoming Economic and Cultural Barriers

Anthony L. Rostain, MD

Activity | Published: 11/15/2014 | Keywords: ADHD, None, None, None, None, None

Do you know what keeps many African American patients from seeking treatment for mental health conditions? Read this new Psychlopedia activity to learn about barriers your African American patients face when seeking mental health services and to implement strategies to improve their care.

Roberta Waite

Brief Report

Culturally Competent Approaches to Assessing ADHD in African American Adults and Overcoming Cultural Issues With Patients and Families

Roberta Waite, EdD, PMHCNS-BC, FAAN

Activity | Published: 10/15/2014 | Keywords: ADHD, None, None, None, None, None

The history of racism within the field of psychiatry still affects African American patients today, making it difficult to diagnose psychiatric illness. Read this Psychlopedia to assess patients’ resistance toward psychiatric treatment in a culturally informed way and to better diagnose and treat African American patients with ADHD.

J. Russell Ramsay

Brief Report

Health Care Systems Issues and Disparities in ADHD Care for African American Adults

J. Russell Ramsay, PhD

Activity | Published: 10/15/2014 | Keywords: ADHD, None, None, None, None, None

African American adults with ADHD are underdiagnosed and undertreated. Explore this activity to learn about issues involving the health care system and disparities in care for African American adults, and discover how you can further assess patient and provider cultural biases toward ADHD symptoms and treatment.

+Cause and Effect in Bipolar Depression: Misdiagnosis Leads to Inappropriate Treatment, Clinical Complications, and Adverse Outcomes [Series Home Page]

Henry A. Nasrallah

Brief Report

Consequences of Misdiagnosis: Inaccurate Treatment and Poor Patient Outcomes in Bipolar Disorder

Henry A. Nasrallah, MD

Activity | Published: 5/5/2015 | Keywords: bipolar disorder, None, None, None, None, None

Misdiagnosis of bipolar depression can create a cascade of negative outcomes for patients. Read this Psychlopedia activity to understand the human costs of misdiagnosis and how to monitor depression in bipolar patients.

Henry A. Nasrallah

Brief Report

Setting the Stage for Success or Failure: Making an Accurate Diagnosis of Bipolar Depression

Henry A. Nasrallah, MD

Activity | Published: 4/14/2015 | Keywords: bipolar depression, None, None, None, None, None

Patients with bipolar depression are too often misdiagnosed as having unipolar depression. Read this Psychlopedia activity to learn clues to aid in making the correct diagnosis and how to detect signs of bipolarity in depressed patients.

J. Sloan Manning

Brief Report

Effective Treatment of Bipolar Depression: Monotherapy and Combination Strategies

J. Sloan Manning, MD

Activity | Published: 4/15/2015 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

To effectively manage bipolar disorder, you need to be familiar with evidence-based pharmacotherapy. Find out which pharmacologic strategies are the most effective for bipolar depression and which agents work well as monotherapy or adjunctive therapy.

J. Sloan Manning

Brief Report

Measuring Patient Outcomes and Making the Transition From Acute to Maintenance Treatment for Bipolar Depression

J. Sloan Manning, MD

Activity | Published: 4/15/2015 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Most patients with bipolar disorder will require maintenance therapy to reduce their risk of recurrent mood episodes. Read this new Psychlopedia activity to learn tools to track depressive and manic symptoms throughout treatment and to discover which maintenance strategies are the most effective for reducing the risk of manic or depressive episodes.

+New Strategies in Sleep [Series Home Page]

Thomas E. Scammell

Brief Report

Overview of Sleep: The Neurologic Processes of the Sleep-Wake Cycle

Thomas E. Scammell, MD

Activity | Published: 3/15/2015 | Keywords: insomnia, sleep disorders, None, None, None, None

Sleep problems are associated with concentration difficulties, mood disorders, and driving accidents. Learn how the sleep cycle should function, what processes can be affected by sleep problems, and what systems are involved in enhancing sleep or blocking wakefulness.

Andrew D. Krystal

Brief Report

Current, Emerging, and Newly Available Insomnia Medications

Andrew D. Krystal, MD, MS

Activity | Published: 3/15/2015 | Keywords: insomnia, None, None, None, None, None

With the increasing number of available insomnia medications, how do you choose the best treatment for your patients? Here, gain a better understanding of how various medications affect sleep processes and which agents enhance sleep-promoting systems or block wake-promoting systems.

+Challenges in the Recognition and Management of ADHD in Hispanic Adults in the United States [Series Home Page]

Rostain et al

JCP CME

Solutions for Treating Hispanic Adults with ADHD

Anthony L. Rostain, MD (Chair), et al

Activity | Published: 2/15/2015 | Keywords: ADHD, None, None, None, None, None

Hispanic Americans often go underserved by the mental health community, though they make up the largest minority group in the United States. Read this new Commentary to learn new strategies for approaching Hispanic patients with ADHD about diagnosis and treatment.

Rostain et al

JCP CME

Barriers to Care for Hispanic Adults With ADHD

Anthony L. Rostain, MD (Chair), et al

Activity | Published: 1/15/2015 | Keywords: ADHD, None, None, None, None, None

Cultural differences may hide problematic symptoms, and minority patients with ADHD can fall behind in the workplace. Read this new Commentary to learn about the treatment disparities between Hispanics and the wider population and to discover the cultural barriers that affect recognition and treatment of ADHD.

Anthony L. Rostain

Brief Report

Cultural Issues, Myths, Misinformation, and Health Care–Seeking Behaviors of Hispanic Patients With ADHD and Their Families

Anthony L. Rostain, MD

Activity | Published: 10/15/2014 | Keywords: ADHD, None, None, None, None, None

About two-thirds of Hispanic people in the United States may not receive treatment for mental illnesses such as ADHD. Read this new Psychlopedia activity to learn about barriers to your Hispanic patients receiving mental health services and to acquire practical steps to address these barriers.

Juan Pedraza

Brief Report

Culturally Competent Approaches to Diagnosing ADHD in Hispanic Adults and Overcoming Cultural Issues With Patients and Families

Juan Pedraza, MD

Activity | Published: 10/15/2014 | Keywords: ADHD, None, None, None, None, None

Hispanics are the most prevalent and diverse minority group in the US, and treating Hispanic adults for ADHD can be difficult. Read this Psychlopedia to learn about the unique characteristics and needs of Hispanic individuals with ADHD and use this knowledge to provide culturally competent diagnosis and treatment.

Yamalis Diaz

Brief Report

Health Care Systems Issues and Disparities in ADHD Care for Hispanic Adults

Yamalis Diaz, PhD

Activity | Published: 8/15/2014 | Keywords: ADHD, None, None, None, None, None

Hispanic adults with ADHD encounter numerous barriers when seeking treatment. Read this Psychlopedia to learn how to assess a Hispanic patient’s cultural biases toward ADHD diagnosis and treatment options.

+Making Connections Between Science and Symptoms in Schizophrenia [Series Home Page]

John M. Kane and Christoph U. Correll

Video

Making the Link Between Science and Symptoms in Schizophrenia

John M. Kane, MD (chair), and Christoph U. Correll, MD

Activity | Published: 1/15/2015 | Keywords: schizophrenia, None, None, None, None, None

Standard hypotheses about the causes of schizophrenia fail to account for all types of symptoms. Watch this video to realize the importance of negative and cognitive symptoms and the limitations of current medications to adequately address those symptoms.

John M. Kane

Brief Report

The Role of NMDA Receptors in Schizophrenia

John M. Kane, MD

Activity | Published: 7/15/2014 | Keywords: schizophrenia, None, None, None, None, None

NMDA receptor function mediates the downstream release of neurotransmitters thought to be involved in schizophrenia, including dopamine, glutamate, and GABA. Here, review the function of NMDA receptors and find out about their possible role as a novel treatment target for schizophrenia.

Anissa Abi-Dargham

Brief Report

Schizophrenia: Overview and Dopamine Dysfunction

Anissa Abi-Dargham, MD

Activity | Published: 7/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Excess dopamine and abnormal dopamine synthesis cause the positive symptoms of schizophrenia, but does this dysfunction also account for the negative and cognitive symptoms seen in this disorder? Here, get an overview of dopamine dysfunction and find out why this treatment target may be limited for patients with schizophrenia.

Christoph U. Correll

Brief Report

Mechanism of Action of Antipsychotic Medications

Christoph U. Correll, MD

Activity | Published: 5/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Do you anticipate your patients' side effects from antipsychotic treatment based on the medication's mechanism of action? Read this new Psychlopedia activity to use the pharmacology of antipsychotics to help predict their clinical activity and to learn how long to wait until a steady state concentration is reached and when dose adjustments can be made.

Jonathan M. Meyer

Brief Report

The Glutamate Hypothesis of Schizophrenia

Jonathan M. Meyer, MD

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Schizophrenia may be partially caused by deficient activity at glutamate synapses. Read this Psychlopedia activity to find out about the glutamate hypothesis to better understand the underlying neuropathology of the disorder and learn about glutamate as a potential treatment target for this illness.

Correll and Kane

JCP CME

Schizophrenia: Mechanism of Action of Current and Novel Treatments

Christoph U. Correll, MD, and John M. Kane, MD

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

New! Review the mechanism of action of available antipsychotics, learn why they're not effective for treating all symptoms, and find out about a potential treatment target.

Abi-Dargham and Meyer

JCP CME

Schizophrenia: The Role of Dopamine and Glutamate

Anissa Abi-Dargham, MD, and Jonathan M. Meyer, MD

Activity | Published: 3/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Antipsychotics primarily address positive symptoms of schizophrenia, while disabling negative and cognitive symptoms can persist. This Commentary briefly explains the dopamine dysfunction of the disorder and how glutamate may provide possible novel targets for pharmacotherapy to more comprehensively manage the constellation of schizophrenia symptoms.

+Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

Mary K. Colvin and Theodore A. Stern

Virtual Rounds in Neurology

Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder

Mary K. Colvin, PhD, and Theodore A. Stern, MD

Activity | Published: 12/15/2014 | Keywords: ADHD, None, None, None, None, None

Have you wondered how you could reliably make a diagnosis of ADHD and differentiate it from a learning disorder or another psychiatric condition? If you have, then this case vignette and discussion should prove useful in your evaluation and management of patients and their families.

+Treating and Caring for the Patient With Moderate-to-Severe Alzheimer's Disease [Series Home Page]

William J. Burke

Neurology Reports

Managing Patients With Moderate-to-Severe Alzheimer’s Disease: Expectations, Treatments, and Prognosis

William J. Burke, MD

Activity | Published: 12/15/2014 | Keywords: Alzheimer's, None, None, None, None, None

In this Neurology Report, experts from Banner Alzheimer’s Institute summarize ways to effectively communicate with patients and caregivers about an Alzheimer’s disease diagnosis and prognosis. Plus, they cover how to select appropriate treatments to slow functional decline and manage troublesome behavioral and psychological symptoms.

Jan Dougherty

Neurology Reports

Effective Communication Strategies to Help Patients and Caregivers Cope With Moderate-to-Severe Alzheimer’s Disease

Jan Dougherty, RN, MS

Activity | Published: 12/15/2014 | Keywords: Alzheimer's, None, None, None, None, None

Language impairment may cause more difficulty than memory impairment among caregivers and patients with Alzheimer's disease. Gain knowledge of ways to educate caregivers about communication problems, mistakes to avoid, and effective strategies to improve communication.

+The Impact of Oral Medications on the Treatment of Multiple Sclerosis [Series Home Page]

Clyde E. Markowitz

Neurology Reports

Switching Therapies in MS: What Are the Options?

Clyde E. Markowitz, MD

Activity | Published: 12/16/2014 | Keywords: medical conditions, None, None, None, None, None

Breakthrough disease is common, even in patients with good adherence to their medications. Read this Neurology Report to learn ways to assess and manage adherence, monitor disease course through clinical and MRI measures, and make timely treatment adjustments in your patients with multiple sclerosis.

Clyde E. Markowitz

Neurology Reports

Identifying and Addressing Unmet Therapeutic Needs in MS

Clyde E. Markowitz, MD

Activity | Published: 12/16/2014 | Keywords: medical conditions, None, None, None, None, None

Current disease-modifying treatments in multiple sclerosis (MS) are effectively mainly in relapsing forms of MS and do not restore function. Read this Neurology Report to discover unmet needs for treatments of progressive MS and MS symptoms and to learn about the development of neuroprotective agents.

Harold Moses, Jr

Neurology Reports

Recognizing and Overcoming Potential Barriers to Oral Medications for MS

Harold Moses, Jr, MD

Activity | Published: 5/15/2014 | Keywords: medical conditions, None, None, None, None, None

New! Learn about the positive and negative aspects of the 3 FDA-approved oral medications for MS including their associated risks and benefits.

Harold Moses, Jr

Neurology Reports

Current Standards of Treatment in MS and the Role of Oral Agents

Harold Moses, Jr, MD

Activity | Published: 5/29/2014 | Keywords: medical conditions, None, None, None, None, None

New! In this Neurology Report, learn about the efficacy and safety profiles of current MS treatments. Plus, weigh the advantages and disadvantages associated with oral medications.

+Improving Depression Outcomes by Providing Safe and Effective Care in the Rural Setting [Series Home Page]

J. Sloan Manning and W. Clay Jackson

Brief Report

Treating Depression in Primary Care: Initial and Follow-Up Treatment Strategies

J. Sloan Manning, MD, and W. Clay Jackson, MD, DipTh

Activity | Published: 12/15/2014 | Keywords: depression, None, None, None, None, None

What follow-up strategies do you use to help your patients with depression who don’t respond adequately to initial treatment? Here, get guidance on how to choose appropriate first-line treatment, and learn how to monitor patients and make timely treatment adjustments.

J. Sloan Manning and W. Clay Jackson

Brief Report

Providing Guideline-Concordant Assessment and Monitoring for Major Depression in Primary Care

J. Sloan Manning, MD, and W. Clay Jackson, MD, DipTh

Activity | Published: 12/15/2014 | Keywords: depression, None, None, None, None, None

How do you screen patients for depression in a busy primary care setting? In this new activity, read about effective assessment tools and strategies to diagnose depression and how to set goals and monitor progress once patients begin treatment.

+Depression: Addressing Partial Response After First-Line Antidepressant Treatment [Series Home Page]

Thase et al

JCP CME

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Michael E. Thase, MD (Chair), et al

Activity | Published: 9/15/2014 | Keywords: depression, None, None, None, None, None

How do you assess and treat residual symptoms in your patients who experience partial response to antidepressant therapy? Explore this Commentary to read a summary of 3 activities that provide assessment tools and treatment strategies for partial response and to learn areas of unmet needs and future education in depression treatment.

Andrew A. Nierenberg

Brief Report

Strategies for Achieving Full Remission When First-Line Antidepressants Are Not Enough

Andrew A. Nierenberg, MD

Activity | Published: 9/15/2013 | Keywords: depression, None, None, None, None, None

Discover how to assess problems with first-line treatment and implement the best second-line treatment option to help your patients achieve asympomatic remission.

Maurizio Fava

Brief Report

Assessing Response to Treatment and Recognizing Residual Depressive Symptoms

Maurizio Fava, MD

Activity | Published: 9/15/2013 | Keywords: depression, None, None, None, None, None

New! Discover how to assess your patients' response to treatment and recognize residual symptoms so that you can implement appropriate next-step strategies.

Michael E. Thase

Brief Report

Residual Symptoms and the Risk of Relapse in Major Depression

Michael E. Thase, MD

Activity | Published: 8/15/2013 | Keywords: depression, None, None, None, None, None

Find out how residual symptoms increase your patients' risk for relapse and how to apply treatment options to help them achieve asymptomatic remission.

+Controversies in the Psychopharmacology of Bipolar Disorder [Series Home Page]

Robert M. Post, et al

Brief Report

Controversies in the Psychopharmacology of Bipolar Disorder

Robert M. Post, MD (Chair), et al

Activity | Published: 8/15/2014 | Keywords: bipolar disorder, None, None, None, None, None

What decision-making process do you use for selecting treatment for your patients with bipolar disorder? In this activity, review pharmacologic principles for the use of mood stabilizers, antipsychotics, and antidepressants, and find out how to choose appropriate therapies for maintenance treatment and partial response.

+Poster Sessions From The 2014 ASCP Annual Meeting [Series Home Page]

Various Presenters

Poster Session

2014 ASCP Annual Meeting Poster Session 4

Various Presenters

Activity | Published: 7/15/2014 | Keywords: depression, bipolar depression, schizophrenia, anxiety, None, None

Read NEW award-winning research from the 2014 ASCP Annual Meeting (formerly NCDEU)! This online poster session features the latest news on everything from bipolar depression and schizophrenia to pain and obsessive-compulsive disorder.

Various Presenters

Poster Session

2014 ASCP Annual Meeting Poster Session 3

Various Presenters

Activity | Published: 7/15/2014 | Keywords: depression, bipolar depression, schizophrenia, anxiety, None, None

This online poster session features award-winning research from the 2014 ASCP Annual Meeting (formerly NCDEU)--get the latest updates on a wide variety of topics, such as addiction, bipolar depression, sexual dysfunction, and culturally focused consultation!

Various Presenters

Poster Session

2014 ASCP Annual Meeting Poster Session 2

Various Presenters

Activity | Published: 7/15/2014 | Keywords: depression, bipolar depression, schizophrenia, bipolar disorder, None, None

NEW! Featuring the best research posters from the 2014 ASCP Annual Meeting (formerly NCDEU)--read the latest research on antipsychotic treatment, bipolar depression, and use of assessment scales in practice!

Various Presenters

Poster Session

2014 ASCP Annual Meeting Poster Session 1

Various Presenters

Activity | Published: 7/15/2014 | Keywords: depression, ADHD, bipolar depression, None, None, None

NEW! View some of the best research posters from the 2014 ASCP Annual Meeting (formerly NCDEU), including original unpublished studies on using technology in practice, the role of ketamine in the management of depression, subtypes in adult ADHD, and evidence for new antidepressant treatments.

+Appropriate Management of Multiple Sclerosis in Primary Care [Series Home Page]

Levin and Jackson

Neurology Reports

Developing a Therapeutic Plan for MS: Evidence for New Treatments

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

Activity | Published: 7/15/2014 | Keywords: medical conditions, None, None, None, None, None

Do you tailor your treatment plan for patients with MS according to their disease course and preferred administration method? Read this new Neurology Report to review the benefits and adverse effects of the available disease-modifying agents for MS and to select appropriate relapse treatment.

Levin and Jackson

Neurology Reports

Diagnosing MS: Recognizing Common Symptoms and Interpreting MRI Results

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

Activity | Published: 6/15/2014 | Keywords: medical conditions, None, None, None, None, None

Early diagnosis of MS is critical for patients to begin disease-modifying therapy as soon as possible. Read this new Neurology Report to learn how to apply updated diagnostic criteria to recognize MS in its early stages and to rule out conditions similar to MS using appropriate tests.

+Update on Best Practices for Managing Bipolar Depression [Series Home Page]

Gary S. Sachs and Terence A. Ketter

JCP CME

Update on Best Practices for Managing Bipolar Depression

Gary S. Sachs, MD, and Terence A. Ketter, MD

Activity | Published: 5/15/2014 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

New! This Commentary summarizes 2 CME activities on managing bipolar depression through using measurement-based assessments and knowing which medications are most effective.

Terence A. Ketter

Brief Report

Important Distinctions Between Bipolar I and Bipolar II Depression

Terence A. Ketter, MD

Activity | Published: 4/15/2013 | Keywords: bipolar depression, None, None, None, None, None

Discover ways to apply study results to calculate the risk/benefit ratio of agents and determine the best treatment plan for your patients with bipolar depression.

Gary S. Sachs

Brief Report

Unmet Needs in the Assessment and Management of Bipolar I Depression

Gary S. Sachs, MD

Activity | Published: 4/15/2013 | Keywords: bipolar depression, None, None, None, None, None

Learn how pre-assessment tools can create more time for you to engage with patients and increase the number of wise treatment choices made collaboratively.

+Measurement-Based Strategies to Assess and Manage Schizophrenia    [Series Home Page]

Leslie Citrome

Brief Report

New Treatment Targets to Improve Symptoms in Schizophrenia

Leslie Citrome, MD, MPH

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

A paradigm shift in schizophrenia treatment is focusing on the glutamate system for new agents to address all symptom domains. Read this new Psychlopedia activity to learn what adjunctive agents are in development to treat negative and cognitive symptoms as well as agents that work through different pathways.

Philip D. Harvey

Brief Report

Assessing Disability in Schizophrenia: Tools and Contributors

Philip D. Harvey, PhD

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

How do you measure everyday functioning in your patients with schizophrenia? Read this Psychlopedia activity to learn about strategies and tools to assess your patients' functional disability and to discover factors that contribute to functional disability so you can select appropriate interventions.

Stefan Leucht, MD

Brief Report

Measuring Outcomes in Schizophrenia and Examining Their Clinical Application

Stefan Leucht, MD

Activity | Published: 3/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Different definitions for patient outcomes can make study results difficult to compare and apply to your patients' treatment. Read this new Psychlopedia activity to understand criteria for response, remission, and recovery and how to apply study results to your own patients' treatment plans and goals.

Brian Kirkpatrick

Brief Report

Recognizing Primary Vs Secondary Negative Symptoms and Apathy Vs Expression Domains

Brian Kirkpatrick, MD, MSPH

Activity | Published: 2/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Your patients' negative symptoms could be caused by depression, psychotic symptoms, medication side effects, or substance abuse. Read this new Psychlopedia activity to learn how to differentiate and treat the cause of negative symptoms and to recognize symptoms of apathy and diminished expression that emerge in most factor analysis studies of rating scales.

Leslie Citrome et al

Journal Supplement

Measurement-Based Strategies to Assess and Manage Schizophrenia

Leslie Citrome, MD, MPH (Chair), et al

Activity | Published: 3/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Persisting negative and cognitive symptoms negatively impact patients' functioning, quality of life, and chances for achieving recovery. In this Supplement, learn how to disinguish between primary and secondary negative symptoms, find out how to assess your patients' treatment response and functioning, and discover new therapeutic targets in the treatment of schizophrenia to comprehensively address all presentations of the disorder.

+Benefits and Barriers to Using Long-Acting Injectable Antipsychotics in Schizophrenia [Series Home Page]

Christoph U. Correll

Brief Report

The Role of the Extended Health Care Team in Successful LAI Therapy: Education to Overcome Barriers

Christoph U. Correll, MD

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Learn about the pros and cons of LAI antipsychotics and ways to address health care team concerns.

Christoph U. Correll

Brief Report

Recognition of Patients Who Would Benefit From LAI Antipsychotic Treatment: How to Assess Adherence

Christoph U. Correll, MD

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

What methods do you use to assess your patients' medication adherence? Read this Psychlopedia activity to realize the factors that contribute to adherence problems and to discover multiple methods to assess adherence as well as how to identify patients who would benefit from long-acting injectable antipsychotic treatment.

John M. Kane

Brief Report

Attitudinal Barriers to Prescribing LAI Antipsychotics in the Outpatient Setting: Communicating With Patients, Families, and Caregivers

John M. Kane, MD

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

What concerns regarding long-acting injectable antipsychotic treatment do you have? Check out this activity to review common attitudes that keep some clinicians from using this treatment as well as how to recognize which patients would benefit the most from this option.

John M. Kane

Brief Report

Organizational Barriers to Using Long-Acting Injectable Antipsychotics in Practice

John M. Kane, MD

Activity | Published: 4/15/2014 | Keywords: schizophrenia, None, None, None, None, None

Despite evidence of their benefits, long-acting injectable antipsychotics are underused in the US. In this multimedia activity, learn ways to overcome common misconceptions and logistical problems that hinder the use of LAI antipsychotics. Plus, see how leadership and staff buy-in are crucial for implementing this treatment.

+Improving the Diagnosis and Management of Depression in Bipolar Disorder [Series Home Page]

Paul E. Keck

Brief Report

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder

Paul E. Keck, Jr., MD

Activity | Published: 3/15/2014 | Keywords: bipolar disorder, None, None, None, None, None

New! Learn how to use rating scales to track efficacy and discover ways to monitor common side effects.

Terence A. Ketter

Brief Report

Acute and Maintenance Treatment for Bipolar Depression

Terence A. Ketter, MD

Activity | Published: 2/15/2014 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Depression in bipolar disorder can be difficult to diagnose and challenging to treat. Learn how to select evidence-based treatment and help your patients with bipolar depression achieve and maintain remission.

Eduard Vieta

Brief Report

Emerging Trends: Novel Molecular Targets and Moving Beyond Acute Symptoms in Bipolar Depression

Eduard Vieta, PhD

Activity | Published: 2/15/2014 | Keywords: bipolar disorder, None, None, None, None, None

Are you up on the latest research for bipolar depression treatments? Here, review existing medications and find out about new treatments, like glutamatergic modulators, dopamine agonists, psychostimulants, and other agents, to help your patients with bipolar depression achieve remission while having a low side-effect burden.

Roger S. McIntyre

Brief Report

Improving the Early Recognition and Diagnosis of Bipolar Disorder

Roger S. McIntyre, MD, FRCPC

Activity | Published: 12/15/2013 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Find out how to use DSM criteria to screen for bipolar disorder and to recognize other features that indicate this illness.

+Improving the Differential Diagnosis and Treatment of Bipolar Depression in Primary Care [Series Home Page]

Susan L. McElroy

Brief Report

Prescribing Antidepressants for Bipolar Depression: What Does the Evidence Say?

Susan L. McElroy, MD

Activity | Published: 2/15/2014 | Keywords: bipolar depression, None, None, None, None, None

Antidepressants continue to be prescribed as monotherapy to patients with bipolar depression even though guidelines advise against them. Here, Dr McElroy summarizes why antidepressant monotherapy is not recommended by current guidelines, what risks are associated with their use, and when their use is indicated.

Susan L. McElroy, MD

Brief Report

Pros and Cons of Approved Therapies for Bipolar Depression and Ongoing Unmet Needs

Susan L. McElroy, MD

Activity | Published: 2/15/2014 | Keywords: bipolar depression, None, None, None, None, None

Only 3 medications are currently FDA-approved for the treatment of bipolar depression. Read this new Psychlopedia to learn the effectiveness and adverse effects of approved bipolar depression treatments and to discover areas for future study.

Larry Culpepper

Brief Report

Differential Diagnosis of Unipolar Vs Bipolar Depression

Larry Culpepper, MD, MPH

Activity | Published: 2/15/2014 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

New! Read about 2 effective tools for screening for bipolar disorder and how to use them throughout treatment to recognize red flags that indicate this illness.

Larry Culpepper, MD, MPH

Brief Report

Misdiagnosis of Bipolar Depression in Primary Care Practices

Larry Culpepper, MD, MPH

Activity | Published: 11/15/2013 | Keywords: bipolar depression, None, None, None, None, None

About one-third of patients with bipolar disorder wait 10 or more years before receiving a correct diagnosis. Read this new Psychlopedia activity to learn how to provide an accurate and timely diagnosis for your patients with bipolar disorder by differentiating unipolar and bipolar depression and assessing patients for manic and hypomanic episodes.

+Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies [Series Home Page]

Michael E. Thase

Brief Report

Translating Clinical Science Into Effective Therapies

Michael E. Thase, MD

Activity | Published: 1/15/2014 | Keywords: depression, None, None, None, None, None

How do you know if your patients are treatment resistant? In this activity, find out how to categorize treatment-resistant depression, what the risk factors are, and how to recognize and treat it to improve overall outcomes.

+Restless Legs Syndrome: Recognition, Diagnosis, and Treatment of a Common Sleep Disorder [Series Home Page]

Christopher J. Earley

Neurology Reports

Latest Guidelines and Advances for Treatment of Restless Legs Syndrome

Christopher J. Earley, MBBCh, PhD, FRCPI

Activity | Published: 1/15/2014 | Keywords: sleep disorders, pain, None, None, None, None

Which agents are best for which patients with restless legs syndrome? Find out about treatment options to relieve your patients' disturbed sleep and painful symptoms.

William G. Ondo

Neurology Reports

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

William G. Ondo, MD

Activity | Published: 12/15/2013 | Keywords: medical conditions, sleep disorders, None, None, None, None

New! Discover which disorders are often confused with restless legs syndrome (RLS) and which conditions and medications are associated with secondary RLS.

Richard P. Allen

Neurology Reports

Screening for Sleep Disorders: Recognizing the Features and Presentations of Restless Legs Syndrome

Richard P. Allen, PhD

Activity | Published: 12/15/2013 | Keywords: medical conditions, sleep disorders, None, None, None, None

New! Learn how misconceptions about restless legs syndrome can hinder its correct diagnosis and discover how diagnostic criteria can improve your ability to identify this condition.

+Treatment of Depression in Primary Care: Using Tools to Improve Outcomes [Series Home Page]

Larry Culpepper and Madhukar H. Trivedi

PCC CME

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

Larry Culpepper, MD, MPH, and Madhukar H. Trivedi, MD

Activity | Published: 11/30/2013 | Keywords: depression, atypical depression, medical conditions, None, None, None

New! This Commentary summarizes an online CME program on the treatment of depression and assesses outcomes of that program.

Larry Culpepper

Brief Report

Improving Patient Outcomes in Depression Through Guideline-Concordant, Measurement-Based Care

Larry Culpepper, MD, MPH

Activity | Published: 2/15/2013 | Keywords: depression, medical conditions, None, None, None, None

Learn what guideline-concordant care means for your practice and what assessment tools you can use to measure your patients’ symptoms.

Madhukar H. Trivedi

Brief Report

Evaluating and Monitoring Treatment Response in Depression Using Measurement-Based Assessment and Rating Scales

Madhukar H. Trivedi, MD

Activity | Published: 2/15/2013 | Keywords: depression, None, None, None, None, None

Find out about using tools to assess your patients, track their symptoms, and modify their treatment plans.

+Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission [Series Home Page]

Zajecka, MD et al

Journal Supplement

Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission

John M. Zajecka, MD (Chair), et al

Activity | Published: 10/15/2013 | Keywords: depression, None, None, None, None, None

Do you treat your patients with MDD until they are asymptomatic? Read this CME Supplement to find out how to recognize, monitor, and treat residual symptoms.

+Working Together to Restore Mental Well-Being and Address Domestic Violence Among Veterans: A Call To Action [Series Home Page]

Casey T. Taft

Brief Report

Working Together to Address Domestic Violence Among Veterans

Casey T. Taft, PhD

Activity | Published: 10/15/2013 | Keywords: PTSD, mental illness, None, None, None, None

Participate in this brief activity to get an overview of core themes in troubled relationships as well as ways to assess for, prevent, and address intimate partner violence in veterans and their families.

Dao et al

JCP CME

Preventing Domestic Violence in Families of Veterans

Jim Dao (moderator), et al

Activity | Published: 10/15/2013 | Keywords: PTSD, substance use disorders, mental illness, None, None, None

Review highlights from a discussion among experts regarding best practices for preventing and identifying violence in the families of veterans.

+Complicated OCD: Issues of Comorbidity and Clinical Challenges [Series Home Page]

Jennifer G. Wells

Brief Report

Obsessive-Compulsive Disorder in Youth: Assessment and Treatment

Jennifer G. Wells, MSW, LISW

Activity | Published: 10/15/2013 | Keywords: anxiety, obsessive-compulsive disorder, None, None, None, None

Do you have young patients with OCD? Engage in this brief activity to understand how developmental factors, family involvement, and comorbidities affect treatment. Also, find out how to distinguish typical OCD from an infection-triggered illness in youth.

Charles F. Brady

Brief Report

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Charles F. Brady, PhD, ABPP

Activity | Published: 10/15/2013 | Keywords: anxiety, obsessive-compulsive disorder, None, None, None, None

Do you have patients with OCD whose obsessions are of suicide or whose compulsions are dangerous? Get practical tips on addressing these issues.

Charles F. Brady

Brief Report

Obsessive-Compulsive Disorder and Common Comorbidities

Charles F. Brady, PhD, ABPP

Activity | Published: 9/15/2013 | Keywords: anxiety, obsessive-compulsive disorder, depression, eating disorders, None, None

New! Find out about adjustments in both psychotherapy and pharmacotherapy for patients with OCD and comorbid depression, bipolar disorder, schizophrenia, or eating disorders.

+Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System [Series Home Page]

Andrew D. Krystal, MD, MS (Chair), et al

Journal Supplement

Academic Proceedings: Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System

Andrew D. Krystal, MD, MS (Chair), et al

Activity | Published: 9/15/2013 | Keywords: insomnia, sleep disorders, None, None, None, None

Learn about current treatments for insomnia, new research into understanding the sleep-wake cycle, and how that research might play out in treatments.

+Assessing and Managing Pain and Major Depression With Medical Comorbidities [Series Home Page]

W. Clay Jackson

VS - Virtual Slide Set

Assessing and Managing Pain and Major Depression With Medical Comorbidities

W. Clay Jackson, MD, DipTh

Activity | Published: 9/15/2013 | Keywords: depression, pain, medical conditions, None, None, None

Watch this multimedia slide show to learn about the co-occurrence of pain, depression, and medical comorbidities.

+Schizophrenia: Using Long-Acting Injectable Antipsychotics to Improve Treatment Adherence [Series Home Page]

Stephen R. Marder

Brief Report

Monitoring Treatment and Managing Adherence in Schizophrenia

Stephen R. Marder, MD

Activity | Published: 7/15/2013 | Keywords: schizophrenia, None, None, None, None, None

Review ways to assess and address barriers to adherence and to monitor side effects that contribute to nonadherence and dangerous health conditions.

John M. Kane

Brief Report

Improving Patient Outcomes in Schizophrenia: Achieving Remission, Preventing Relapse, and Measuring Success

John M. Kane, MD

Activity | Published: 7/15/2013 | Keywords: schizophrenia, None, None, None, None, None

Get an overview of how to apply treatment goals to improve your patients' adherence and increase the proportion who reach recovery.

Christoph U. Correll

Brief Report

Addressing Barriers to Using Long-Acting Injectable Antipsychotics and Appropriately Monitoring Antipsychotic Adverse Effects

Christoph U. Correll, MD

Activity | Published: 6/15/2013 | Keywords: schizophrenia, None, None, None, None, None

See how study design affects the results of LAI efficacy in schizophrenia, how to overcome barriers to using LAI treatment, and how to monitor common side effects associated with antipsychotics.

+The Effects of the Affordable Care Act on the Practice of Psychiatry [Series Home Page]

Ebert et al

Brief Report

The Affordable Care Act and Practice in Psychiatry

Michael H. Ebert, MD (Chair), et al

Activity | Published: 6/15/2013 | Keywords: mental illness, None, None, None, None, None

Find out how the Affordable Care Act will affect the care of patients with mental health disorders, practitioners, and future research.

Ebert et al

JCP CME

The Effects of the Affordable Care Act on the Practice of Psychiatry

Michael H. Ebert, MD (Chair), et al

Activity | Published: 4/15/2013 | Keywords: mental illness, medical conditions, None, None, None, None

Find out how recent laws are changing psychiatry by using an integrated approach, moving toward team-based practices, and incorporating the latest technology.

+ADHD in College, Phase II: Managing the Risk of Misuse, Abuse, and Diversion [Series Home Page]

J. Sloan Manning

Brief Report

Strategies for Managing the Risks Associated With ADHD Medications

J. Sloan Manning, MD

Activity | Published: 5/15/2013 | Keywords: ADHD, None, None, None, None, None

Find out how DSM criteria and rating scales can help you diagnose ADHD and screen for common comorbid conditions, and learn ways to reduce nonmedical use of your patients' prescriptions.

Larry Culpepper

Brief Report

Recognizing and Addressing Barriers to the Effective Management of ADHD in College Students

Larry Culpepper, MD, MPH

Activity | Published: 5/15/2013 | Keywords: ADHD, None, None, None, None, None

Review the unique barriers to the diagnosis and management of ADHD in college students, and find out how to recognize those at risk for misusing their medication.

+Caring for Returning Veterans: Meeting Mental Health Needs [Series Home Page]

Keane et al

Brief Report

Mental Health Needs of Returning Veterans

Terence M. Keane, PhD (Chair), et al

Activity | Published: 5/15/2013 | Keywords: mental illness, PTSD, None, None, None, None

Find out what challenges veterans face in receiving mental health care, what you can do to better understand these patients, and what resources are available to help you meet their needs.

Keane et al

JCP CME

Commentary: Caring for Returning Veterans: Meeting Mental Health Needs

Terence M. Keane, PhD; Basit Chaudhry, MD, PhD; John P. Docherty, MD; Robert L. Jesse, MD, PhD; Jennifer Lee, MD; Jessica McNurlen, MA, CRC; and Eileen Zeller, MPH

Activity | Published: 1/15/2013 | Keywords: PTSD, None, None, None, None, None

Read about the challenges that returning veterans face in receiving mental health care and the ways that family members, employers, and communities can support them.

+Alzheimer's Disease: The Importance of Early Diagnosis and Appropriate Management [Series Home Page]

Pierre N. Tariot

Neurology Reports

Early Diagnosis and Management of Alzheimer's Disease

Pierre N. Tariot, MD

Activity | Published: 3/15/2013 | Keywords: Alzheimer's, None, None, None, None, None

Learn about the latest laboratory and imaging tests to help diagnose Alzheimer's disease and the available therapies to help slow disease progression.

+Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences [Series Home Page]

Peskind et al

JCP CME

Commentary: Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences

Elaine R. Peskind, MD (Chair), et al

Activity | Published: 2/15/2013 | Keywords: medical conditions, dementia, anxiety, depression, None, None

Read this discussion among the experts to gain insight into the possible short-term and long-term effects of mild traumatic brain injury.

Peskind et al

Neurology Reports

Military- and Sports-Related Mild Traumatic Brain Injury: An Overview

Elaine R. Peskind, MD (Chair), et al

Activity | Published: 2/15/2013 | Keywords: pain, dementia, PTSD, medical conditions, None, None

Discover how to screen for mild traumatic brain injury (mTBI) in patients who have experienced head injury and how to treat mTBI according to current guidelines.

+Expired Other [Series Home Page]

Pierre N. Tariot and P. Murali Doraiswamy

Webcast

Alzheimer's Disease: The Importance of Early Diagnosis and Appropriate Management

Pierre N. Tariot, MD, and P. Murali Doraiswamy, MBBS, FRCP

Activity | Published: 1/15/2013 | Keywords: Alzheimer's, None, None, None, None, None

Do you use assessment tolls or neuroimaging to aid in diagnosing Alzheimer's disease (AD)? In this Webcast, learn about dementia and AD presentation, completing the differential diagnosis, and using neuropsychiatric tests and neuroimaging to comprehensively assess patients with suspected AD.

+Negative Symptoms in Schizophrenia: Treatment Gaps and Unmet Needs [Series Home Page]

John M. Kane

Brief Report

Tools to Assess Negative Symptoms in Schizophrenia

John M. Kane, MD

Activity | Published: 12/15/2012 | Keywords: schizophrenia, None, None, None, None, None

Do you regularly use an assessment tool to track your schizophrenia patients' negative symptoms? Read this new Psychlopedia activity to review the current and future assessment tools you can use to measure negative symptom severity and track treatment response.

Robert W. Buchanan

Brief Report

Novel Pharmacologic Targets for the Treatment of Negative Symptoms in Schizophrenia

Robert W. Buchanan, MD

Activity | Published: 12/15/2012 | Keywords: schizophrenia, None, None, None, None, None

Learn how glutamatergic agents are being used to alleviate negative symptoms by affecting the glycine modulatory site.

Christoph U. Correll

Brief Report

The Prevalence of Negative Symptoms in Schizophrenia and Their Impact on Patient Functioning and Course of Illness

Christoph U. Correll, MD

Activity | Published: 11/15/2012 | Keywords: schizophrenia, None, None, None, None, None

New! Find out which patients with schizophrenia are likely to have negative symptoms and how these symptoms affect patients’ functioning, outcome, and quality of life.

Brian Kirkpatrick

Brief Report

Understanding the Physiology of Schizophrenia

Brian Kirkpatrick, MD

Activity | Published: 11/15/2012 | Keywords: schizophrenia, None, None, None, None, None

Discover how glutamate, serotonin, and acetylcholine systems, as well as diabetes and inflammation, may contribute to schizophrenia symptoms.

Stephen R. Marder

Brief Report

Clinician Perceptions, Expectations, and Management of Negative Symptoms in Schizophrenia

Stephen R. Marder, MD

Activity | Published: 10/15/2012 | Keywords: schizophrenia, None, None, None, None, None

How do you address negative symptoms of schizophrenia? Get an overview of ways to recognize these problematic symptoms and discover options for improving patient functioning.

+The Effect of Marijuana Use on the Risk for Schizophrenia [Series Home Page]

Evins et al

Brief Report

Does Using Marijuana Increase the Risk for Developing Schizophrenia?

A. Eden Evins, MD, MPH (Chair), et al

Activity | Published: 12/15/2012 | Keywords: schizophrenia, substance use disorders, None, None, None, None

Learn which of your patients are most at risk for schizophrenia and should be warned about marijuana use.

Evins et al

JCP CME

Commentary: The Effect of Marijuana Use on the Risk for Schizophrenia

A. Eden Evins, MD, MPH (Chair), et al

Activity | Published: 11/15/2012 | Keywords: schizophrenia, substance use disorders, None, None, None, None

Discover how cannabis affects youths and the risk for psychosis and how potency can impact the effect of marijuana.

+Depression, Pain, and Comorbid Medical Conditions [Series Home Page]

Manning and Jackson

VS - Virtual Slide Set

Depression, Pain, and Comorbid Medical Conditions

J. Sloan Manning, MD, and W. Clay Jackson, MD

Activity | Published: 11/15/2012 | Keywords: depression, pain, medical conditions, None, None, None

View this multimedia slide show to learn about the co-occurrence of depression, pain, and medical conditions and why multi-directional relationships may happen.

+Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management [Series Home Page]

Emmanuelle Waubant, MD, PhD

PCC CME

Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management

Emmanuelle Waubant, MD, PhD

Activity | Published: 10/15/2012 | Keywords: medical conditions, None, None, None, None, None

Learn about making an accurate diagnosis of MS, why early recognition is critical, and what treatments are most effective.

Emmanuelle Waubant, MD, PhD

Neurology Reports

Accurately Diagnosing and Comprehensively Managing MS

Emmanuelle Waubant, MD, PhD

Activity | Published: 10/15/2012 | Keywords: medical conditions, None, None, None, None, None

Read this Neurology Report to discover ways to recognize and assess early symptoms of MS and review effective treatment strategies to help delay the disease’s progression.

+A Fresh Look at Monoamine Oxidase Inhibitors for Depression [Series Home Page]

Cohen et al

Journal Supplement

A Fresh Look at Monoamine Oxidase Inhibitors for Depression

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP (Co-Chair), and David A. Sclar, BPharm, PhD (Co-Chair), et al

Activity | Published: 7/15/2012 | Keywords: depression, atypical depression, None, None, None, None

Update your understanding of the mechanism of action of MAOIs and find out about a newer formulation with transdermal delivery.

Cohen et al

Brief Report

MAOIs: Issues in Treatment Adherence and Rates of Treatment Failure

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP, and David A. Sclar, BPharm, PhD

Activity | Published: 6/15/2012 | Keywords: depression, None, None, None, None, None

New! Here, discover strategies that are effective in improving patients' treatment adherence and learn about new MAOI formulations that can aid in that process.

David A. Flockhart, MD, PhD

Brief Report

An Update on MAOIs: Dietary Restrictions and Drug Interactions

David A. Flockhart, MD, PhD

Activity | Published: 5/15/2012 | Keywords: depression, None, None, None, None, None

Review which foods should be avoided and which drugs are contraindicated with MAOIs. Then, find out about newer MAOIs that can lessen the need for dietary modifications.

Chad M. VanDenBerg, PharmD, BCPP

Brief Report

MAOIs and Transdermal Delivery

Chad M. VanDenBerg, PharmD, BCPP

Activity | Published: 4/15/2012 | Keywords: atypical depression, depression, None, None, None, None

Find out about the mechanism of action of MAOIs, and learn about a newer MAOI formulation that may make adherence to treatment easier for your patients.

Robert M. A. Hirschfeld, MD

Brief Report

Depression Epidemiology and Its Treatment Evolution

Robert M. A. Hirschfeld, MD

Activity | Published: 3/15/2012 | Keywords: depression, None, None, None, None, None

Learn about the prevalence and burden of depression and review how depression treatments came about.

Michael E. Thase, MD

Brief Report

MAOIs and Depression Treatment Guidelines

Michael E. Thase, MD

Activity | Published: 2/15/2012 | Keywords: depression, None, None, None, None, None

Learn how to safely prescribe MAOIs and find out which patients, according to treatment guidelines, might gain the most benefit from these medications.

Larry Culpepper, MD, MPH

Brief Report

The Use of MAOIs in Primary Care

Larry Culpepper, MD, MPH

Activity | Published: 1/15/2012 | Keywords: depression, atypical depression, None, None, None, None

Read about the safety, tolerability, and efficacy of MAOIs, and find out which of your primary care patients may best respond to these agents.

+NCDEU Poster Session 2012 [Series Home Page]

Various Presenters

Poster Session

NCDEU Poster Session 4

Various Presenters

Activity | Published: 6/15/2012 | Keywords: depression, bipolar disorder, schizophrenia, None, None, None

Why do you think many clinical trials aren't successful? Check 4 of the best posters from NCDEU that give insight to this issue and suggest using guidelines to aid in accurate reporting, review the evidence for trial strategies, and examine the influence of family history and of investigator attitudes on placebo response rates. A poster comparing atypical antipsychotics in preventing relapse in schizophrenia is also presented.

Various Presenters

Poster Session

NCDEU Poster Session 3

Various Presenters

Activity | Published: 6/15/2012 | Keywords: depression, None, None, None, None, None

Get the latest research on depression by viewing 4 of the best posters from NCDEU! Learn about potential biomarkers in MDD, predictors for likely response to treatment, and the efficacy of adjunctive treatment in achieving early and sustained response.

Various Presenters

Poster Session

NCDEU Poster Session 2

Various Presenters

Activity | Published: 6/15/2012 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

The best posters from the 2012 NCDEU meeting are here! These 4 posters feature original unpublished studies on schizophrenia, including topics like computer-aided simulation, poor antipsychotic treatment adherence, and study methodology comparisons, and bipolar disorder, focusing on cognitive deficits as treatment targets.

Various Presenters

Poster Session

NCDEU Poster Session 1

Various Presenters

Activity | Published: 6/15/2012 | Keywords: depression, None, None, None, None, None

View 4 of the best research posters from the NCDEU meeting featuring original unpublished studies on major depression, including genetic predictors of treatment resistance, ketamine as a novel antidepressant, and more!

+The Appropriate Use of Opiates in Chronic Pain [Series Home Page]

Autry J. Parker, MD, MPH

Neurology Reports

The Appropriate Use of Opiates in Chronic Pain

Autry J. Parker, MD, MPH

Activity | Published: 2/15/2012 | Keywords: pain, None, None, None, None, None

Review the use of opioid therapy for chronic pain and discover tools that can help you assess patients for abuse risk and safeguard them during treatment.

+Multiple Sclerosis Syndromes and Symptoms: A Clinical Primer [Series Home Page]

Lance J. Wright, MD

Neurology Reports

Identifying and Treating Pain Caused by MS

Lance J. Wright, MD

Activity | Published: 1/15/2012 | Keywords: pain, None, None, None, None, None

Learn about central neuropathic and nociceptive pain in MS and discover which evidence-based treatments are the most appropriate to alleviate each pain syndrome.

+New Treatment Approaches for Major Depressive Disorder   [Series Home Page]

Anita H. Clayton, MD

Brief Report

Understanding Antidepressant Mechanism of Action and Its Effect on Efficacy and Safety

Anita H. Clayton, MD

Activity | Published: 1/15/2012 | Keywords: depression, None, None, None, None, None

Participate in this activity to get an overview of how antidepressants work and find out how their mechanisms of action can help you tailor treatments to your patients.

Michael E. Thase, MD

Brief Report

Applying Antidepressant Study Results to Clinical Practice

Michael E. Thase, MD

Activity | Published: 12/15/2011 | Keywords: depression, None, None, None, None, None

Learn how to analyze antidepressant trial design, methodology, publication bias, and placebo response rates to glean the most useful information and apply the results to your clinical practice.

Andrew A. Nierenberg, MD

Brief Report

Advancing the Treatment of Depression With Personalized Medicine

Andrew A. Nierenberg, MD

Activity | Published: 11/15/2011 | Keywords: depression, atypical depression, None, None, None, None

Learn about personalizing variables in antidepressant therapy, like gender and family history, and discover how you can match treatments to your patients with depression.

+Bipolar Disorder: Lessons for Rural Physicians: Adjunctive Interventions for Maintaining Remission [Series Home Page]

Michael E. Thase, MD

Brief Report

Monitoring Bipolar Disorder Maintenance Treatment

Michael E. Thase, MD

Activity | Published: 11/15/2011 | Keywords: bipolar disorder, bipolar mania, bipolar depression, None, None, None

Here, review the long-term efficacy and safety profiles of mood stabilizers and atypical antipsychotics so that you can help your patients stay in remission.

Michael E. Thase, MD

Brief Report

Strategies for Increasing Treatment Adherence in Bipolar Disorder

Michael E. Thase, MD

Activity | Published: 11/15/2011 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

Review factors that can affect adherence in your patients with bipolar disorder and discover how to proactively address these issues to improve their treatment outcomes.

Alan Podawiltz, DO, MS, FAPA

Brief Report

A Review of Current Bipolar Disorder Treatment Guidelines

Alan Podawiltz, DO, MS, FAPA

Activity | Published: 11/15/2011 | Keywords: bipolar disorder, bipolar depression, bipolar mania, bipolar mixed episodes, None, None

Get a summary of TIMA recommendations for the acute and maintenance treatment of bipolar disorder and find out when you should refer patients to a specialist.

Alan Podawiltz, DO, MS, FAPA

Brief Report

Diagnosing Bipolar Disorder: Signs and Symptoms

Alan Podawiltz, DO, MS, FAPA

Activity | Published: 11/15/2011 | Keywords: depression, bipolar depression, bipolar mania, substance use disorders, None, None

Discover how to use tools like the DSM criteria and assessment mnemonics to accurately diagnose bipolar disorder and distinguish it from other conditions.

+Schizophrenia: When First-Line Treatment Fails [Series Home Page]

John M. Kane, MD

Brief Report

Addressing Nonresponse in Schizophrenia

John M. Kane, MD

Activity | Published: 11/15/2011 | Keywords: schizophrenia, None, None, None, None, None

Discover what to do when your patients with schizophrenia don’t respond to first-line treatments and get recommendations for monitoring and managing adverse events with last-line therapies.

John M. Kane, MD

Brief Report

Assessing and Measuring Nonresponse in Schizophrenia

John M. Kane, MD

Activity | Published: 11/15/2011 | Keywords: schizophrenia, None, None, None, None, None

Find out how to use measurement-based tools to assess your patients' baseline symptomatology and measure their improvement so that the results can inform your treatment decisions.

+Diagnosing and Managing Patients With Dementia [Series Home Page]

Robbie Cooksey, DO (Chair)

Brief Report

Diagnosing and Managing Patients With Dementia

Robbie Cooksey, DO, and Janice Knebl, DO, MBA

Activity | Published: 11/15/2011 | Keywords: dementia, None, None, None, None, None

Find out about the consequences of a missed or delayed diagnosis of dementia, discover screening tools to assess your patients, and learn how to recognize this illness early.

+ADHD in College: Seeking and Receiving Care During the Transition From Child to Adult [Series Home Page]

Larry Culpepper, MD (Chair)

Brief Report

Treating ADHD: Addressing the Needs of College Students

Larry Culpepper, MD, and Paul King, MD

Activity | Published: 11/15/2011 | Keywords: ADHD, None, None, None, None, None

Review evidence and experience as provided by community clinicians about the presentation, diagnosis, and management of ADHD in college students.

Larry Culpepper, MD, MPH

Brief Report

Prevalence and Impact of ADHD in College Students

Larry Culpepper, MD, MPH

Activity | Published: 7/15/2011 | Keywords: ADHD, None, None, None, None, None

Discover how ADHD affects young adults and learn what behaviors to look for in your college-aged patients.

Larry Culpepper, MD, MPH

Brief Report

Recognizing and Diagnosing ADHD in College Students

Larry Culpepper, MD, MPH

Activity | Published: 7/15/2011 | Keywords: ADHD, None, None, None, None, None

Find out how to assess for ADHD in college students by adapting diagnostic criteria, using measurement-based tools, evaluating for comorbidities, and completing a differential diagnosis.

+Overview of Current Issues in the Management of Multiple Sclerosis [Series Home Page]

Emmanuelle Waubant, MD, PhD

Neurology Reports

Treatment Options in Multiple Sclerosis

Emmanuelle Waubant, MD, PhD

Activity | Published: 11/15/2011 | Keywords: medical conditions, None, None, None, None, None

How can you slow the progression of MS? Update your understanding of first- and second-line MS treatments to help manage the disorder and optimize outcomes for your patients.

Emmanuelle Waubant, MD, PhD

Neurology Reports

Early Recognition and Diagnosis of Multiple Sclerosis

Emmanuelle Waubant, MD, PhD

Activity | Published: 11/15/2011 | Keywords: medical conditions, None, None, None, None, None

Learn about the wide range of symptoms, updated diagnostic criteria, clinical subtypes, and psychiatric issues associated with multiple sclerosis.

+International Consensus Group on Depression Prevention in Bipolar Disorder [Series Home Page]

Mark A. Frye, MD

JCP CME

International Consensus Group on Depression Prevention in Bipolar Disorder

Mark A. Frye, MD (Chair), et al

Activity | Published: 10/15/2011 | Keywords: bipolar depression, None, None, None, None, None

Review the standards of care for bipolar depression in America, Japan, Korea, Turkey, and Argentina and get treatment advice from international experts in psychiatry.

+Alzheimer's Disease: Implications of the Updated Diagnostic and Research Criteria [Series Home Page]

Eric M. Reiman, MD (Chair)

Brief Report

Clinical Impact of Updated Diagnostic and Research Criteria for Alzheimer’s Disease

Eric M. Reiman, MD (Chair), et al

Activity | Published: 9/15/2011 | Keywords: Alzheimer's, dementia, None, None, None, None

Review the diagnostic and research criteria for Alzheimer’s disease and consider their implications for evaluating and managing your patients.

Eric M. Reiman, MD

JCP CME

Alzheimer’s Disease: Implications of the Updated Diagnostic and Research Criteria

Eric M. Reiman, MD (Chair), et al

Activity | Published: 9/15/2011 | Keywords: Alzheimer's, dementia, None, None, None, None

Read this Commentary to find out why experts recently updated the Alzheimer’s disease (AD) criteria and to review new advances in AD that may apply to your clinical practice.

+Fibromyalgia: Creating a Patient-Centered Diagnostic and Therapeutic Roadmap [Series Home Page]

Larry Culpepper, MD, MPH

Brief Report

Management of Fibromyalgia in Primary Care

Larry Culpepper, MD, MPH

Activity | Published: 9/15/2011 | Keywords: fibromyalgia, pain, None, None, None, None

Here, learn about organizational strategies, pharmacologic and nonpharmacologic treatments, and tools to measure symptomatic improvement for your patients with fibromyalgia.

Larry Culpepper, MD, MPH

Brief Report

Presentation and Diagnosis of Fibromyalgia

Larry Culpepper, MD, MPH

Activity | Published: 9/15/2011 | Keywords: fibromyalgia, None, None, None, None, None

Learn about the new ACR diagnostic criteria for fibromyalgia, review common symptoms and co-occurring conditions, and get an overview of standardized assessments that can help you in making an accurate diagnosis.

Larry Culpepper, MD, MPH

Brief Report

A Roadmap for the Management of Fibromyalgia

Larry Culpepper, MD, MPH

Activity | Published: 9/15/2011 | Keywords: fibromyalgia, None, None, None, None, None

Find out about ways to help your patients with fibromyalgia set realistic goals and then develop treatment strategies to accomplish those goals.

+2011 ICBD Conference Coverage: Practical Applications of New Research in Bipolar Disorder [Series Home Page]

Paul King, MD

Brief Report

2011 ICBD Conference Coverage

Paul King, MD

Activity | Published: 8/15/2011 | Keywords: bipolar disorder, bipolar mania, bipolar mixed episodes, None, None, None

Get the latest in bipolar disorder research, including medical lifestyle management and interventions, new DSM criteria for mixed and hypomanic episodes, and more!

+Evidence for Using L-Methylfolate Combined With Antidepressants in MDD [Series Home Page]

Maurizio Fava, MD (Chair)

Brief Report

Evidence for the Use of l-Methylfolate Combined With Antidepressants in MDD

Maurizio Fava, MD (Chair), et al

Activity | Published: 5/15/2011 | Keywords: depression, None, None, None, None, None

Here, review the latest research of L-methylfolate by the authors and find out how using folate may enhance antidepressant response for your patients with major depression.

+Depression: When Initial Therapy Fails [Series Home Page]

Michael E. Thase, MD

Brief Report

Using Adjunctive Treatments When First-Line Antidepressants Fail

Michael E. Thase, MD

Activity | Published: 4/15/2011 | Keywords: depression, None, None, None, None, None

Discover augmentation therapies, including lithium, thyroid hormones, anxiolytics, and atypical antipsychotics, for your patients with treatment-resistant depression.

Roger S. McIntyre, MD, FRCPC

Brief Report

Implementing Guideline-Based Strategies to Avoid Relapse and Recurrence in Depression

Roger S. McIntyre, MD, FRCPC

Activity | Published: 4/15/2011 | Keywords: depression, dementia, anxiety, medical conditions, None, None

Use the strategies described here to find out why patients may not achieve remission, what that means for them, and how you can help.

J. Sloan Manning, MD

Brief Report

Selecting Appropriate Treatment for Patients Who Are Nonresponsive to Initial Therapy

J. Sloan Manning, MD

Activity | Published: 4/15/2011 | Keywords: depression, None, None, None, None, None

Discover how to select appropriate treatment for patients whose depression does not remit with initial antidepressant monotherapy.

Larry Culpepper, MD, MPH

Brief Report

Understanding the Burden of Depression

Larry Culpepper, MD, MPH

Activity | Published: 4/15/2011 | Keywords: depression, None, None, None, None, None

NEW! Update your understanding of the burden of depression and the importance of treating to full remission.

+Using Diagnostic and Assessment Tools for Adolescents With ADHD [Series Home Page]

Lenard A. Adler, MD (Chair)

Brief Report

Administering and Evaluating the Results of the Adult ADHD Self-Report Scale (ASRS) in Adolescents

Lenard A. Adler, MD, and Jeffrey H. Newcorn, MD

Activity | Published: 3/15/2011 | Keywords: ADHD, None, None, None, None, None

Learn about factors that may affect the accuracy of rating scales and discover methods for evaluating the information reported.

Lenard A. Adler, MD (Chair)

Brief Report

Assessing Adolescents Using ADHD Rating Scales

Lenard A. Adler, MD, and Jeffrey H. Newcorn, MD

Activity | Published: 3/15/2011 | Keywords: ADHD, None, None, None, None, None

Learn about tools that can help you accurately assess for ADHD, target key symptoms, and measure treatment response.

+Using Moderator-Based Algorithms  and Electronic Medical Records  to Achieve Optimal Outcomes in Depression [Series Home Page]

Richard C. Shelton, MD, and Madhukar H. Trivedi, MD

Brief Report

Treating Depression With Algorithms and CDSS

Richard C. Shelton, MD, and Madhukar H. Trivedi, MD

Activity | Published: 2/15/2011 | Keywords: depression, None, None, None, None, None

Discover how integrating algorithms and measurement-based care into a software system can make optimizing patient care easier and more efficient.

Richard C. Shelton, MD (Chair)

Brief Report

Moderators of Antidepressant Response in Major Depression

Richard C. Shelton, MD, and Madhukar H. Trivedi, MD

Activity | Published: 2/15/2011 | Keywords: depression, atypical depression, anxiety, substance use disorders, None, None

In this activity, find out how moderators can help you predict individual patient outcomes, select effective treatments, and progress your patients through treatment steps.

Richard C. Shelton, MD, and Madhukar H. Trivedi, MD

Brief Report

Challenges and Algorithm-Guided Treatment in Major Depressive Disorder

Richard C. Shelton, MD, and Madhukar H. Trivedi, MD

Activity | Published: 2/15/2011 | Keywords: depression, None, None, None, None, None

Learn how to improve outcomes for your patients with depression by using algorithms and measurement-based care.

Richard C. Shelton, MD, and Madhukar H. Trivedi, MD

Webcast

Using Moderator-Based Algorithms and Electronic Medical Records to Achieve Optimal Outcomes in Depression

Richard C. Shelton, MD, and Madhukar H. Trivedi, MD

Activity | Published: 11/15/2010 | Keywords: depression, None, None, None, None, None

Watch this Webcast to discover how to evaluate predictors of treatment response and to learn how to integrate this information into your practice via electronic medical records.

+The Current Crisis of Confidence in Antidepressants [Series Home Page]

Andrew A. Nierenberg, MD (Chair)

Brief Report

Crisis of Confidence: Antidepressant Risk Versus Benefit

Andrew A. Nierenberg, MD (Chair), et al

Activity | Published: 1/15/2011 | Keywords: depression, None, None, None, None, None

Read a discussion regarding how recent events have affected the public's perception of the safety and efficacy of antidepressants.

Andrew A. Nierenberg, MD (Chair)

JCP CME

Commentary: The Current Crisis of Confidence in Antidepressants / Suicidality in Obsessive-Compulsive Disorder: Prevalence and Relation to Symptom Dimensions and Comorbid Conditions / Panic Attacks and Panic Disorder in a Population-Based Sample of Active Canadian Military Personnel

Andrew A. Nierenberg, MD (Chair), et al / Albina R. Torres, Ana Teresa A. Ramos-Cerqueira, Ygor A. Ferrão, Leonardo F. Fontenelle, Maria Conceição do Rosário, and Euripedes C. Miguel/ D. Jolene Kinley, John R. Walker, Corey S. Mackenzie, and Jitender Sareen

Activity | Published: 1/15/2011 | Keywords: depression, obsessive-compulsive disorder, panic disorder, None, None, None

Experts in psychiatry discuss how the public’s perception of the safety and efficacy of antidepressants has been affected by media reports and what that means for practicing clinicians.

+New Approaches to Managing Schizoaffective Disorder From Diagnosis to Treatment [Series Home Page]

John M. Kane, MD (Chair)

Journal Supplement

Managing Schizoaffective Disorder From Diagnosis to Treatment

John M. Kane, MD (Chair), et al

Activity | Published: 12/15/2010 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Review the etiology of schizoaffective disorder and find out how to complete differential diagnoses and encourage treatment adherence.

Christoph U. Correll, MD

Brief Report

Psychobiology and Psychosocial Functioning of Schizoaffective Disorder

Christoph U. Correll, MD

Activity | Published: 10/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Get an overview of the possible nosologic overlaps between schizoaffective disorder, schizophrenia, and mood disorders.

Donald C. Goff, MD

Brief Report

Treatment Adherence in Schizophrenia and Schizoaffective Disorder

Donald C. Goff, MD, et al

Activity | Published: 9/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Find out why your patients may be nonadherent to pharmacologic treatment and what you can do to improve their medication compliance.

John M. Kane, MD

Brief Report

The Differential Diagnosis of Schizoaffective Disorder

John M. Kane, MD

Activity | Published: 9/15/2010 | Keywords: bipolar disorder, schizophrenia, None, None, None, None

Schizoaffective disorder is often misdiagnosed as mood and other psychotic disorders, but an effective initial evaluation and accurate patient history can help in the differential diagnosis. Participate in this new Web activity to learn the distinguishing characteristics of schizoaffective disorder so you avoid common diagnostic mistakes when evaluating patients with psychosis.

Eduard Vieta, MD, PhD

Brief Report

Individualizing Treatment for Patients With Schizoaffective Disorder

Eduard Vieta, MD, PhD

Activity | Published: 9/15/2010 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Learn how to develop an individualized, evidence-based treatment regimen for your patients with schizoaffective disorder.

+Looking Past First-Line Therapy for Major Depressive Disorder [Series Home Page]

Larry Culpepper, MD, MPH

Journal Supplement

Looking Past First-Line Therapy for Major Depressive Disorder

Larry Culpepper, MD, MPH (Chair), et al

Activity | Published: 10/15/2010 | Keywords: depression, None, None, None, None, None

Learn what to do when first-line treatments don’t elicit adequate symptomatic improvement for your patients with depression, including choosing and implementing next-step strategies.

+Considerations in Managing Schizophrenia in Adolescents [Series Home Page]

Christoph U. Correll, MD

Brief Report

Addressing Adverse Effects of Antipsychotic Treatment in Young Patients With Schizophrenia

Christoph U. Correll, MD

Activity | Published: 10/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Participate in this activity to receive tips on monitoring and managing adverse effects of antipsychotic treatment to help your young patients achieve optimal outcomes.

Christoph U. Correll, MD

Brief Report

Symptomatic Presentation and Initial Treatment for Schizophrenia in Children and Adolescents

Christoph U. Correll, MD

Activity | Published: 10/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Certain clinical features can help to differentiate childhood-onset schizophrenia from mood and other psychotic disorders. Read this new activity to learn about the onset, course, and distinguishing features of early-onset and very-early-onset schizophrenia and review initial treatments for your young patients with this disorder.

Christoph U. Correll, MD

Brief Report

Safety and Tolerability of Antipsychotic Treatment in Young Patients With Schizophrenia

Christoph U. Correll, MD

Activity | Published: 10/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Receive the latest information regarding the varying risk profiles of antipsychotics for your young patients with schizophrenia.

+Challenges in the Long-Term Treatment of Schizophrenia [Series Home Page]

John M. Kane, MD

Brief Report

Addressing Side Effects From Antipsychotic Treatment in Schizophrenia

John M. Kane, MD

Activity | Published: 10/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Find out which medications are likely to cause specific adverse events and how you can manage these effects to ensure optimal outcomes.

John M. Kane, MD

Brief Report

Transitioning From Acute to Long-Term Treatment in Schizophrenia

John M. Kane, MD

Activity | Published: 10/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Read about strategies for transitioning your patients with schizophrenia from acute to maintenance treatment.

John M. Kane, MD

Brief Report

Improving Treatment Adherence in Patients With Schizophrenia

John M. Kane, MD

Activity | Published: 10/15/2010 | Keywords: schizophrenia, None, None, None, None, None

Patients with schizophrenia are at high risk for antipsychotic nonadherence. Learn how to address this problem in your patients.

+Improving Outcomes in Bipolar Disorder: From Early Recognition and Treatment to Remission [Series Home Page]

Andrew A. Nierenberg, MD

Brief Report

Alternatives to Antidepressants in Treating Acute Bipolar Depression

Andrew A. Nierenberg, MD

Activity | Published: 7/15/2010 | Keywords: bipolar depression, None, None, None, None, None

Discover alternatives to antidepressants that have shown efficacy in treating bipolar depressive episodes.

Alan C. Swann, MD

Brief Report

Approaches to Preventing Relapse in Bipolar Disorder: Addressing Nonadherence and Prodromal Symptoms

Alan C. Swann, MD

Activity | Published: 7/15/2010 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

How can you help your patients detect symptoms that may indicate the onset of an affective episode? Find out in this activity.

Terence A. Ketter, MD

Brief Report

Strategies for the Early Recognition of Bipolar Disorder

Terence A. Ketter, MD

Activity | Published: 7/15/2010 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

Here, learn about the prevalence and risk factors for bipolar disorder and find out how to complete a differential diagnosis for this condition.

Francesc Colom, PsyD, MSc, PhD

Brief Report

Achieving Remission and Recovery in Bipolar Disorder

Francesc Colom, PsyD, MSc, PhD

Activity | Published: 7/15/2010 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

Learn how psychoeducation can effectively address treatment nonadherence and other barriers to recovery to help your patients with bipolar disorder achieve and maintain remission.

+Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain [Series Home Page]

Scott M. Fishman, MD

Brief Report

Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain

Scott M. Fishman, MD

Activity | Published: 7/15/2010 | Keywords: pain, None, None, None, None, None

Review the guidelines for safely prescribing opioids and receive advice for managing risk during chronic pain treatment.

+Strategies for the Long-Term Treatment of Bipolar Disorder in Children and Adults [Series Home Page]

Karen Dineen Wagner, MD, PhD

Brief Report

Long-Term Treatment of Bipolar Disorder in Children

Karen Dineen Wagner, MD, PhD

Activity | Published: 6/15/2010 | Keywords: bipolar disorder, None, None, None, None, None

View this brief activity about the efficacy of various medications as acute and maintenance therapies for pediatric bipolar disorder.

Roger S. McIntyre, MD, FRCPC

Brief Report

Long-Term Treatment of Bipolar Disorder in Adults

Roger S. McIntyre, MD, FRCPC

Activity | Published: 6/15/2010 | Keywords: bipolar disorder, bipolar II, bipolar depression, bipolar mania, None, None

Update your understanding of the prevalence and impact of bipolar disorder, and discover new long-term treatment strategies.

+Improving the Recognition and Treatment of Bipolar Disorder in Primary Care [Series Home Page]

Larry Culpepper, MD, MPH (Chair)

Journal Supplement

Improving the Recognition and Treatment of Bipolar Disorder in Primary Care

Larry Culpepper, MD, MPH (Chair), et al

Activity | Published: 5/15/2010 | Keywords: bipolar disorder, None, None, None, None, None

Review the symptoms of bipolar disorder, receive recommendations on using diagnostic and monitoring tools, and find out how to treat this illness in the presence of comorbidities.

+Improving Executive Function in Adults With ADHD [Series Home Page]

Jeffrey H. Newcorn, MD

Brief Report

Risks and Benefits of Available Treatments for Adult ADHD

Jeffrey H. Newcorn, MD

Activity | Published: 5/15/2010 | Keywords: ADHD, None, None, None, None, None

Learn how to minimize the risk for adverse events and to individualize treatment based on your patients' comorbidity profiles and risk for abuse potential.

Lenard A. Adler, MD

Brief Report

Monitoring Adults With ADHD: A Focus on Executive and Behavioral Function

Lenard A. Adler, MD

Activity | Published: 4/15/2010 | Keywords: ADHD, None, None, None, None, None

Learn about the roles that neuropsychological tests and rating scales can play in diagnosing and monitoring the treatment course of ADHD in adults.

Russell A. Barkley, PhD

Brief Report

Differential Diagnosis of Adults With ADHD: The Role of Executive Function and Self-Regulation

Russell A. Barkley, PhD

Activity | Published: 4/15/2010 | Keywords: ADHD, None, None, None, None, None

Examine the role of executive function in ADHD and review symptoms that can help you differentiate adult ADHD from other disorders.

+Improving Outcomes in Depression [Series Home Page]

Michael E. Thase, MD

Brief Report

The Role of Neurobiologic Processes in Symptoms of Depression

Michael E. Thase, MD

Activity | Published: 4/15/2010 | Keywords: depression, None, None, None, None, None

Discover how genes, environmental factors, and neurobiologic processes contribute to the development of depression.

Michael E. Thase, MD

Brief Report

The Role of Neurobiologic Processes in Treating Depression

Michael E. Thase, MD

Activity | Published: 4/15/2010 | Keywords: depression, None, None, None, None, None

Gain insight into the mechanism of action of modern antidepressants, and discover novel treatment targets for depression pharmacotherapies.

Alan J. Gelenberg, MD

Brief Report

A Review of Current Guidelines for Depression Treatment

Alan J. Gelenberg, MD

Activity | Published: 4/15/2010 | Keywords: depression, None, None, None, None, None

Discover what the major international treatment guidelines recommend for different patient populations with depression.

Alan J. Gelenberg, MD

Brief Report

Optimizing Depression Treatment to Increase the Likelihood of Remission

Alan J. Gelenberg, MD

Activity | Published: 4/15/2010 | Keywords: depression, None, None, None, None, None

Discover how to use standardized measurement tools during all phases of treatment for depression.

+International Consensus Group on Depression [Series Home Page]

David J. Nutt, DM, FRCP, FRCPsych, FMedSci

Brief Report

Highlights of the International Consensus Statement on Major Depressive Disorder

David J. Nutt, DM, FRCP, FRCPsych, FMedSci

Activity | Published: 3/15/2010 | Keywords: depression, None, None, None, None, None

Get practical recommendations on screening for, diagnosing, and treating major depression.

David J. Nutt, DM, FRCP, FRCPsych, FMedSci

Journal Supplement

International Consensus Group on Depression

David J. Nutt, DM, FRCP, FRCPsych, FMedSci (Chair), et al

Activity | Published: 3/15/2010 | Keywords: depression, None, None, None, None, None

Read this Supplement to learn about the current depression guidelines in America, Europe, Japan, China, and the Middle East and to get advice on managing depression from international experts in psychiatry.

+Debates and Directions in Fibromyalgia: Recognizing Signs and Selecting the Appropriate Paths [Series Home Page]

Larry Culpepper, MD, MPH

Brief Report

Pharmacologic Therapy for Fibromyalgia

Larry Culpepper, MD, MPH

Activity | Published: 4/15/2010 | Keywords: fibromyalgia, pain, None, None, None, None

Read this short summary of pharmacologic options that can help your patients with fibromyalgia feel better and regain function.

Larry Culpepper, MD, MPH

Brief Report

Recognizing and Diagnosing Fibromyalgia

Larry Culpepper, MD, MPH

Activity | Published: 4/15/2010 | Keywords: fibromyalgia, pain, None, None, None, None

Get practical tips on assessing your patients for fibromyalgia.

Larry Culpepper, MD, MPH

Brief Report

Nonpharmacologic Care of Patients With Fibromyalgia

Larry Culpepper, MD, MPH

Activity | Published: 4/15/2010 | Keywords: fibromyalgia, pain, None, None, None, None

Review strategies that will help your patients become experts in recognizing and managing their fibromyalgia symptoms.

Larry Culpepper, MD, MPH

Brief Report

Evaluating the Patient With Fibromyalgia

Larry Culpepper, MD, MPH

Activity | Published: 4/15/2010 | Keywords: pain, fibromyalgia, None, None, None, None

If you suspect that a patient has fibromyalgia, what do you do next? Find out how to evaluate that patient and perform an efficient differential diagnosis.

+Tackling Partial Remission to Depression Treatment [Series Home Page]

Michael E. Thase, MD

Brief Report

Treatment-Resistant Depression: Prevalence, Risk Factors, and Treatment Strategies

Michael E. Thase, MD

Activity | Published: 1/15/2010 | Keywords: depression, None, None, None, None, None

Learn how to modify your treatment strategy to help your patients with resistant depression achieve and maintain recovery.

Michael E. Thase, MD (Chair)

Journal Supplement

Tackling Partial Remission to Depression Treatment

Michael E. Thase, MD (Chair), et al

Activity | Published: 11/15/2009 | Keywords: depression, None, None, None, None, None

What factors lead to partial response or nonresponse to depression treatment? Find out in this Supplement.

Michael E. Thase, MD (Chair)

PCC CME

Tackling Partial Response to Depression Treatment

Michael E. Thase, MD (Chair), et al

Activity | Published: 8/15/2009 | Keywords: depression, None, None, None, None, None

Get recommendations from the experts on tracking response and remission in treatment-resistant depression.

+The Use of Complementary and Alternative Medicines to Achieve Remission in Major Depressive Disorder [Series Home Page]

Drs Fava and Mischoulon

Brief Report

Evidence for Folate in Combination with Antidepressants at Initiation of Therapy

Maurizio Fava, MD, and David Mischoulon, MD, PhD

Activity | Published: 1/15/2010 | Keywords: depression, None, None, None, None, None

Learn more about folate and when it may be appropriate to initiate therapy with an antidepressant in combination with folate.

Maurizio Fava, MD

Brief Report

Using Complementary and Alternative Medicines for Depression

Maurizio Fava, MD

Activity | Published: 12/15/2009 | Keywords: depression, None, None, None, None, None

Discover when and when not to use CAM therapies in your patients' pharmacotherapeutic regimens.

Maurizio Fava, MD (Chair)

Journal Supplement

Complementary and Alternative Medicines in Major Depressive Disorder

Maurizio Fava, MD (Chair), et al

Activity | Published: 11/15/2009 | Keywords: depression, None, None, None, None, None

Review new research and receive expert recommendations on CAM therapies, including omega-3 fatty acids, folate, SAM-e, and St John's wort, to help optimize your patients' medications.

+What Is Bipolar Disorder? [Series Home Page]

Terence A. Ketter, MD

Brief Report

Nosology, Diagnostic Challenges, and Unmet Needs in Bipolar Disorder

Terence A. Ketter, MD

Activity | Published: 10/15/2009 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

Read this short summary for answers to your questions about screening for and accurately diagnosing bipolar disorder.

Terence A. Ketter, MD

Brief Report

Diagnostic Features, Prevalence, and Impact of Bipolar Disorder

Terence A. Ketter, MD

Activity | Published: 10/15/2009 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

Brief activity about the defining characteristics and burden of bipolar disorder on your patients and society

+An Introduction to the Clinical Correlates of Disrupted Slow-Wave Sleep [Series Home Page]

Thomas Roth, PhD (Moderator)

Brief Report

Disrupted Slow-Wave Sleep

Thomas Roth, PhD (Moderator), et al

Activity | Published: 10/15/2009 | Keywords: sleep disorders, insomnia, None, None, None, None

Review the clinical significance of slow-wave sleep (SWS), and learn how to treat SWS deficits.

+Following Up on The Expert Consensus Guidelines for Geriatric Depression [Series Home Page]

George S. Alexopoulos, MD

Brief Report

Pharmacotherapy for Late-Life Depression

George S. Alexopoulos, MD

Activity | Published: 9/15/2009 | Keywords: depression, None, None, None, None, None

Read this brief update to review the role of SSRIs, SNRIs, MAOIs, atypical antipsychotics, and other medications when treating your geriatric patients with depression.

George S. Alexopoulos, MD

Brief Report

Psychotherapy for Late-Life Depression

George S. Alexopoulos, MD

Activity | Published: 9/15/2009 | Keywords: depression, None, None, None, None, None

Read about expert-recommended psychotherapies for geriatric depression, including when to use them, which methods to use, and when to combine them with antidepressants.

+Depression in Latinos: A Focus on Overcoming Barriers [Series Home Page]

Drs Podawiltz and Culpepper

Brief Report

MDD Risk in Family Members of Hispanic Military Veterans

Alan Podawiltz, DO, MS, FAPA, and Larry Culpepper, MD, MPH

Activity | Published: 8/15/2009 | Keywords: depression, None, None, None, None, None

Summary of the impact that military recruitment has on the Hispanic population and the mental health issues that affect their family members

Drs Podawiltz and Culpepper

Brief Report

Treatment-Resistant Depression in Hispanic Patients

Alan Podawiltz, DO, MS, FAPA, and Larry Culpepper, MD, MPH

Activity | Published: 8/15/2009 | Keywords: depression, None, None, None, None, None

In this activity, review treatments for resistant depression and find out which ones to use when treating your Hispanic patients.

Alan Podawiltz, DO, MS, FAPA, and Larry Culpepper, MD, MPH

Brief Report

Medical Therapy for Major Depressive Disorder in Latinos

Alan Podawiltz, DO, MS, FAPA, and Larry Culpepper, MD, MPH

Activity | Published: 8/15/2009 | Keywords: depression, None, None, None, None, None

Short summary of the special issues involved in choosing depression medication for your Hispanic patients

Drs Podawiltz and Culpepper

Brief Report

Psychotherapy for Major Depressive Disorder in Latinos

Alan Podawiltz, DO, MS, FAPA, and Larry Culpepper, MD, MPH

Activity | Published: 8/15/2009 | Keywords: depression, None, None, None, None, None

Find out how to modify psychotherapy to reflect cultural issues in Hispanic patients with major depressive disorder.

+Bipolar Disorder in Children and Adolescents [Series Home Page]

Kiki D. Chang, MD

Brief Report

Course and Impact of Bipolar Disorder in Young Patients

Kiki D. Chang, MD

Activity | Published: 6/15/2009 | Keywords: bipolar disorder, bipolar II, ADHD, None, None, None

View this short summary to find out more about the course of early-onset bipolar illness and the risk factors associated with poor prognosis.

Kiki D. Chang, MD

Brief Report

Diagnosing Bipolar Disorder in Children and Adolescents

Kiki D. Chang, MD

Activity | Published: 6/15/2009 | Keywords: bipolar disorder, bipolar mania, None, None, None, None

Learn to differentiate bipolar disorder from other common childhood psychiatric illnesses, such as unipolar depression and ADHD.

Robert L. Findling, MD

Brief Report

Safety and Tolerability of Bipolar Disorder Treatment in Youth

Robert L. Findling, MD

Activity | Published: 6/15/2009 | Keywords: bipolar disorder, None, None, None, None, None

Examine the safety and tolerability of lithium, anticonvulsants, and atypical antipsychotics for pediatric bipolar disorder.

Robert L. Findling, MD

Brief Report

Treatment Options for Children and Adolescents With Bipolar Disorder

Robert L. Findling, MD

Activity | Published: 6/15/2009 | Keywords: bipolar disorder, None, None, None, None, None

Read about the efficacy of atypical antipsychotics and mood stabilizers for treating your young patients with bipolar disorder.

+Definition and Management of Suicidality in Psychiatric Patients [Series Home Page]

Jan A. Fawcett, MD (Chair)

JCP CME

Commentary: Defining and Managing Suicidal Risk in Patients Taking Psychotropic Medications / The Longitudinal Course of Posttraumatic Stress Disorder Symptom Clusters Among War Veterans

Jan A. Fawcett, MD (Chair), et al / Zahava Solomon, Danny Horesh, and Tsachi Ein-Dor

Activity | Published: 6/15/2009 | Keywords: depression, None, None, None, None, None

Find out how to identify suicidality in your patients and weigh the risks and benefits of pharmacologic treatment.

Jan A. Fawcett, MD (Chair)

Brief Report

Definition and Management of Suicidality in Psychiatric Patients

Jan A. Fawcett, MD (Chair), et al

Activity | Published: 5/15/2009 | Keywords: depression, bipolar depression, schizophrenia, None, None, None

In this activity, examine the risks and benefits of medications used to treat psychiatric disorders and find out how to recognize and manage suicidal thoughts and behaviors in your patients.

+Balancing the Equation: Managing Medical Comorbidities in Patients With Severe Mental Illness [Series Home Page]

Roger S. McIntyre, MD, FRCPC (Chair)

Journal Supplement

Balancing the Equation: Managing Comorbidities in Patients With Severe Mental Illness

Roger S. McIntyre, MD, FRCPC (Chair), et al

Activity | Published: 6/15/2009 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

Learn how to implement treatment strategies that address modifiable health risk factors and provide a better quality of life for your patients.

Roger S. McIntyre, MD, FRCPC

Brief Report

Overview of Managing Medical Comorbidities in Patients With Severe Mental Illness

Roger S. McIntyre, MD, FRCPC

Activity | Published: 3/15/2009 | Keywords: bipolar disorder, schizophrenia, mental illness, medical conditions, None, None

Short summary about serious medical conditions associated with illnesses such as bipolar disorder and schizophrenia

+Expired Case & Comment [Series Home Page]

Robert L. Findling, MD

Case & Comment

Diagnosis and Treatment of Bipolar Disorder in Young Patients

Robert L. Findling, MD

Activity | Published: 6/15/2009 | Keywords: bipolar disorder, bipolar mania, ADHD, None, None, None

Diagnose and initiate a treatment plan for a 13-year old girl who exhibits spontaneous bouts of extreme irritability and a decreased need for sleep.

Charles L. Bowden, MD

Case & Comment

Diagnosis, Treatment, and Recovery Maintenance in Bipolar Depression

Charles L. Bowden, MD

Activity | Published: 6/15/2009 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Your patients with bipolar depression may not be receiving adequate care. In this interactive patient case, discover the best methods for correctly diagnosing and treating bipolar depression.

Michael E. Thase, MD

Case & Comment

Pharmacotherapeutic Treatment Strategies for Antidepressant Nonresponse

Michael E. Thase, MD

Activity | Published: 3/15/2009 | Keywords: depression, None, None, None, None, None

Find out how to treat patients with complicated major depression who do not respond to initial SSRI treatment.

Michael E. Thase, MD

Case & Comment

Diagnosis and Treatment of a Major Depressive Episode

Michael E. Thase, MD

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

In this activity, discover how an appropriate diagnostic approach can increase remission rates and improve quality of life for patients with MDD.

Roger S. McIntyre, MD, FRCPC

Case & Comment

Managing Weight Gain in Patients With Severe Mental Illness

Roger S. McIntyre, MD, FRCPC

Activity | Published: 3/15/2009 | Keywords: bipolar disorder, medical conditions, mental illness, None, None, None

Discover how to manage weight gain and associated medical illnesses in your severely mentally ill patients.

Madhukar H. Trivedi, MD

Case & Comment

Treating Partial Responders to Antidepressant Treatment

Madhukar H. Trivedi, MD

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

In this patient case, choose an appropriate next-step strategy for a patient who partially responded to first-line treatment, and learn about effective agents that will help your patients achieve remission.

John F. Greden, MD

Case & Comment

Treating Depression and Pain

John F. Greden, MD

Activity | Published: 12/15/2008 | Keywords: depression, pain, None, None, None, None

Select a next-step treatment strategy that will alleviate Mr F’s painful physical symptoms and depressed mood.

Rakesh Jain, MD, MPH

Case & Comment

Treating Patients With Emotional and Physical Symptoms

Rakesh Jain, MD, MPH

Activity | Published: 11/15/2008 | Keywords: depression, pain, None, None, None, None

In this interactive patient case, find out how to address Ms S's emotional and somatic symptoms and learn about effective agents to help your patients achieve remission of all symptoms.

Lenard A. Adler, MD

Case & Comment

Diagnosing and Treating Adult ADHD and Comorbid Conditions

Lenard A. Adler, MD

Activity | Published: 9/15/2008 | Keywords: ADHD, None, None, None, None, None

In this interactive patient case, assess Ms. R, a 45-year-old woman, for ADHD and dysthymia, and determine the most effective course of treatment for her dual diagnoses.

Terence A. Ketter, MD

Case & Comment

Combination Therapy Versus Monotherapy in Bipolar Disorder

Terence A. Ketter, MD

Activity | Published: 9/15/2008 | Keywords: bipolar disorder, None, None, None, None, None

Review the most efficacious treatment options to help Ms. B achieve and maintain remission after a breakthrough hypomanic episode.

Andrew A. Nierenberg, MD

Case & Comment

Diagnosing and Treating Patients With Symptoms of Depression

Andrew A. Nierenberg, MD

Activity | Published: 9/15/2008 | Keywords: bipolar disorder, depression, None, None, None, None

In this interactive case, choose how you would diagnose and treat Mr. G, a 30-year-old lawyer with fatigue and depressed mood and a history of irritability, risk-taking, and inability to concentrate.

Lesley M. Arnold, MD

Case & Comment

Pain and the Brain: Chronic Widespread Pain

Lesley M. Arnold, MD

Activity | Published: 6/15/2008 | Keywords: fibromyalgia, medical conditions, None, pain, None, None

In this interactive case, determine the best treatment strategy for Ms. A, and learn psychotherapeutic approaches to help relieve her chronic pain.

Rakesh Jain, MD, MPH

Case & Comment

Pain and the Brain: Lower Back Pain

Rakesh Jain, MD, MPH

Activity | Published: 6/15/2008 | Keywords: pain, medical conditions, depression, None, None, None

Participate in this interactive case to assess Mr C’s tolerance for his current pain medication and learn what other factors should be evaluated to effectively treat his condition.

Rakesh Jain, MD, MPH

Case & Comment

Pain and the Brain: Diabetic Neuropathic Pain

Rakesh Jain, MD, MPH

Activity | Published: 6/15/2008 | Keywords: pain, medical conditions, depression, None, None, None

Choose how to evaluate and treat Ms. L, a 53-year-old woman with diabetes, pain, and depressed mood, and discover how somatic and psychiatric symptoms may be linked.

Don L. Goldenberg, MD

Case & Comment

Using Multidisciplinary Care to Treat Fibromyalgia

Don L. Goldenberg, MD

Activity | Published: 8/15/2008 | Keywords: None, None, None, None, None, None

Engage in this interactive patient case to learn about adjunctive nonpharmacologic interventions to effectively treat your patients with fibromyalgia.

Daniel J. Clauw, MD

Case & Comment

Assessing and Diagnosing Fibromyalgia in the Clinical Setting

Daniel J. Clauw, MD

Activity | Published: 7/15/2008 | Keywords: fibromyalgia, medical conditions, None, pain, None, None

In this Case and Comment, assess Ms K for fibromyalgia and review common comorbid psychiatric disorders that may require additional diagnostic strategies.

Claudio N. Soares, MD, PhD

Case & Comment

Practical Strategies for Diagnosing and Treating Depression in Women: Menopausal Transition

Claudio N. Soares, MD, PhD, FRCPC

Activity | Published: 4/15/2008 | Keywords: depression, None, None, None, None, None

Mrs. N presents with fatigue, headaches, and frequent crying spells. Participate in this interactive patient case to learn how to diagnose and treat patients like her.

Alan Podawiltz, DO, MS, FAPA

Case & Comment

Practical Strategies for Diagnosing and Treating Depression in Women: Chronic Depression

Alan Podawiltz, DO, MS, FAPA

Activity | Published: 5/15/2008 | Keywords: depression, None, None, None, None, None

In this interactive case, diagnose Ms. A, who presents with fatigue, low self-esteem, and anhedonia, and determine the most appropriate treatment strategy for her.

Stephen R. Marder, MD

Case & Comment

Treatment of Agitation in Patients With Schizophrenia

Stephen R. Marder, MD

Activity | Published: 2/15/2008 | Keywords: schizophrenia, None, None, None, None, None

Learn how to stabilize Mr. F, a 20-year-old patient with schizophrenia in his first psychotic break, and review pharmacotherapeutic approaches to treat acute agitation.

John M. Kane, MD

Case & Comment

Relapse Prevention in Patients With Schizophrenia

John M. Kane, MD

Activity | Published: 12/15/2007 | Keywords: schizophrenia, None, None, None, None, None

Mr. J becomes aggressive during psychotic relapses, refuses to take his medication regularly, and abuses substances. How would you proceed with Mr. J’s treatment?

Jonathan M. Meyer, MD

Case & Comment

Sexual Dysfunction in Patients Treated With Atypical Antipsychotics

Jonathan M. Meyer, MD

Activity | Published: 5/15/2008 | Keywords: schizophrenia, None, None, None, None, None

Choose a treatment strategy that addresses Mr. H’s antipsychotic-induced diminished libido, and receive recommendations for switching antipsychotics for your patients experiencing these adverse events.

Christoph U. Correll, MD

Case & Comment

Effect of Hyperprolactinemia During Development in Children and Adolescents

Christoph U. Correll, MD

Activity | Published: 4/15/2008 | Keywords: bipolar disorder, medical conditions, None, None, None, None

Participate in this interactive patient case to evaluate Ms. G’s elevated prolactin levels and recently discovered pituitary adenoma and learn how to manage these adverse events in your young patients.

John M. Kane, MD

Case & Comment

Sedation as a Side Effect of the Treatment of Mental Disorders

John M. Kane, MD

Activity | Published: 3/15/2008 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Assess Mr. E’s antipsychotic-induced daytime somnolence, and learn how address issues of sedation for your patients on pharmacotherapy.

Michael E. Thase, MD

Case & Comment

Management of Patients With Treatment-Resistant Depression

Michael E. Thase, MD

Activity | Published: 12/15/2007 | Keywords: depression, None, None, None, None, None

In this interactive case, review possible causes of Ms. D’s resistance to an SSRI and learn strategies to optimize your own patients’ treatment regimens.

Terence A. Ketter, MD

Case & Comment

Incorporating Clinical Trial Data Into Bipolar Disorder Management

Terence A. Ketter, MD

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Participate in this interactive case to choose which treatment you think is the most appropriate to stabilize Ms. A, a 35-year-old single mother, and learn about interventions that may help prevent her from relapsing.

Valentim Gentil, MD, PhD

Case & Comment

Introduction to Bipolar Disorder and Comorbid Conditions

Valentim Gentil, MD, PhD

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

See if you can accurately assess Mr. C in the clinical setting and recommend treatments to minimize his risk of metabolic syndrome.

Steven P. Roose, MD

Case & Comment

Identifying and Treating Cognitive Impairments in Elderly Patients

Steven P. Roose, MD

Activity | Published: 10/15/2007 | Keywords: depression, dementia, None, None, None, None

In this interactive case, screen Mr. P for mild cognitive impairment with depression. Then, review neuropsychological measurements to predict his conversion to Alzheimer's disease.

Peter F. Buckley, MD

Case & Comment

Treating Movement Disorders and Akathisia as Side Effects of Antipsychotic Pharmacotherapy

Peter F. Buckley, MD

Activity | Published: 1/15/2008 | Keywords: schizophrenia, None, None, None, None, None

Decide the best treatment strategy for Ms. B, a 41-year-old woman with a 20-year history of schizophrenia who has serious muscle rigidity and tremors, in this interactive case report.

David C. Henderson, MD

Case & Comment

Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics

David C. Henderson, MD

Activity | Published: 11/15/2007 | Keywords: schizophrenia, medical conditions, None, None, None, None

Evaluate a patient for maintenance therapy to improve his antipsychotic-induced weight gain and metabolic issues.

Dan W. Haupt, MD

Case & Comment

Metabolic Risks and Effects of Atypical Antipsychotic Treatment

Dan W. Haupt, MD

Activity | Published: 9/15/2007 | Keywords: schizophrenia, medical conditions, None, None, None, None

Evaluate and treat Ms. A’s antipsychotic-induced weight gain and learn monitoring strategies for other metabolic disturbances to optimize your patients’ overall health outcomes.

Philip D. Harvey, PhD

Case & Comment

Managing Cognitive Deficits and Functioning in Patients With Schizophrenia

Philip D. Harvey, PhD

Activity | Published: 4/15/2007 | Keywords: schizophrenia, None, None, None, None, None

Participate in this interactive case to address Mr. A's cognitive deficits and find out about additional factors that may impact his overall functioning.

Case & Comment

Adjunctive Atypical Antipsychotic Use in Treatment-Resistant Depression

Anita H. Clayton, MD, and Maria C. Melo, MD, PGY-III

Activity | Published: 9/15/2004 | Keywords: None, None, None, None, None, None

Case & Comment

Management of Dementia-Related Falls

Robert Pfoff, MD

Activity | Published: 10/15/2003 | Keywords: None, None, None, None, None, None

Case & Comment

Long-Term Treatment of Chronic Schizophrenia

Mark B. Hamner, MD

Activity | Published: 8/15/2003 | Keywords: None, None, None, None, None, None

+Maintenance of Certification in Psychiatry [Series Home Page]

Michael H. Ebert, MD (Chair)

Brief Report

Maintenance of Certification in Psychiatry

Michael H. Ebert, MD (Chair), et al

Activity | Published: 6/15/2009 | Keywords: mental illness, None, None, None, None, None

NEW! In this activity, find out more about maintenance of certification and how it promotes a cycle of lifelong learning that intends to improve physician competency.

Michael H. Ebert, MD (Chair)

JCP CME

Commentary: Maintenance of Certification in Psychiatry / Responses to Depressed Mood and Suicide Attempt in Young Adults With a History of Childhood-Onset Mood Disorder

Michael H. Ebert, MD (Chair), et al / Xianchen Liu, Amy L. Gentzler, Charles J. George, and Maria Kovacs

Activity | Published: 5/15/2009 | Keywords: None, None, None, None, None, None

This Commentary focuses on maintenance of certification and how it promotes a cycle of lifelong learning and self-assessment.

+Bipolar Depression [Series Home Page]

Charles L. Bowden, MD

Brief Report

Treatment Strategies for Bipolar Depression

Charles L. Bowden, MD

Activity | Published: 6/15/2009 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Patients with bipolar disorder have a high risk of relapse, especially of depressive episodes. Read this new J Clin Psychlopedia activity to learn about strategies for maintaining recovery and preventing deressive episodes in your patients with bipolar disorder.

Charles L. Bowden, MD

Brief Report

Diagnosis and Impact of Bipolar Depression

Charles L. Bowden, MD

Activity | Published: 6/15/2009 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Are you correctly diagnosing your depressed patients? Because individuals with bipolar disorder often seek treatment for depression, misdiagnosis is common. Read this new J Clin Psychlopedia activity to learn about detecting bipolarity during depressive episodes.

Eduard Vieta, MD, PhD

Brief Report

Long-Term Treatment of Bipolar Depression and Other Issues

Eduard Vieta, MD, PhD

Activity | Published: 6/15/2009 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Engage in this activity to learn about maintenance treatments for bipolar depression and find out how to prevent recurrence in your patients.

Eduard Vieta, MD, PhD

Brief Report

Role of Antidepressants in Bipolar Depression

Eduard Vieta, MD, PhD

Activity | Published: 6/15/2009 | Keywords: bipolar depression, bipolar disorder, None, None, None, None

Contrary to what is advised in practice guidelines, approximately 50% of patients with bipolar disorder are initially treated with an antidepressant. Read this new J Clin Psychlopedia activity to review the efficacy and safety of antidepressants in bipolar disorder and learn about alternative treatment options for your patients.

+What Is Depression? [Series Home Page]

Alan J. Gelenberg, MD

Brief Report

The Prevalence and Impact of Depression

Alan J. Gelenberg, MD

Activity | Published: 5/15/2009 | Keywords: depression, None, None, None, None, None

Review the chronic nature of depression. Learn how you can reduce its overall burden in your patients.

Alan J. Gelenberg, MD

Brief Report

Depression Symptomatology and Neurobiology

Alan J. Gelenberg, MD

Activity | Published: 5/15/2009 | Keywords: depression, None, None, None, None, None

How do you distinguish between depression, sadness, and grief? What is the underlying neurobiology of depression? To find out, read this interactive activity.

+Pain and the Brain 2: The Recognition and Management of Chronic Pain in Primary Care [Series Home Page]

Rakesh Jain, MD, MPH (Moderator)

Video

Pain and the Brain 2: The Recognition and Management of Chronic Pain in Primary Care

Rakesh Jain, MD, MPH (Moderator), et al

Activity | Published: 6/15/2009 | Keywords: pain, depression, medical conditions, fibromyalgia, None, None

Video featuring expert recommendations on accurately diagnosing and treating the illnesses related to somatic symptoms.

+MDD in Women: Focus on Reproductive Events [Series Home Page]

Marlene P. Freeman, MD

Brief Report

Managing Depression During Pregnancy

Marlene P. Freeman, MD

Activity | Published: 4/15/2009 | Keywords: depression, None, None, None, None, None

Short interactive summary about benefits and risks to mother and baby of treatments for depression

Marlene P. Freeman, MD

Brief Report

Postpartum Depression Treatment and Breastfeeding

Marlene P. Freeman, MD

Activity | Published: 4/15/2009 | Keywords: depression, None, None, None, None, None

To answer your patients' questions and formulate a treatment plan for postpartum depression, review the risks and benefits of various treatment options in this activity.

+Using Atypical Antipsychotics to Optimize the Clinical Management of Patients With Mental Illnesses [Series Home Page]

Sheldon H. Preskorn, MD (Chair)

JCP CME

Using Antipsychotics in Clinical Practice

Sheldon H. Preskorn, MD (Chair), et al

Activity | Published: 4/15/2009 | Keywords: schizophrenia, bipolar depression, None, None, None, None

Update your understanding of the pharmacodynamics and pharmacokinetics of antipsychotics to help your patients achieve the best treatment outcomes.

John M. Kane, MD (Chair)

Journal Supplement

Using Atypical Antipsychotics to Optimize the Clinical Management of Patients With Mental Illnesses

John M. Kane, MD (Chair), et al.

Activity | Published: 2/15/2008 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Read this Supplement to update your understanding of the safety and efficacy of atypical antipsychotics and learn strategies to help reduce adverse events.

+Depression in the Elderly [Series Home Page]

Gary W. Small, MD

Brief Report

Pharmacotherapy and Other Treatments for Elderly Patients With Depression

Gary W. Small, MD

Activity | Published: 4/15/2009 | Keywords: depression, None, None, None, None, None

Review treatment guidelines and evidence-based treatment modalities for geriatric depression, including psychotherapy, ECT, and pharmacotherapy.

Gary W. Small, MD

Brief Report

Differential Diagnoses and Assessment of Depression in Elderly Patients

Gary W. Small, MD

Activity | Published: 4/15/2009 | Keywords: depression, dementia, None, None, None, None

Participate in this activity to learn about the differential diagnoses of depression in the elderly and review methods for assessing this condition.

+Insights Into Generalized Anxiety Disorder [Series Home Page]

Mark H. Pollack, MD (Chair)

Journal Supplement

Insights Into Generalized Anxiety Disorder

Mark H. Pollack, MD (Chair), et al

Activity | Published: 4/15/2009 | Keywords: generalized anxiety disorder, anxiety, medical conditions, mental illness, None, None

Discover how to manage and facilitate remission from generalized anxiety disorder in the presence of comorbidities.

+Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection [Series Home Page]

JCP CME

Relationship of Nicotine Dependence, Subsyndromal and Pathological Gambling, and Other Psychiatric Disorders: Data From the National Epidemiologic Survey on Alcohol and Related Conditions / Risk Factors for Violent Crime in Schizophrenia: A National Cohort Study of 13,806 Patients / Long-Term Mental Health Resource Utilization and Cost of Care Following Group Psychoeducation or Unstructured Group Support for Bipolar Disorders: A Cost-Benefit Analysis

Jon E. Grant, Rani A. Desai, and Marc N. Potenza / Seena Fazel, Martin Grann, Eva Carlström, Paul Lichtenstein, and Niklas Långström / Jan Scott, Francesc Colom, Ekaterina Popova, Antonio Benabarre, Nuria Cruz, Marc Valenti, José M. Goikolea, Jose Sánchez-Moreno, Miguel A. Asenjo, and Eduard Vieta

Activity | Published: 3/15/2009 | Keywords: pathological gambling, substance use disorders, schizophrenia, bipolar disorder, None, None

Jeffrey A. Lieberman, MD

E-View

Neurobiology and the Natural History of Schizophrenia

Jeffrey A. Lieberman, MD (Chair)

Activity | Published: 8/15/2006 | Keywords: schizophrenia, None, None, None, None, None

Early detection and treatment of schizophrenia may attenuate or prevent neurologic deterioration. Learn about the natural history and pathophysiology of this disorder by participating in this lecture.

L. Fredrik Jarskog, MD

E-View

Neuroprotection in Schizophrenia

L. Fredrik Jarskog, MD

Activity | Published: 7/15/2006 | Keywords: None, None, None, None, None, None

Schizophrenia is associated with limited neurodegeneration, which suggests benefits for implementing neuroprotective strategies. In this E-View, learn about therapeutic and prophylactic interventions aimed at reducing gray matter loss and improving function in your patients.

Dolores Malaspina, MD

E-View

Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder?

Dolores Malaspina, MD

Activity | Published: 7/15/2006 | Keywords: None, None, None, None, None, None

In schizophrenia, neurodevelopmental abnormalities and neurodegeneration are not exclusive processes. Participate in this E-View to learn about the pathology of the disorder and what you can do to effectively treat your patients.

Jeffrey A. Lieberman, MD (Chair)

JCP CME

Mood and Sleep in Parkinson's Disease / Academic Highlights: Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection

Leora L. Borek, Robert Kohn, and Joseph H. Friedman / Jeffrey A. Lieberman, MD (Chair) et al.

Activity | Published: 6/15/2006 | Keywords: sleep disorders, schizophrenia, None, None, None, None

Find out what you can do to try to prevent neurodegeneration in your patients with schizophrenia and improve their social and occupational functioning.

+ADHD and Comorbid Disorders in Adults [Series Home Page]

Russell A. Barkley, MD, and Jeffrey H. Newcorn, MD

PCC CME

Academic Highlights Update: Assessing Adults With ADHD and Comorbidities

Russell A. Barkley, MD, and Jeffrey H. Newcorn, MD

Activity | Published: 2/15/2009 | Keywords: ADHD, None, None, None, None, None

NEW! Read this Academic Highlights Update to find out what symptoms adults with ADHD commonly have, how you should assess them, and what other psychiatric disorders may be present.

Lenard A. Adler, MD

PCC CME

Prevalence of Depressive Symptoms and Associated Factors in Elderly Primary Care Patients: A Descriptive Study / Academic Highlights Update: Adult ADHD Pharmacotherapy

Lenard A. Adler, MD

Activity | Published: 12/15/2008 | Keywords: ADHD, None, None, None, None, None

NEW! In this brief Academic Highlights Update, review various medications for adult ADHD, and find out about treatments to help you successfully manage your patients with ADHD and psychiatric comorbidities.

Jeffrey H. Newcorn, MD

Brief Report

Managing ADHD and Comorbidities in Adults

Jeffrey H. Newcorn, MD

Activity | Published: 10/15/2008 | Keywords: ADHD, None, None, None, None, None

Adult patients with ADHD have a high incidence of co-occurring psychiatric disorders. In this Brief Report, review the prevalence, symptoms, and impact of ADHD and comorbid disorders, and learn how to recognize and manage these illnesses in patients.

Russell A. Barkley, PhD

Brief Report

Challenges in Diagnosing Adults With ADHD

Russell A. Barkley, PhD

Activity | Published: 10/15/2008 | Keywords: ADHD, None, None, None, None, None

In this Brief Report, learn about recommended adjustments to the DSM-IV-TR criteria that assist in the accurate evaluation and diagnosis of ADHD in adults.

Lenard A. Adler, MD

Brief Report

Pharmacotherapy for Adult ADHD

Lenard A. Adler, MD

Activity | Published: 9/15/2008 | Keywords: ADHD, None, None, None, None, None

View this short summary to learn about pharmacologic and nonpharmacologic therapies for patients with ADHD and find out how to treat this illness in the presence of comorbidities.

Lenard A. Adler, MD (Chair)

JCP CME

Language in Alzheimer's Disease / Predictors for Switch From Unipolar Major Depressive Disorder to Bipolar Disorder Type I or II: A 5-Year Prospective Study / ADHD and Comorbid Disorders in Adults

Myron F. Weiner, Katherine E. Neubecker, Mary E. Bret, and Linda S. Hynan / K. Mikael Holma, Tarja K. Melartin, Irina A. K. Holma, and Erkki T. Isometsä / Lenard A. Adler, MD (Chair), et al

Activity | Published: 8/15/2008 | Keywords: Alzheimer's, bipolar disorder, ADHD, depression, None, None

View this ACADEMIC HIGHLIGHTS to review the proposed diagnostic criteria for adult ADHD and learn about stimulant and nonstimulant treatments for your patients with this condition, including those with comorbid disorders.

+A Critical Appraisal to Improve the Management of Schizophrenia [Series Home Page]

Henry A. Nasrallah, MD (Chair)

Journal Supplement

A Critical Appraisal to Improve the Management of Schizophrenia

Henry A. Nasrallah, MD (Chair), et al

Activity | Published: 2/15/2009 | Keywords: schizophrenia, mental illness, substance use disorders, None, None, None

How many of the commonly held clinical beliefs about schizophrenia are supported by evidence? Find out in this Supplement.

+Major Depressive Disorder [Series Home Page]

Mark Hyman Rapaport, MD

Brief Report

Helping Patients With Depression Achieve Wellness

Mark Hyman Rapaport, MD

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

In this activity, discover how implementing measurement-based care and collaborative approaches can facilitate wellness in patients with depression.

Mark Hyman Rapaport, MD

Brief Report

Beyond Acute Treatment of Depressive Disorders

Mark Hyman Rapaport, MD

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

In this J Clin Psychlopedia activity, learn about continuation and maintenance phase strategies that will help your patients achieve and maintain remission from depression.

George I. Papakostas, MD

Brief Report

Initial Treatment Approaches for Patients With Major Depressive Disorder

George I. Papakostas, MD

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

What factors do you consider when choosing an antidepressant? How much time elapses before you consider it effective or ineffective? In this new J Clin Psychlopedia section, learn about antidepressants as first-line treatments for depression, including their efficacy, safety, and tolerability, to help your patients achieve response and remission.

George I. Papakostas, MD

Brief Report

Diagnostic Assessment of Major Depressive Disorder

George I. Papakostas, MD

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

Participate in this activity to review the diagnostic criteria for depression and learn how to systematically evaluate your patients for this common disorder.

+Easing the Burden of Treatment-Resistant Depression [Series Home Page]

Peter V. Rabins, MD, MPH (Chair)

JCP CME

Family Problems Among Recently Returned Military Veterans Referred for a Mental Health Evaluation/Effectiveness of Brief Cognitive-Behavioral Therapy for Schizophrenia Delivered by Mental Health Nurses: Relapse and Recovery at 24 Months/Easing the Burden of Treatment-Resistant Depression/New Developments in the Treatment of Alzheimer’s Disease

Steven L. Sayers, Victoria A. Farrow, Jennifer Ross, and David W. Oslin / Navdeep Malik, David Kingdon, Jeremy Pelton, Raj Mehta, and Douglas Turkington / Maurizio Fava, MD (Chair), et al / Peter V. Rabins, MD, MPH (Chair), et al

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

In this ACADEMIC HIGHLIGHTS, review the pathology and progression of Alzheimer's disease, and discover advances in pharmacotherapy.

Maurizio Fava, MD

Brief Report

Partial Responders to Antidepressant Treatment: Switching Strategies

Maurizio Fava, MD

Activity | Published: 11/15/2008 | Keywords: depression, None, None, None, None, None

Read this Brief Report to learn about the safety, efficacy, and implementation of different switching strategies for antidepressant partial responders.

J. Craig Nelson, MD

Brief Report

Augmentation and Combination Strategies in Resistant Depression

J. Craig Nelson, MD

Activity | Published: 11/15/2008 | Keywords: depression, None, None, None, None, None

Read this Brief Report to review augmentation and combination strategies and learn how to effectively treat your patients who continue to experience symptoms after initial antidepressant treatment.

Madhukar H. Trivedi, MD

Brief Report

Treating Depression to Full Remission

Madhukar H. Trivedi, MD

Activity | Published: 11/15/2008 | Keywords: depression, None, None, None, None, None

Read this Brief Report to learn how to use measurement-based care and evidence-based guidelines to help your patients achieve and sustain remission from depression.

Michael E. Thase, MD

Brief Report

Evaluating Atypical Antipsychotics in the Treatment of Refractory Depression

Michael E. Thase, MD

Activity | Published: 10/15/2008 | Keywords: depression, None, None, None, None, None

NEW! Read this Brief Report to identify risk factors for treatment-resistant depression and learn about augmentation strategies with atypical antipsychotics to help your patients achieve remission.

+Conference Coverage: 21st Annual European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

Angel L. Montejo, MD, PhD

Brief Report

Toward Depression Remission: Balancing Efficacy and Tolerability

Angel L. Montejo, MD, PhD

Activity | Published: 2/15/2009 | Keywords: depression, None, None, None, None, None

In this Brief Report, review presentations from the 21st Annual ECNP Congress, which focus on advances in MDD treatment in nonserotonergic brain pathways and how these pathways influence antidepressant profiles.

+Depression and Pain [Series Home Page]

John H. Greist, MD (Chair)

JCP CME

A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation / Why Don't Psychiatrists Use Scales to Measure Outcome When Treating Depressed Patients? / Academic Highlights: Depression and Pain

Theodore D. Satterthwaite, Daniel H. Wolf, Robert A. Rosenheck, Raquel E. Gur, and Stanley N. Caroff / Mark Zimmerman and Joseph B. McGlinchey / John H. Greist, MD (Chair), et al.

Activity | Published: 12/15/2008 | Keywords: depression, pain, None, None, None, None

Read this Academic Highlights to learn about neuropathic pathways shared by pain and depression, understand how pain affects depression course of illness, and receive treatment recommendations.

+Depression, Pain, and Physical Symptoms [Series Home Page]

David A. Fishbain, MD

Brief Report

Remission as the "Gold Standard" of Treatment for Depression With and Without Physical Symptoms

David A. Fishbain, MD

Activity | Published: 11/15/2008 | Keywords: depression, pain, None, None, None, None

Review this activity to find out how pain affects depression remission and learn how alleviating pain can improve depressive symptoms.

David A. Fishbain, MD

Brief Report

Evidence-Based Treatment Paradigms for Depressed Patients With Pain and Physical Symptoms

David A. Fishbain, MD

Activity | Published: 11/15/2008 | Keywords: depression, pain, fibromyalgia, medical conditions, None, None

Are antidepressants effective for treating both depression and pain? Participate in this activity to find out which agents alleviate painful physical symptoms as well as depressive symptoms.

Rakesh Jain, MD, MPH

Brief Report

The Implications of Pain and Physical Symptoms in Depression

Rakesh Jain, MD, MPH

Activity | Published: 11/15/2008 | Keywords: depression, pain, None, None, None, None

Participate in this activity to understand the relationship between depression and pain and how these disorders impact your patients' overall functioning.

Rakesh Jain, MD, MPH

Brief Report

The Epidemiology and Recognition of Pain and Physical Symptoms in Depression

Rakesh Jain, MD, MPH

Activity | Published: 11/15/2008 | Keywords: depression, pain, fibromyalgia, medical conditions, None, None

Almost half of all patients with depression also report painful physical symptoms. Review this activity to learn how these symptoms manifest in patients with depression and what you can do to optimize symptom recognition.

+Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission [Series Home Page]

Andrew A. Nierenberg, MD (Chair)

Journal Supplement

Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission

Andrew A. Nierenberg, MD (Chair), et al

Activity | Published: 10/15/2008 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

Supplement about bipolar medication mechanisms of action and the efficacy of various acute and long-term treatments for patients with bipolar disorder

Andrew A. Nierenberg, MD (Chair)

PCC CME

Chest Pain and Its Importance in Patients With Panic Disorder: An Updated Literature Review / Academic Highlights: Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission

Andrew A. Nierenberg, MD (Chair), et al

Activity | Published: 10/15/2008 | Keywords: bipolar disorder, None, None, None, None, None

In this Academic Highlights, review the efficacy of various treatments for bipolar disorder, and learn about the neurobiologic mechanisms of action for these agents.

Gerard Sanacora, MD, PhD

Brief Report

Reviewing Medications for Bipolar Disorder: Understanding the Mechanisms of Action

Gerard Sanacora, MD, PhD

Activity | Published: 9/15/2008 | Keywords: bipolar disorder, None, None, None, None, None

Read this Brief Report to learn about the neurobiological effects of the chronic psychosocial stress associated with bipolar disorder, and review the mechanisms by which therapy helps mitigate these effects.

Roy H. Perlis, MD, MSc

Brief Report

Efficacy of Agents in Treating Mania

Roy H. Perlis, MD, MSc

Activity | Published: 8/15/2008 | Keywords: bipolar disorder, bipolar mania, None, None, None, None

Participate in this activity to receive expert recommendations on determining the best pharmacologic option for individual patients experiencing acute mania.

Terence A. Ketter, MD

Brief Report

Treating Bipolar Disorder: Monotherapy Versus Combination Therapy

Terence A. Ketter, MD

Activity | Published: 7/15/2008 | Keywords: bipolar disorder, None, None, None, None, None

In this Brief Report, find out about the efficacy of combining mood stabilizers, antipsychotics, and antidepressants for your patients with acute bipolar mania and depression.

Michael E. Thase, MD

Brief Report

Maintenance Therapy for Bipolar Disorder

Michael E. Thase, MD

Activity | Published: 7/15/2008 | Keywords: bipolar disorder, None, None, None, None, None

Learn about the need for indefinite maintenance therapy for your patients with bipolar disorder as well as primary and adjunctive treatments to help sustain remission.

Andrew A. Nierenberg, MD

Brief Report

Effective Agents in Treating Bipolar Depression

Andrew A. Nierenberg, MD

Activity | Published: 7/15/2008 | Keywords: bipolar disorder, bipolar depression, None, None, None, None

Learn about antidepressants, mood stabilizers, and antipsychotics to optimize short- and long-term therapy for your patients with bipolar depression.

+Understanding Fibromyalgia and Its Related Disorders [Series Home Page]

Don L. Goldenberg, MD (Chair)

Online Insight

Multidisciplinary Care and Stepwise Treatment for Fibromyalgia

Don L. Goldenberg, MD (Chair), et al.

Activity | Published: 8/15/2008 | Keywords: fibromyalgia, depression, medical conditions, pain, None, None

Listen to experts discuss a stepwise fibromyalgia treatment program that includes building multidisciplinary treatment teams that can help improve your patients' overall well-being.

Don L. Goldenberg, MD (Chair)

Online Insight

Evaluating and Diagnosing Fibromyalgia and Comorbid Psychiatric Disorders

Don L. Goldenberg, MD (Chair), et al

Activity | Published: 6/15/2008 | Keywords: fibromyalgia, depression, medical conditions, pain, None, None

Watch this slide show and listen to experts discuss the presentation of fibromyalgia and comorbid conditions and offer effective approaches for evaluating and diagnosing these disorders.

Don L. Goldenberg, MD (Chair)

Journal Supplement

Understanding Fibromyalgia and Its Related Disorders

Don L. Goldenberg, MD (Chair), et al

Activity | Published: 8/15/2008 | Keywords: fibromyalgia, depression, pain, medical conditions, None, None

Supplement about the signs and symptoms of fibromyalgia and efficacious treatments for this condition and its common comorbidities

Larry Culpepper, MD (Chair)

PCC CME

Academic Highlights: Understanding Fibromyalgia and Its Related Disorders / Academic Highlights: Treating Depression and Anxiety in Primary Care

Don L. Goldenberg, MD (Chair), et al

Activity | Published: 4/15/2008 | Keywords: fibromyalgia, medical conditions, depression, anxiety, None, None

Read this Academic Highlights for expert advice on how to recognize depressive and anxious symptoms in primary care patients and learn how to individualize treatments to maximize medication efficacy.

+Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap [Series Home Page]

Roy H. Perlis, MD, MSc

JCP CME

A Roadmap to Key Pharmacologic Principles in Using Antipsychotics in the Treatment of Bipolar Disorder

Roy H. Perlis, MD, MSc

Activity | Published: 7/15/2008 | Keywords: bipolar disorder, None, None, None, None, None

Receive expert recommendations on effectively using antipsychotics to treat your patients with bipolar disorder.

Larry Culpepper, MD, MPH

PCC CME

Academic Highlights: A Roadmap to Key Pharmacologic Principles in Using Antipsychotics

Larry Culpepper, MD, MPH, et al.

Activity | Published: 12/15/2007 | Keywords: None, None, None, None, None, None

In this Academic Highlights, you can read patient cases that detail primary care physicians' issues when using antipsychotics and receive expert recommendations to help individualize treatment for patients.

Peter J. Weiden, MD (Chair)

JCP CME

The Roadmap for Antipsychotic Psychopharmacology: An Overview

Peter J. Weiden, MD (Chair), et al

Activity | Published: 11/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Read this ACADEMIC HIGHLIGHTS to review the guidelines, consensus statements, and recommendations for using antipsychotic agents to treat your patients.

Peter J. Weiden, MD (Chair)

Journal Supplement

Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap

Peter J. Weiden, MD (Chair), et al.

Activity | Published: 7/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Receive expert guidance on how to pharmacologically manage your patients, plus review maintenance models to help those patients achieve stability and recovery.

+Clinical Insights Into Pharmacogenetics and Schizophrenia [Series Home Page]

Patricia R. Recupero, Samara E. Harms, and Jeffrey M. Noble / John M. Kane, MD (Chair)

JCP CME

Googling Suicide: Surfing for Suicide Information on the Internet / Academic Highlights: Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 2

Patricia R. Recupero, Samara E. Harms, and Jeffrey M. Noble / John M. Kane, MD (Chair) et al.

Activity | Published: 6/15/2008 | Keywords: schizophrenia, mental illness, None, None, None, None

Review the impact of genetics on neurocognition, and discover which genes may be potential treatment targets in this Academic Highlights by leading experts.

John M. Kane, MD (Chair) / Mark Olfson and Steven C. Marcus

JCP CME

The Efficacy of Acute Electroconvulsive Therapy in Atypical Depression / A Case-Control Study of Antidepressants and Attempted Suicide During Early Phase Treatment of Major Depressive Episodes / Academic Highlights: Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 1

Mustafa M. Husain, Shawn M. McClintock, A. John Rush, Rebecca G. Knapp, Max Fink, Teresa A. Rummans, Keith Rasmussen, Cynthia Claassen, Georgios Petrides, Melanie M. Biggs, Martina Mueller, Shirlene Sampson, Samuel H. Bailine, Sarah H. Lisanby, and Charles H. Kellner / Mark Olfson and Steven C. Marcus / John M. Kane, MD (Chair) et al.

Activity | Published: 3/15/2008 | Keywords: depression, atypical depression, schizophrenia, None, None, None

Genetic testing may elucidate variants to aid in diagnosing and treating schizophrenia. Here, learn about its implementation and review the limitations of and progress being made in pharmacogenetics.

+Pain and the Brain [Series Home Page]

William M. Glazer, MD (Moderator)

Journal of Clinical Psychiatry DVD

Pain and the Brain

William M. Glazer, MD (Moderator), et al.

Activity | Published: 6/15/2008 | Keywords: pain, depression, fibromyalgia, medical conditions, None, None

Watch this video featuring patient cases and expert commentary to see how pain and mood may interact in your patients and how physical and psychological diagnoses and treatment may be intertwined.

+The Use of Atypical Antipsychotics in Pediatric Psychiatric Disorders [Series Home Page]

Christoph U. Correll, MD (Chair)

Journal Supplement

The Use of Atypical Antipsychotics in Pediatric Psychiatric Disorders

Christoph U. Correll, MD (Chair), et al

Activity | Published: 5/15/2008 | Keywords: None, None, None, None, None, None

Examine how early onset impacts the course of illness, and review the use of atypical antipsychotics and psychosocial interventions in young patients with psychiatric disorders.

+Influencers of Treatment Success in Schizophrenia and Bipolar Disorder [Series Home Page]

John M. Kane, MD (Chair)

Journal Supplement

Influencers of Treatment Success in Schizophrenia and Bipolar Disorder

John M. Kane, MD (Chair), et al

Activity | Published: 5/15/2008 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Examine the differences between response, remission, and recovery in schizophrenia and bipolar disorder and learn how to optimize functional outcomes.

+Maximizing Efficacy of Antidepressants Beyond Selective Serotonin Reuptake Inhibitors [Series Home Page]

David J. Nutt, MD, PhD (Chair)

Journal Supplement

Maximizing Efficacy of Antidepressants: Beyond Selective Serotonin Reuptake Inhibitors

David J. Nutt, MD, PhD (Chair), et al.

Activity | Published: 4/15/2008 | Keywords: depression, None, None, None, None, None

In this online Supplement, review the neurotransmitters involved in depression and antidepressant treatment response, and learn about strategies to optimize your patients’ pharmacotherapy.

+Conference Coverage: 20th European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

W. Wolfgang Fleischhacker, MD

Brief Report

Tolerability of Antipsychotics: Recent Controversies and Future Management

W. Wolfgang Fleischhacker, MD

Activity | Published: 3/15/2008 | Keywords: schizophrenia, medical conditions, None, None, None, None

Find out how to recognize side effects associated with atypical antipsychotics, and discover appropriate interventions for managing these adverse events in your patients.

+Smoking Cessation in Patients With Psychiatric Disorders [Series Home Page]

Alan J. Gelenberg, MD (Chair)

PCC CME

Commentary: Smoking Cessation in Patients With Psychiatric Disorders

Alan J. Gelenberg, MD (Chair) et al.

Activity | Published: 2/15/2008 | Keywords: substance use disorders, None, None, None, None, None

Must Read! In this expert discussion, find out how to help your psychiatric patients quit smoking.

Alan J. Gelenberg, MD (Chair) / Alan J. Gelenberg, Jose de Leon, A. Eden Evins, Joseph J. Parks, and Nancy A. Rigotti / Mauricio Infante, Marcia J. Slattery, Marjorie H. Klein, and Marilyn J. Essex

JCP CME

Depression and Risk of Nursing Home Admission Among Older Adults in Home Care in Europe: Results From the Aged in Home Care (AdHOC) Study / Smoking Cessation in Patients With Psychiatric Disorders / Association of Internalizing Disorders and Allergies in a Child and Adolescent Psychiatry Clinical Sample

Alan J. Gelenberg, MD (Chair), et al. / Alan J. Gelenberg, Jose de Leon, A. Eden Evins, Joseph J. Parks, and Nancy A. Rigotti / Mauricio Infante, Marcia J. Slattery, Marjorie H. Klein, and Marilyn J. Essex

Activity | Published: 9/15/2007 | Keywords: depression, medical conditions, substance use disorders, None, None, None

Read this expert discussion, ranked a “must read” by the Faculty of 1000, to learn about smoking cessation in your psychiatric patients.

+A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia [Series Home Page]

JCP CME

A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia / Spontaneous Social Behaviors Discriminate Behavioral Dementias From Psychiatric Disorders and Other Dementias

Michael R. Law, Stephen B. Soumerai, Dennis Ross-Degnan, Alyce S. Adams / Katherine P. Rankin, Wendy Santos-Modesitt, Joel H. Kramer, Danijela Pavlic, Victoria Beckman, Bruce L. Miller

Activity | Published: 1/15/2008 | Keywords: schizophrenia, dementia, None, None, None, None

+Raising the Bar in Schizophrenia by Treating to Remission [Series Home Page]

John M. Kane, MD (Chair)

Journal Supplement

Raising the Bar in Schizophrenia by Treating to Remission

John M. Kane, MD (Chair), et al.

Activity | Published: 12/15/2007 | Keywords: schizophrenia, None, None, None, None, None

Read this Supplement to find out how schizophrenia affects patients and their cognitive functioning and learn about treatment algorithms to help prevent relapse and encourage remission for your patients.

+Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder [Series Home Page]

Susan L. McElroy, MD (Chair) / Robert L. Findling, L. Eugene Arnold, Laurence L. Greenhill, Christopher J. Kratochvil, and James J. McGough

JCP CME

The Role of Craving in Relapse After Discontinuation of Long-Term Benzodiazepine Use / Commentary: Diagnosing and Managing Complicated ADHD / Academic Highlights: Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder

Audrey J. J. Mol, Richard C. Oude Voshaar, Wim J. M. J. Gorgels, Marinus H. M. Breteler, Anton J. L. M. van Balkom, Eloy H. van de Lisdonk, Cornelis C. Kan, and Frans G. Zitman / Robert L. Findling, L. Eugene Arnold, Laurence L. Greenhill, Christopher J. Kratochvil, and James J. McGough / Susan L. McElroy, MD (Chair) et al.

Activity | Published: 12/15/2007 | Keywords: substance use disorders, ADHD, bipolar disorder, None, None, None

Get an expert definition of mixed states, and learn to accurately assess and treat mixed episodes.

Mark A. Frye, MD

Brief Report

The Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar Disorder

Mark A. Frye, MD

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

Review complete definitions of mixed episodes, learn about their clinical correlates, and differentiate between mixed episodes and other mood states in this Brief Report by an expert in the field.

Joseph F. Goldberg, MD

Brief Report

Bipolar Mixed Episodes: Characteristics and Comorbidities

Joseph F. Goldberg, MD

Activity | Published: 7/15/2007 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

Learn how to differentiate mixed episodes from other mood states, with an emphasis on cognitive functioning, suicidality, and comorbidities.

Roger S. McIntyre, MD, FRCPC

Brief Report

Acute Treatment of Patients With Bipolar Mixed Episodes

Roger S. McIntyre, MD, FRCPC

Activity | Published: 8/15/2007 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

Read this Brief Report to find out about treatment strategies, such as combining pharmacotherapy or implementing treatment algorithms, to manage your patients with both manic and depressive symptoms.

Susan L. McElroy, MD

Brief Report

Understanding the Complexity of Bipolar Mixed Episodes

Susan L. McElroy, MD

Activity | Published: 8/15/2007 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

Read this Brief Report to update your understanding of mixed episodes so that you can recognize this clinical presentation in your patients and determine the best management strategy.

Brief Report

Brief Reports: Bipolar Mixed Episodes: Characteristics and Comorbidities

Joseph F. Goldberg, MD

Activity | Published: 7/15/2007 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

+Presentations From the Seventh International Conference on Bipolar Disorder [Series Home Page]

Andrew A. Nierenberg, MD

Brief Report

What Have We Learned About Bipolar Disorder From STEP-BD and Other Practical Trials?

Andrew A. Nierenberg, MD

Activity | Published: 11/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Review the methodology of practical clinical trials in bipolar disorder research, and learn how to apply data from these trials to your patients’ care.

Valentim Gentil, MD, PhD

Brief Report

Bipolar Disorder and Concurrent Psychiatric and Medical Disorders

Valentim Gentil, MD, PhD

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, medical conditions, None, None, None, None

Find out how to recognize bipolar disorder, and learn how to develop individualized treatment strategies for your patients with this condition.

Eduard Vieta, PhD, and Joseph R. Calabrese, MD, Chair

Brief Report

Defining the Bipolar Spectrum and Treating Bipolar II Disorder

Eduard Vieta, PhD, and Joseph R. Calabrese, MD, Chair

Activity | Published: 9/15/2009 | Keywords: bipolar disorder, bipolar II, None, None, None, None

No consensus definition of the bipolar spectrum exists, but the definition of bipolar spectrum disorders may need to be a broad one. Participate in this Brief Reports to learn more about treating patients with bipolar II disorder and other bipolar spectrum disorders.

Eduard Vieta, MD, PhD

Brief Report

Observational, Pragmatic, and Clinical Trials in Bipolar Disorder

Eduard Vieta, MD, PhD

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Read this Brief Report to understand the advantages and limitations of observational, pragmatic, and clinical studies in bipolar disorder and learn about the role of these methodologies in current bipolar disorder research.

Joseph R. Calabrese, MD

Brief Report

Overview of Patient Care Issues and Treatment in Bipolar Spectrum and Bipolar II Disorder

Joseph R. Calabrese, MD

Activity | Published: 11/15/2007 | Keywords: bipolar disorder, bipolar II, None, None, None, None

Learn how to identify and evaluate problems in the current diagnostic criteria for bipolar disorders.

Gregory E. Simon, MD, MPH

Brief Report

Practical Lessons From Effectiveness Trials of Care Management and Psychoeducation for Bipolar Disorder

Gregory E. Simon, MD, MPH

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Explore organized treatment programs that may improve outcomes for your patients with bipolar disorder.

Kiki D. Chang, MD

Brief Report

The Bipolar Spectrum in Children and Adolescents: Developmental Issues

Kiki D. Chang, MD

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Update your understanding of the impact and course of early-onset bipolar disorders, and learn about the complexities related to the pathogenesis and diagnosis of the pediatric bipolar spectrum.

Andrea Fagiolini, MD

Brief Report

Medical Monitoring in Patients With Bipolar Disorder: A Review of Data

Andrea Fagiolini, MD

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, medical conditions, None, None, None, None

Almost half of US patients with bipolar disorder are obese. Read this Brief Report to learn about the impact of obesity on illness course and review guidelines for monitoring your patients’ weight and risk of metabolic syndrome.

Eduard Vieta, MD, PhD

Brief Report

Defining the Bipolar Spectrum and Treating Bipolar II Disorder

Eduard Vieta, MD, PhD

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, bipolar II, None, None, None, None

Read this Brief Report to become familiar with the dimensions of the bipolar spectrum and the debate among researchers regarding its definition, and learn about new and traditional treatment strategies for your patients with bipolar II disorder.

Allan H. Young, MD, PhD

Brief Report

Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities

Allan H. Young, MD, PhD

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

In this Brief Report, you can discover the consequences of an incorrect initial diagnosis for your patients with bipolar disorder and learn how to differentiate between this condition and common comorbidities.

Holly A. Swartz, MD

Brief Report

The Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know?

Holly A. Swartz, MD

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, bipolar II, None, None, None, None

Read this Brief Report to review combining psychosocial interventions with pharmacotherapy to optimize care for your patients with bipolar II disorder.

Edward S. Friedman, MD

Brief Report

Medical Monitoring in Patients With Bipolar Disorder: Clinical Recommendations

Edward S. Friedman, MD

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, medical conditions, None, None, None, None

Review the clinical parameters that should be monitored during treatment to improve outcomes for your patients with bipolar disorder.

+Narcolepsy and Excessive Daytime Sleepiness: From the Bench to the Bedside [Series Home Page]

Thomas Roth, PhD (Chair)

Journal Supplement

Narcolepsy and Excessive Daytime Sleepiness: From the Bench to the Bedside

Thomas Roth, PhD (Chair) et al.

Activity | Published: 11/15/2007 | Keywords: sleep disorders, narcolepsy, None, None, None, None

This Supplement reviews the pathophysiology of narcolepsy and examines treatment strategies that may effectively manage this and other sleep disorders in your patients.

+Atypical Depression: Management Challenges and New Treatment Advances [Series Home Page]

Jonathan R. T. Davidson, MD

E-View

A History of the Concept of Atypical Depression

Jonathan R. T. Davidson, MD

Activity | Published: 12/15/2006 | Keywords: depression, atypical depression, None, None, None, None

Atypical depression is common, presenting in about 40% of depressed patients. Review the history of the identification and treatment of atypical depression, and learn the current definition of this condition versus other depressive subtypes, by sitting in on this online lecture.

Jonathan W. Stewart, MD

E-View

Treating DSM-IV Depression With Atypical Features

Jonathan W. Stewart, MD

Activity | Published: 2/15/2007 | Keywords: depression, atypical depression, None, None, None, None

Which medications do you use to treat your patients with atypical depression? In this E-View, compare the pharmacotherapeutic studies of atypical depression to determine which treatments are the most appropriate for your patients with this depressive subtype.

Gordon B. Parker, MD, PhD, DSc

E-View

Atypical Depression: A Valid Subtype?

Gordon B. Parker, MD, PhD, DSc

Activity | Published: 1/15/2007 | Keywords: depression, atypical depression, None, None, None, None

Did you know that atypical depression is a common, nonmelancholic mood spectrum disorder that presents in certain personality styles? Sit in on this online lecture to review the history of and models for atypical depression to better recognize and treat your patients with this disorder.

Michael E. Thase, MD (Chair)

E-View

New Directions in the Treatment of Atypical Depression

Michael E. Thase, MD (Chair)

Activity | Published: 11/15/2006 | Keywords: depression, atypical depression, None, None, None, None

Mark Hyman Rapaport, MD

E-View

Translating the Evidence on Atypical Depression Into Clinical Practice

Mark Hyman Rapaport, MD

Activity | Published: 2/15/2007 | Keywords: depression, atypical depression, None, None, None, None

Jonathan W. Stewart, MD

E-View

Treating DSM-IV Depression With Atypical Features

Jonathan W. Stewart, MD

Activity | Published: 2/15/2007 | Keywords: depression, atypical depression, None, None, None, None

Which medications do you use to treat your patients with atypical depression? In this E-View, compare the pharmacotherapeutic studies of atypical depression to determine which treatments are the most appropriate for your patients with this depressive subtype.

Mark Hyman Rapaport, MD

E-View

Translating the Evidence on Atypical Depression Into Clinical Practice

Mark Hyman Rapaport, MD

Activity | Published: 2/15/2007 | Keywords: depression, atypical depression, None, None, None, None

View this online lecture to compare antidepressant medications for atypical depression and review the efficacy and tolerability of oral and transdermal MAOIs.

Michael E. Thase, MD (Chair)

Journal Supplement

Atypical Depression: Management Challenges and New Treatment Advances

Michael E. Thase, MD (Chair), et al.

Activity | Published: 2/15/2007 | Keywords: depression, atypical depression, None, None, None, None

Learn how to differentiate atypical depression from other mood disorders, and find out about interventions to effectively treat your patients with this condition.

Gordon B. Parker, MD, PhD, DSc

E-View

Atypical Depression: A Valid Subtype?

Gordon B. Parker, MD, PhD, DSc

Activity | Published: 1/15/2007 | Keywords: depression, atypical depression, None, None, None, None

Atypical depression is a common disorder that presents in patients with certain personality styles. In this online activity, you can review the history of and models for atypical depression to help you recognize and treat your patients with this disorder.

Jonathan R. T. Davidson, MD

E-View

A History of the Concept of Atypical Depression

Jonathan R. T. Davidson, MD

Activity | Published: 12/15/2006 | Keywords: depression, atypical depression, None, None, None, None

Atypical depression presents in about 40% of depressed patients. Review the history of the identification and treatment of atypical depression, and learn the current definition of this condition versus other depressive subtypes.

Michael E. Thase, MD

E-View

New Directions in the Treatment of Atypical Depression

Michael E. Thase, MD

Activity | Published: 11/15/2006 | Keywords: depression, atypical depression, None, None, None, None

How many of your patients have depression with atypical features? How do you usually manage those patients? In this lecture, you can review the diagnostic criteria for this depressive subtype and discover medications to help you treat your patients.

+Cognitive Impairment Associated With Depression in the Elderly [Series Home Page]

Steven P. Roose, MD (Chair) / Keith Hawton and Louise Harriss

JCP CME

Self-Reported History of Manic-Hypomanic Switch Associated With Antidepressant Use: Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) / Deliberate Self-Harm in Young People: Characteristics and Subsequent Mortality in a 20-Year Cohort of Patients Presenting to Hospital / Academic Highlights: Cognitive Impairment Associated With Depression in the Elderly

Christine J. Truman, Joseph F. Goldberg, S. Nassir Ghaemi, Claudia F. Baldassano, Stephen R. Wisniewski, Ellen B. Dennehy, Michael E. Thase, and Gary S. Sachs / Keith Hawton and Louise Harriss / Steven P. Roose, MD (Chair), et al.

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, depression, dementia, None, None, None

Read this section of the Journal to find out about the impact of depression on dementia and Alzheimer's disease, and learn strategies to improve your elderly patients’ functioning.

+Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy [Series Home Page]

Rakesh Jain, MD, MPH (Chair)

PCC CME

Academic Highlights: Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy

Rakesh Jain, MD, MPH (Chair) et al.

Activity | Published: 10/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Read this section of the Journal to discover the importance of accurately diagnosing bipolar disorder and learn how to transition your patients from acute to maintenance therapy.

Rakesh Jain, MD, MPH (Chair) / Lynne J. Lamarche and Joseph De Koninck

JCP CME

Mood Symptoms, Functional Impairment, and Disability in People With Bipolar Disorder: Specific Effects of Mania and Depression / Sleep Disturbance in Adults With Posttraumatic Stress Disorder: A Review/Academic Highlights: Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy, Part 2: Focus on Maintenance

Gregory E. Simon, Mark S. Bauer, Evette J. Ludman, Belinda H. Operskalski, and Jürgen Unützer / Lynne J. Lamarche and Joseph De Koninck / Rakesh Jain, MD, MPH (Chair), et al.

Activity | Published: 8/15/2007 | Keywords: bipolar disorder, PTSD, anxiety, None, None, None

Learn how to individualize long-term treatment and facilitate adherence to help your patients with bipolar disorder sustain remission.

Rakesh Jain, MD, MPH (Chair)

JCP CME

Are Overweight, Obesity, and Extreme Obesity Associated With Psychopathology? Results From the National Epidemiologic Survey on Alcohol and Related Conditions/Positive Childhood Experiences: Resilience and Recovery From Personality Disorder in Early Adulthood/Academic Highlights: Advances in the Treatment of Alcohol Dependence/Academic Highlights: Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy, Part 1: Urgent Situations

Roger P. Pickering, Bridget F. Grant, S. Patricia Chou, and Wilson M. Compton / Andrew E. Skodol, Donna S. Bender, Maria E. Pagano, M. Tracie Shea, Shirley Yen, Charles A. Sanislow, Carlos M. Grilo, Maria T. Daversa, Robert L. Stout, Mary C. Zanarini, Thomas H. McGlashan, and John G. Gunderson / Richard N. Rosenthal, MD, (Chair), et al. / Rakesh Jain, MD, MPH (Chair), et al.

Activity | Published: 7/15/2007 | Keywords: substance use disorders, personality disorders, None, None, None, None

Review the presentation of acute mood episodes in bipolar disorder, and find out how to quickly stabilize your patients who present in urgent situations.

Rakesh Jain, MD, MPH

Brief Report

Introduction to Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy

Rakesh Jain, MD, MPH

Activity | Published: 8/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

With this Brief Report, review the clinical issues pertaining to acute mood episodes in patients with bipolar disorder, and learn how to transition your patients from short-term to long-term therapy.

Noel C. Gardner, MD

Brief Report

A Clinician's View of the Data on Bipolar Disorder

Noel C. Gardner, MD

Activity | Published: 7/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

The maintenance phase of bipolar treatment is important in managing the illness across the patient’s lifespan. The problem with implementing evidence-based treatments for maintenance therapy is . . .

W. Clay Jackson, MD, DipTh

Brief Report

The Importance of Facilitating Adherence in Maintenance Therapy for Bipolar Disorder

W. Clay Jackson, MD, DipTh

Activity | Published: 7/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

After attaining syndromal and functional recovery during the acute and continuation phases of treatment, the goal of therapy during maintenance treatment is . . .

Vladimir Maletic, MD

Brief Report

What Clinicians Need to Know About Neuroprotective Issues in Bipolar Disorder

Vladimir Maletic, MD

Activity | Published: 7/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Review the neurobiology of bipolar disorder, and learn how neuroimaging and pathohistology may help identify the effects of this illness on the brain.

Steven J. Garlow, MD, PhD

Brief Report

Interventions for Acute Mood Episodes in Patients With Bipolar Disorder

Steven J. Garlow, MD, PhD

Activity | Published: 7/15/2007 | Keywords: bipolar disorder, bipolar depression, bipolar mania, None, None, None

Examine treatment goals for patients with bipolar disorder in acute episodes and receive medication recommendations to help quickly alleviate their symptoms.

Tracey G. Skale, MD

Brief Report

Practical Strategies for Assessing and Stabilizing Bipolar Patients in Urgent Situations

Tracey G. Skale, MD

Activity | Published: 7/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Review interventions to stabilize bipolar patients who are suicidal or aggressive, who are pregnant, or who have a comorbid condition.

+Weighing the Evidence: Weight Management Insights for Treating Major Mental Illness [Series Home Page]

Leslie Citrome, MD, MPH (Chair)

Journal Supplement

Weighing the Evidence: Weight Management Insights for Treating Major Mental Illness

Leslie Citrome, MD, MPH (Chair), et al.

Activity | Published: 9/15/2007 | Keywords: schizophrenia, medical conditions, bipolar disorder, None, None, None

Read this new Supplement to review antipsychotic profiles and learn how to balance medication efficacy with risk of weight gain when treating your patients with these agents.

+ADHD and Comorbid Substance Use Disorder [Series Home Page]

Himanshu P. Upadhyaya, MBBS, MS (Chair)

Journal Supplement

Attention-Deficit/Hyperactivity Disorder and Comorbid Substance Use Disorder

Himanshu P. Upadhyaya, MBBS, MS (Chair), et al.

Activity | Published: 9/15/2007 | Keywords: None, None, None, None, None, None

With this Supplement, you can find out why some patients with ADHD develop substance use disorders and learn how to recognize and treat this dual diagnosis in your patients.

Timothy E. Wilens, MD

E-View

Impact of Substance Use Disorder on ADHD and Its Treatment

Timothy E. Wilens, MD

Activity | Published: 7/15/2007 | Keywords: ADHD, substance use disorders, None, None, None, None

In this E-View, discover why ADHD and SUDs commonly co-occur in adolescence and adulthood and find out about the impact of this comorbid condition on ADHD treatment.

Stephen V. Faraone, PhD

E-View

The Effect of Stimulant Treatment for ADHD on Later Substance Abuse and the Potential for Medication Misuse, Abuse, and Diversion

Stephen V. Faraone, PhD

Activity | Published: 9/15/2007 | Keywords: ADHD, substance use disorders, None, None, None, None

ADHD is a risk factor for SUD, and these 2 disorders often co-occur. In this E-View, review treatments for ADHD that may minimize your patients’ risk of developing an SUD.

Himanshu P. Upadhyaya, MBBS, MS

E-View

Managing ADHD in the Presence of Comorbid Substance Use Disorder

Himanshu P. Upadhyaya, MBBS, MS

Activity | Published: 5/15/2007 | Keywords: ADHD, substance use disorders, None, None, None, None

Review the abuse liability of ADHD medications, and learn to effectively treat your patients with this common comorbidity.

Frances R. Levin, MD

E-View

Diagnosing ADHD in Adults With Substance Use Disorder: DSM-IV Criteria and Differential Diagnosis

Frances R. Levin, MD

Activity | Published: 4/15/2007 | Keywords: ADHD, substance use disorders, None, None, None, None

Find out about the factors that can complicate diagnosing substance use disorders in patients with ADHD.

+Mixed Depression in Bipolar Disorders: Diagnosis and Treatment Strategies [Series Home Page]

Steven C. Dilsaver, MD, and Franco Benazzi, MD, PhD

Brief Report

Treating Depressive Mixed States in Bipolar Disorders

Steven C. Dilsaver, MD, et al.

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

Receive expert recommendations from American and European perspectives on treating your patients in mixed depressive states.

Steven C. Dilsaver, MD, and Franco Benazzi, MD, PhD

Brief Report

Diagnosing Depressive Mixed States in Bipolar Disorders

Steven C. Dilsaver, MD, et al.

Activity | Published: 9/15/2007 | Keywords: bipolar disorder, bipolar mixed episodes, None, None, None, None

Read this Brief Report to receive a comprehensive definition of depressive mixed states and learn additional strategies for recognizing and evaluating this presentation in your patients.

+The Role of Folate in Depression and Dementia [Series Home Page]

Maurizio Fava, MD (Chair)

Journal Supplement

The Role of Folate in Depression and Dementia

Maurizio Fava, MD (Chair), et al.

Activity | Published: 9/15/2007 | Keywords: depression, dementia, None, None, None, None

Review the limitations of antidepressant monotherapy, and find out how to select appropriate augmentation strategies, such as adjunctive folate, to maximize treatment efficacy and tolerability for your patients.

+Strategies to Integrate Physical Health Care Into Mental Health [Series Home Page]

Joseph J. Parks, MD

E-View

Implementing Evidence-Based Medicine: Lessons From Public Mental Health Settings

Joseph J. Parks, MD

Activity | Published: 5/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

In this online lecture, receive recommendations for implementing evidence-based medicine to improve mental and medical health care for your patients with psychiatric disorders.

Donald C. Goff, MD

E-View

Integrating General Health Care in Private Community Psychiatry Practice

Donald C. Goff, MD

Activity | Published: 5/15/2007 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

Chronically mentally ill patients have high mortality rates from medical illnesses. Watch this E-View to find out what you can do in your practice to educate patients about medical risk factors, and learn monitoring strategies to improve their overall health outcomes.

Peter J. Weiden, MD

E-View

Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances

Peter J. Weiden, MD

Activity | Published: 4/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Benjamin G. Druss, MD, MPH

E-View

Challenges and Solutions to Integrating Mental and Physical Health Care

Benjamin G. Druss, MD, MPH

Activity | Published: 2/15/2007 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

In this online lecture, discover the factors contributing to the poor quality of health care that many psychiatric patients receive and learn what you can do to close the gap between physical and mental health care for your patients.

Newcomer and Sernyak

E-View

Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies

John W. Newcomer, MD (Chair), and Michael J. Sernyak, MD

Activity | Published: 5/15/2007 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

Review the adverse effects of antipsychotics and learn how to implement monitoring guidelines to minimize the impact of these effects on your patients.

Ganguli and Vreeland

E-View

Monitoring and Managing Weight Gain in the Mentally Ill

Rohan Ganguli, MD, and Betty Vreeland, MSN, APRN, NP-C, BC

Activity | Published: 5/15/2007 | Keywords: schizophrenia, medical conditions, bipolar disorder, None, None, None

Weight gain from medications can be minimized and, sometimes, reversed or prevented. In this E-View, learn how you can manage weight gain and other modifiable risk factors to improve your patients’ overall health.

Hennekens and Newcomer

E-View

Series Introduction and Cardiovascular Disease in Patients With Schizophrenia

Charles H. Hennekens, MD, and John W. Newcomer, MD, (Chair)

Activity | Published: 7/15/2007 | Keywords: schizophrenia, medical conditions, None, None, None, None

Newcomer and Sernyak

E-View

Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies

John W. Newcomer, MD (Chair), et al.

Activity | Published: 5/15/2007 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

Review the adverse effects of antipsychotics and learn how to implement monitoring guidelines to minimize the impact of these effects on your patients.

Donald C. Goff, MD

E-View

Integrating General Health Care in Private Community Psychiatry Practice

Donald C. Goff, MD

Activity | Published: 5/15/2007 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

Watch this E-View to find out what you can do in your practice to educate patients about their medical risk factors and learn monitoring strategies to improve their overall health outcomes.

Ganguli and Vreeland

E-View

Monitoring and Managing Weight Gain in the Mentally Ill

Rohan Ganguli, MD, et al.

Activity | Published: 5/15/2007 | Keywords: schizophrenia, medical conditions, bipolar disorder, None, None, None

Participate in this online lecture to learn how you can minimize the negative impact of medications on patients’ weight and other modifiable risk factors to improve their overall health.

Joseph J. Parks, MD

E-View

Implementing Evidence-Based Medicine: Lessons From Public Mental Health Settings

Joseph J. Parks, MD

Activity | Published: 5/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Watch this online lecture to receive expert recommendations for implementing evidence-based medicine in your practice to help improve mental and medical health care for your patients with psychiatric disorders.

Hennekens and Newcomer

E-View

Series Introduction and Cardiovascular Disease in Patients With Schizophrenia

John W. Newcomer, MD (Chair), et al.

Activity | Published: 4/15/2007 | Keywords: schizophrenia, medical conditions, None, None, None, None

In this E-View, experts review the burden of cardiovascular disease in schizophrenia and address treatment for modifiable risk factors to optimize your patients’ outcomes.

Peter J. Weiden, MD

E-View

Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances

Peter J. Weiden, MD

Activity | Published: 4/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Watch this online lecture to find out about antipsychotic-induced metabolic side effects and receive recommendations for switching these agents to improve your patients’ overall health.

Benjamin G. Druss, MD, MPH

E-View

Challenges and Solutions to Integrating Mental and Physical Health Care

Benjamin G. Druss, MD, MPH

Activity | Published: 2/15/2007 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

In this online lecture, find out how mental and medical health care can be integrated to provide your patients with comprehensive treatment, improve their overall outcomes, and reduce their health care costs.

+Special Issues Related to the Management of Bipolar Disorder in Women: Tolerability of Treatment [Series Home Page]

Lee S. Cohen, MD (Chair)

Journal Supplement

Special Issues Related to the Management of Bipolar Disorder in Women: Tolerability of Treatment

Lee S. Cohen, MD (Chair), et al.

Activity | Published: 8/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

Learn about the impact of hormonal changes on bipolar disorder, and learn how to manage patients with this condition during pregnancy, breastfeeding, and menopause.

+Translating Evidence on Depression and Physical Symptoms into Effective Clinical Practice [Series Home Page]

David A. Fishbain, MD (Chair)

PCC CME

Commentary: Exercise for Mood and Anxiety Disorders / Academic Highlights: Translating Evidence on Depression and Physical Symptoms into Effective Clinical Practice

David A. Fishbain, MD (Chair) et al.

Activity | Published: 8/15/2007 | Keywords: depression, anxiety, medical conditions, None, None, None

Read this new Academic Highlights to get expert opinions about diagnostic and treatment strategies for patients with overlapping pain and depression in primary care settings.

+Distance Rounds [Series Home Page]

Wayne K. Goodman, MD

Distance Rounds

Recognition and Treatment of Obsessive-Compulsive Disorder

Wayne K. Goodman, MD

Activity | Published: 10/15/2007 | Keywords: obsessive-compulsive disorder, anxiety, None, None, None, None

Patients often do not disclose obsessive and compulsive behaviors to their clinicians. In this Distance Rounds, learn about the prevalence and pathogenesis of OCD and find out how you can recognize, diagnose, and treat this disorder.

Thomas Mellman, MD

Distance Rounds

Posttraumatic Stress Disorder: Characteristics and Treatment

Thomas Mellman, MD

Activity | Published: 11/15/2007 | Keywords: PTSD, anxiety, None, None, None, None

Up to 14% of the general population has PTSD and women are often affected more than men. In this online activity, find out about the symptoms of and risk factors for PTSD and learn how to effectively treat your patients with this condition.

R. Bruce Lydiard, MD, PhD

Distance Rounds

Recognition and Treatment of Panic Disorder

R. Bruce Lydiard, MD, PhD

Activity | Published: 8/15/2007 | Keywords: panic disorder, anxiety, None, None, None, None

Participate in this Distance Rounds to review the symptomatology, course of illness, and common comorbidities of panic disorder and learn how to effectively treat your patients with this condition.

+Monoamine Oxidase Inhibitors Revisited: Their Role in Depressive Disorders [Series Home Page]

Prakash S. Masand, MD (Facilitator)

Journal Supplement

Monoamine Oxidase Inhibitors Revisited: Their Role in Depressive Disorders

Prakash S. Masand, MD (Facilitator), et al.

Activity | Published: 7/15/2007 | Keywords: depression, atypical depression, None, None, None, None

Read expert advice on how to differentiate atypical depression from other depressive subtypes, and review the role of MAOIs in the treatment of this disorder in this Supplement.

+The Art and Science of Switching Antipsychotic Medications [Series Home Page]

Peter F. Buckley, MD (Chair) et al.

Journal Supplement

The Art and Science of Switching Antipsychotic Medications

Peter F. Buckley, MD (Chair), et al.

Activity | Published: 6/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Read this Supplement to receive experts’ recommendations for switching among antipsychotics and learn how to minimize adverse events when initiating, titrating, or switching these medications.

Peter F. Buckley, MD (Chair)

E-View

The Art and Science of Switching Antipsychotic Medications, Part 2

Peter F. Buckley, MD (Chair) et al.

Activity | Published: 11/15/2006 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Review the TMAP recommendations for switching antipsychotics, and learn about dosing and titration strategies to improve your patients’ overall outcomes when switching among these agents.

Peter F. Buckley, MD (Chair)

E-View

The Art and Science of Switching Antipsychotic Medications, Part 1

Allan H. Young, MD; Peter J. Weiden, MD; Peter F. Buckley, MD (Chair)

Activity | Published: 9/15/2006 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

In this online slide show, you can update your understanding of the differential pharmacology of atypical antipsychotics, and learn about factors that influence the switching of these agents.

+Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness [Series Home Page]

JCP CME

Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness

Risa B. Gershon Grand, Sun Hwang, Juliette Han, Tony George, and Arthur L. Brody

Activity | Published: 6/15/2007 | Keywords: substance use disorders, None, None, None, None, None

+Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder [Series Home Page]

David L. Dunner, MD (Chair)

PCC CME

Academic Highlights: Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

David L. Dunner, MD (Chair), et al.

Activity | Published: 6/15/2007 | Keywords: None, None, None, None, None, None

Read this expert discussion to find out which patients are candidates for maintenance treatment and learn how to implement long-term therapy in patients with recurrent depression.

David L. Dunner, MD (Chair)

JCP CME

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

David L. Dunner, MD (Chair), et al

Activity | Published: 4/15/2007 | Keywords: None, None, None, None, None, None

In this Academic Highlights, find out which patients are candidates for maintenance treatment, and learn how to best implement long-term therapy in your patients with recurrent depression.

David L. Dunner, MD (Chair)

Online Insight

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

David L. Dunner, MD (Chair), et al.

Activity | Published: 1/15/2007 | Keywords: depression, None, None, None, None, None

Watch this online slide show to learn about using maintenance pharmacotherapy and psychotherapy to help prevent relapse so that your patients with recurrent depression can maintain remission.

+Understanding Neuronal Pathways: Novel Targets for the Management of Insomnia [Series Home Page]

Thomas Roth, PhD (Chair)

Journal Supplement

Understanding Neuronal Pathways: Novel Targets for the Management of Insomnia

Thomas Roth, PhD (Chair), et al.

Activity | Published: 5/15/2007 | Keywords: sleep disorders, insomnia, None, None, None, None

Read this Supplement to examine the neurobiology involved in sleep pathology and discover how combining medication and psychoeducation can improve your patients' insomnia.

+Exercise for Mood and Anxiety Disorders [Series Home Page]

Michael W. Otto, PhD (Chair) / Carlos M. Grilo, Maria E. Pagano, Andrew E. Skodol, Charles A. Sanislow, Thomas H. McGlashan, John G. Gunderson, and Robert L. Stout

JCP CME

Commentary: Exercise for Mood and Anxiety Disorders/Natural Course of Bulimia Nervosa and of Eating Disorder Not Otherwise Specified: 5-Year Prospective Study of Remissions, Relapses, and the Effects of Personality Disorder Psychopathology

Michael W. Otto, PhD (Chair), et al. / Carlos M. Grilo, Maria E. Pagano, Andrew E. Skodol, Charles A. Sanislow, Thomas H. McGlashan, John G. Gunderson, and Robert L. Stout

Activity | Published: 5/15/2007 | Keywords: anxiety, depression, eating disorders, None, None, None

Read this expert Commentary to find out about exercise as an effective treatment intervention for your patients with mood and anxiety disorders.

+Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety [Series Home Page]

Lenard A. Adler, MD (Chair)

PCC CME

Academic Highlights: Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety in Primary Care

Lenard A. Adler, MD (Chair) et al.

Activity | Published: 4/15/2007 | Keywords: ADHD, anxiety, None, None, None, None

Learn how to select treatments for your patients who present with not only symptoms of inattention, hyperactivity, and impulsivity, but also anxiety.

Lenard A. Adler, MD (Chair)

JCP CME

Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia/Academic Highlights: Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety/Academic Highlights: New Developments in the Treatment of Schizophrenia

Stefan Leucht, Raymonde Busch, Werner Kissling, and John M. Kane / Lenard A. Adler, MD (Chair), et al. / John M. Kane, MD (Chair), et al.

Activity | Published: 3/15/2007 | Keywords: schizophrenia, ADHD, anxiety, None, None, None

Experts review how to diagnose ADHD as well as how to treat symptoms of ADHD and anxiety.

+Impact of Bipolar Disorder: Results From a Screening Study [Series Home Page]

PCC CME

Impact of Bipolar Disorder: Results From a Screening Study

Paul Stang, Cathy Frank, Marianne Ulcickas Yood, Karen Wells, and Steven Burch

Activity | Published: 2/15/2007 | Keywords: bipolar disorder, None, None, None, None, None

+Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression [Series Home Page]

Alan F. Schatzberg, MD (Chair)

JCP CME

Health-Related Quality of Life in Eurythmic Bipolar Disorder Patients: Differences Between Bipolar I and II Subtypes/Academic Highlights: Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression

Giuseppe Maina, Umberto Albert, Laura Bellodi, Cristina Colombo, Carlo Faravelli, Palmiero Monteleone, Filippo Bogetto, Giovanni B. Cassano, and Mario Maj / Alan F. Schatzberg, MD (Chair), et al.

Activity | Published: 2/15/2007 | Keywords: bipolar disorder, depression, None, None, None, None

Find out about the development, mechanism of action, and effectiveness of TMS as a noninvasive, device-based procedure for treatment-resistant depression.

+Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond [Series Home Page]

Henry A. Nasrallah, MD (Chair)

Journal Supplement

Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond

Henry A. Nasrallah, MD (Chair), et al.

Activity | Published: 1/15/2007 | Keywords: schizophrenia, None, None, None, None, None

Update your understanding of the safety and tolerability profiles of antipsychotics, and learn long-term treatment strategies to improve your patients’ overall outcomes.

+Practical Applications of Recent Antipsychotic Effectiveness Data [Series Home Page]

Jeffrey A. Lieberman, MD (Chair)

JCP CME

Personality Disorder and Cardiovascular Disease: Results From a National Household Survey / Self-Injurious Behavior in a Community Sample of Young Women: Relationship With Childhood Abuse and Other Types of Self-Damaging Behaviors / Academic Highlights: The Evolving Paradigm for Bipolar Disorder / Academic Highlights: Practical Applications of Recent Antipsychotic Effectiveness Data

Paul Moran, Robert Stewart, Traolach Brugha, Paul Bebbington, Dinesh Bhugra, Rachel Jenkins, and Jeremy W. Coid/Angela Favaro, Silvia Ferrara, and Paolo Santonastaso/Paul E. Keck, Jr., MD (Chair) et al./Jeffrey A. Lieberman, MD (Chair) et al.

Activity | Published: 1/15/2007 | Keywords: personality disorders, bipolar disorder, medical conditions, None, None, None

In this section of the Journal, review the effectiveness data on antipsychotics from the CATIE study to learn how to select the most appropriate agent for your patients with schizophrenia.

John W. Newcomer, MD

E-View

Comparing Safety and Tolerability of Antipsychotic Treatment

John W. Newcomer, MD

Activity | Published: 1/15/2007 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Participate in this E-View to review the potential adverse effects of antipsychotic medications on patients’ health and receive treatment recommendations on how to minimize metabolic risk factors to optimize your patients’ overall outcomes.

Jeffrey A. Lieberman, MD

E-View

Effectiveness of Antipsychotic Drugs in Patients With Chronic Schizophrenia: Efficacy, Safety, and Cost Outcomes of CATIE and Other Trials

Jeffrey A. Lieberman, MD

Activity | Published: 1/15/2007 | Keywords: schizophrenia, None, None, None, None, None

Sit in on this lecture to review the results of the CATIE trial and find out which antipsychotics are most effective for certain patients.

Robert A. Rosenheck, MD

E-View

Cost-Effectiveness Measures, Methods, and Policy Implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia

Robert A. Rosenheck, MD

Activity | Published: 12/15/2006 | Keywords: schizophrenia, None, None, None, None, None

In this slide show, review the results of the CATIE trial to evaluate the costs of antipsychotics and how those expenses impact your patients.

Philip D. Harvey, PhD

E-View

Cognitive and Functional Effects of Atypical Antipsychotic Medications

Philip D. Harvey, PhD

Activity | Published: 9/15/2006 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Is cognition a sufficient treatment target to improve functional outcomes for patients with mental illness? Find out about atypical antipsychotics and their role in cognition and function in this online lecture.

+Pathological Gambling: A Review of Phenomenological Models and Treatment Modalities for an Underrecognized Psychiatric Disorder [Series Home Page]

PCC CME

Pathological Gambling: A Review of Phenomenological Models and Treatment Modalities for an Underrecognized Psychiatric Disorder

Pinhas N. Dannon, Katherine Lowengrub, Yehudit Gonopolski, Ernest Musin, and Moshe Kotler

Activity | Published: 12/15/2006 | Keywords: pathological gambling, None, None, None, None, None

+ADHD: Applying Practice Guidelines to Improve Patient Outcome and Executive Function [Series Home Page]

Joseph Biederman, MD (Chair)

JCP CME

The Trichotillomania Impact Project (TIP): Exploring Phenomenology, Functional Impairment, and Treatment Utilization/Academic Highlights: New Paradigms in the Treatment of Alzheimer's Disease/Academic Highlights: ADHD: Applying Practice Guidelines to Improve Patient Outcome and Executive Function

Douglas W. Woods, Christopher A. Flessner, Martin E. Franklin, Nancy J. Keuthen, Renee D. Goodwin, Dan J. Stein, Michael R. Walther, and the Trichotillomania Learning Center-Scientific Advisory Board/Pierre N. Tariot, MD (Chair) et al./Joseph Biederman, MD (Chair) et al.

Activity | Published: 12/15/2006 | Keywords: anxiety, Alzheimer's, ADHD, None, None, None

Update your knowledge of the neurobiology of ADHD and its effect on executive function, and find out about treatments for ADHD, including the abuse liability of stimulants.

+Practical Pharmacotherapeutic Management Strategies for Patients With Alcohol Dependence [Series Home Page]

Robert M. Swift, MD, PhD (Chair)

Journal Supplement

Practical Pharmacotherapeutic Management Strategies for Alcohol Dependence

Robert M. Swift, MD, PhD (Chair)

Activity | Published: 12/15/2006 | Keywords: substance use disorders, None, None, None, None, None

In this Supplement, learn techniques to detect alcohol dependence, and review practical strategies to improve your patients' outcomes.

+The Evolving View on Delta Sleep and Its Relationship to Daytime Function: A CME-Certified Virtual Symposium [Series Home Page]

Jerome Siegel, PhD (Chair)

VS - Virtual Slide Set

The Evolving View on Delta Sleep and Its Relationship to Daytime Function: A CME-Certified Virtual Symposium

Jerome Siegel, PhD (Chair) et al.

Activity | Published: 11/15/2006 | Keywords: None, None, None, None, None, None

Discover the effects of sleep fragmentation, slow-wave sleep deprivation, and novel sedating agents on daytime function.

+New Developments in Addiction Treatment [Series Home Page]

Charles P. O'Brien, MD (Chair)

JCP CME

The Brown Longitudinal Obsessive Compulsive Study: Treatments Received and Patient Impressions of Improvement/Academic Highlights: New Developments in Addiction Treatment

Maria C. Mancebo, Jane L. Eisen, Anthony Pinto, Benjamin D. Greenberg, Ingrid R. Dyck, and Steven A. Rasmussen/Charles P. O'Brien, MD (Chair), et al.

Activity | Published: 11/15/2006 | Keywords: obsessive-compulsive disorder, substance use disorders, None, None, None, None

Learn treatment strategies to manage your patients with SUDs, and find out how to integrate addiction services into your practice.

+Psychiatry in Brief: Insomnia and Emerging Therapies: Treating the Whole Patient [Series Home Page]

William M. Glazer, MD (Chair)

Journal Supplement

Psychiatry in Brief: Insomnia and Emerging Therapies: Treating the Whole Patient

William M. Glazer, MD (Chair) et al.

Activity | Published: 11/15/2006 | Keywords: sleep disorders, insomnia, None, None, None, None

Update your understanding of how comorbid conditions can influence the presentation and course of insomnia, and discover safe and effective treatments for your patients with this common sleep disorder.

+Improving Cognitive Function and Functional Outcome in Severe Mental Illness [Series Home Page]

Paul E. Keck, Jr., MD

E-View

Long-Term Management Strategies to Achieve Optimal Function in Patients With Bipolar Disorder

Paul E. Keck, Jr., MD

Activity | Published: 10/15/2006 | Keywords: bipolar disorder, None, None, None, None, None

Watch this slide show to learn about psychotherapeutic and long-term pharmacotherapeutic interventions that can help your patients achieve symptomatic remission.

Michael F. Green, MD

E-View

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

Michael F. Green, MD

Activity | Published: 8/15/2006 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Cognitive impairment is a core feature of both bipolar disorder and schizophrenia. Watch this online presentation to learn about treatments that target cognition to improve your patients' functional outcomes.

John W. Newcomer, MD

E-View

Medical Risk in Patients With Bipolar Disorder and Schizophrenia

John W. Newcomer, MD

Activity | Published: 8/15/2006 | Keywords: schizophrenia, bipolar disorder, medical conditions, None, None, None

In this E-View, you can update your knowledge of the adverse events associated with the treatment of bipolar disorder and schizophrenia, and learn about modifiable risk factors to manage medical illnesses in patients with these psychiatric conditions.

Stephen R. Marder, MD (Chair)

Journal Supplement

Improving Cognitive Function and Functional Outcome in Severe Mental Illness

Stephen R. Marder, MD (Chair) et al.

Activity | Published: 8/15/2006 | Keywords: schizophrenia, bipolar disorder, None, None, None, None

Learn about the neurobiology of cognitive impairment, and find out how maintenance therapies and drug initiatives may help to improve cognitive and functional outcomes for your patients.

Carol A. Tamminga, MD

E-View

The Neurobiology of Cognition in Schizophrenia

Carol A. Tamminga, MD

Activity | Published: 7/15/2006 | Keywords: None, None, None, None, None, None

Participate in this online activity to find out how the dopaminergic, serotonergic, glutamatergic, and GABAergic effects of medications may improve cognitive functioning in your patients with schizophrenia.

Philip D. Harvey, PhD

E-View

Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia

Philip D. Harvey, PhD

Activity | Published: 7/15/2006 | Keywords: None, None, None, None, None, None

Participate in this online lecture to find out how to help your mentally ill patients achieve remission and functional recovery by establishing short- and long-term treatment goals.

Stephen R. Marder, MD

E-View

Initiatives to Promote the Discovery of Drugs to Improve Cognitive Function in Severe Mental Illness

Stephen R. Marder, MD (Chair)

Activity | Published: 6/15/2006 | Keywords: None, None, None, None, None, None

In this E-View, review the limitations of current pharmacotherapy for mental illness and learn about the MATRICS approach for facilitating drug development.

+Social Anxiety Disorder: Diagnosis, Outcome, Mechanisms, and Management [Series Home Page]

Jonathan R. T. Davidson, MD (Chair)

Journal Supplement

Social Anxiety Disorder: Diagnosis, Outcome, Mechanisms, and Management

Jonathan R. T. Davidson, MD (Chair) et al.

Activity | Published: 10/15/2006 | Keywords: social anxiety disorder, anxiety, None, None, None, None

Here, review the epidemiology, etiology, and neurobiology of social anxiety disorder, and learn about pharmacotherapuetic and psychosocial strategies to improve your patients' functioning.

+Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms [Series Home Page]

Madhukar H. Trivedi, MD (Chair)

Online Insight

Treating Depression Complicated by Comorbid Medical Illness or Anxiety

Madhukar H. Trivedi, MD (Chair) et al.

Activity | Published: 11/15/2006 | Keywords: depression, anxiety, medical conditions, None, None, None

Learn pharmacotherapeutic strategies to treat your patients with depression and comorbidities.

Wayne J. Katon, MD, and Ella Daly, MRCPsych

Online Insight

General Medical Comorbidities and Pain in Depression

Wayne J. Katon, MD, and Ella Daly, MRCPsych

Activity | Published: 5/15/2006 | Keywords: None, None, None, None, None, None

Review the common medical comorbidities of depression and the effect on patients’ functioning and medication adherence.

Madhukar H. Trivedi, MD (Chair)

JCP CME

Commentary: The State of Knowledge of Chronic Depression/A Randomized Controlled Trial of Cognitive Therapy for Bipolar Disorder: Focus on Long-Term Change/Academic Highlights: Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms

Alan J. Gelenberg, MD (Chair) et al./Jillian R. Ball, Philip B. Mitchell, Justine C. Corry, Ashleigh Skillecorn, Meg Smith, and Gin S. Malhi/Madhukar H. Trivedi, MD (Chair) et al.

Activity | Published: 2/15/2006 | Keywords: depression, bipolar disorder, medical conditions, None, None, None

Learn how you can help your patients with medical and psychiatric comorbidities successfully manage their depression.

+Managing Patients With Vascular Disease and Depression [Series Home Page]

Steven P. Roose, MD (Chair)

JCP CME

Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods / Antipsychotic Adherence Over Time Among Patients Receiving Treatment for Schizophrenia: A Retrospective Review / Academic Highlights: Managing Patients With Vascular Disease and Depression

Ruud van Winkel, Marc De Hert, Dominique Van Eyck, Linda Hanssens, Martien Wampers, Andre Scheen, and Joseph Peuskens/Marcia Valenstein, Dara Ganoczy, John F. McCarthy, Hyungjin Myra Kim, Todd A. Lee, and Frederic C. Blow/Steven P. Roose, MD (Chair) et al.

Activity | Published: 10/15/2006 | Keywords: schizophrenia, medical conditions, None, None, None, None

The combination of depression and vascular disease multiplies patients’ risk of death. Participate in this CME activity to learn how to effectively treat your patients with these co-occurring conditions.

+Use of Treatment Algorithms for Depression [Series Home Page]

Madhukar H. Trivedi, MD (Chair)

PCC CME

Commentary: Use of Treatment Algorithms for Depression

Madhukar H. Trivedi, MD (Chair), et al.

Activity | Published: 10/15/2006 | Keywords: depression, None, None, None, None, None

Gain insight from the experts regarding the pros and cons of using treatment algorithms to navigate treatment options for your patients with depression.

Madhukar H. Trivedi, MD (Chair)

JCP CME

Lifetime Trauma Exposure in Veterans With Military-Related Posttraumatic Stress Disorder: Association With Current Symptomatology/Realistic Expectations and a Disease Management Model for Depressed Patients With Persistent Symptoms/Commentary: Use of Treatment Algorithms for Depression

Carolina P. Clancy, Anna Graybeal, Whitney P. Tompson, Kourtni S. Badgett, Michelle E. Feldman, Patrick S. Calhoun, Alaattin Erkanli, Michael A. Hertzberg, and Jean C. Beckham/Gabor I. Keitner, Christine E. Ryan, and David A. Solomon/Madhukar H. Trivedi, MD (Chair) et al.

Activity | Published: 9/15/2006 | Keywords: PTSD, anxiety, depression, None, None, None

Algorithms can help you choose appropriate strategies for treating depression. Read this expert commentary to learn about the effectiveness of treatment algorithms for depression and how to implement them into your practice.

+Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD): A Clinical View [Series Home Page]

Gary S. Sachs, MD (Chair)

Journal Supplement

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD): A Clinical View

Gary S. Sachs, MD (Chair) et al.

Activity | Published: 8/15/2006 | Keywords: bipolar disorder, None, None, None, None, None

Review the STEP-BD model of collaborative care to treat manic, mixed, or depressive episodes.

+New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

Joseph Biederman, MD (Chair)

PCC CME

Human Immunodeficiency Virus and Depression in Primary Care: A Clinical Review / Academic Highlights: New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder in Primary Care

Tiziano Colibazzi, Teresa T. Hsu, and William S. Gilmer/Joseph Biederman, MD (Chair) et al.

Activity | Published: 8/15/2006 | Keywords: medical conditions, ADHD, None, None, None, None

ADHD affects up to 7% of children and 4% of adults. Here, learn about ADHD medication mechanisms of action and multimodal treatment approaches to improve outcomes for your patients with this disorder.

Joseph Biederman, MD (Chair)

Journal Supplement

New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder

Joseph Biederman, MD (Chair), et al.

Activity | Published: 8/15/2006 | Keywords: ADHD, None, None, None, None, None

Review the mechanism of action and efficacy of ADHD agents, and find out how to manage your patients with this and other, common comorbid psychiatric or medical conditions.

Joseph Biederman, MD (Chair)

JCP CME

The Impact of Disasters and Their Aftermath on Mental Health/ Prevalence and Severity of Intimate Partner Violence and Associations With Family Functioning and Alcohol Abuse in Psychiatric Inpatients With Suicidal Intent/Academic Highlights: New Developments in the Treatment of ADHD

Robert J. Ursano, MD (Chair) et al./Francesco Benedetti, Barbara Barbini, Mara Cigala Fulgosi, Cristina Colombo, Sara Dallaspezia, Adriana Pontiggia, and Enrico Smeraldi/Joseph Biederman, MD (Chair) et al.

Activity | Published: 1/15/2006 | Keywords: ADHD, substance use disorders, mental illness, None, None, None

ADHD affects approximately up to 7% of children and 4% of adults. In this Academic Highlights, learn about the neurobiology of ADHD and multimodal approaches to optimally treat this growing population.

+Antecedents to Panic Disorder in Nonreferred Adults [Series Home Page]

JCP CME

Antecedents to Panic Disorder in Nonreferred Adults/Concomitant Medications May Not Improve Outcome of Antipsychotic Monotherapy for Stabilized Patients With Nonacute Schizophrenia/Anxiety Disorders During Pregnancy and the Postpartum Period: A Systematic Review

Joseph Biederman, Carter R. Petty, Stephen V. Faraone, Dina R. Hirshfeld-Becker, Aude Henin, Lindsay Brauer, Bonnie Kaufman, and Jerrold F. Rosenbaum/Ira D. Glick, Diana Pham, and John M. Davis/Lori E. Ross and Linda M. McLean

Activity | Published: 8/15/2006 | Keywords: panic disorder, anxiety, schizophrenia, None, None, None

+The Challenges of Dual Diagnosis: Managing Substance Abuse in Severe Mental Illness [Series Home Page]

Alan I. Green, MD

E-View

Comorbid Schizophrenia and Substance Abuse

Alan I. Green, MD

Activity | Published: 8/15/2006 | Keywords: schizophrenia, substance use disorders, None, None, None, None

In this online slide show, learn about the prevalence, impact, and signs of substance use disorder in individuals with schizophrenia, the possible connections between the 2 disorders, and how to effectively treat your patients with this dual diagnosis.

E. Sherwood Brown, PhD, MD (Chair)

Journal Supplement

The Challenges of Dual Diagnosis: Managing Substance Abuse in Severe Mental Illness

E. Sherwood Brown, PhD, MD (Chair) et al.

Activity | Published: 9/15/2006 | Keywords: schizophrenia, substance use disorders, bipolar disorder, None, None, None

Learn how to recognize and treat substance abuse in your patients with severe mental illness and how to integrate therapies to treat them.

E. Sherwood Brown, PhD, MD

E-View

Management of Comorbid Bipolar Disorder and Substance Abuse

E. Sherwood Brown, PhD, MD

Activity | Published: 6/15/2006 | Keywords: None, None, None, None, None, None

Watch this slide show to review the efficacy of antipsychotic, antimanic, and adjunctive antiaddiction agents to effectively manage your patients with this dual diagnosis.

Deborah Deas, MD, MPH

E-View

Adolescent Substance Abuse and Psychiatric Comorbidities

Deborah Deas, MD, MPH

Activity | Published: 6/15/2006 | Keywords: None, None, None, None, None, None

Youth with a history of anxiety or depression have twice the risk of developing an SUD. Sit in on this online lecture to learn why SUDs and psychiatric disorders commonly co-occur.

Peter F. Buckley, MD

E-View

Prevalence and Consequences of Dual Diagnosis

Peter F. Buckley, MD

Activity | Published: 6/15/2006 | Keywords: None, None, None, None, None, None

Almost 50% of psychiatric patients will meet the criteria for a substance abuse disorder sometime in their lives. Here, you can review the prevalence and impact of this comorbidity on your patients with schizophrenia or bipolar disorder.

Mary F. Brunette, MD

E-View

Psychosocial Intervention for Dual Diagnosis

Mary F. Brunette, MD

Activity | Published: 5/15/2006 | Keywords: None, None, None, None, None, None

Separate interventions are not effective in treating mental illness and substance abuse. Watch this slide show to find out about the principles, strategies, and goals of integrated treatment programs for these co-occurring disorders.

+A Systematic Review of Assessment and Treatment of Moderate to Severe Alzheimer's Disease [Series Home Page]

PCC CME

A Systematic Review of Assessment and Treatment of Moderate to Severe Alzheimer's Disease

Frederick A. Schmitt and Christine H. Wichems

Activity | Published: 6/15/2006 | Keywords: Alzheimer's, dementia, None, None, None, None

+Emerging Therapies for Bipolar Depression [Series Home Page]

Lauren B. Marangell, MD (Chair)

JCP CME

Prevalence, Correlates, and Comorbidity of Nonmedical Prescription Drug Use and Drug Use Disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions / Academic Highlights: Emerging Therapies for Bipolar Depression

Boji Huang, Deborah A. Dawson, Frederick S. Stinson, Deborah S. Hasin, W. June Ruan, Tulshi D. Saha, Sharon M. Smith, Risë B. Goldstein, and Bridget F. Grant / Lauren B. Marangell, MD (Chair) et al.

Activity | Published: 7/15/2006 | Keywords: substance use disorders, None, None, None, None, None

Review the course of illness of and learn long-term treatment strategies for bipolar depression, including treatment resistance or rapid cycling.

+The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment [Series Home Page]

David J. Nutt, MD, PhD (Chair)

Journal Supplement

The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

David J. Nutt, MD, PhD (Chair) et al.

Activity | Published: 6/15/2006 | Keywords: None, None, None, None, None, None

Here, experts elucidate the importance of dopamine and norepineprhine in treating depression as well as address common treatment obstacles.

+Agitated "Unipolar" Major Depression: Prevalence, Phenomenology, and Outcome [Series Home Page]

JCP CME

Agitated "Unipolar" Major Depression: Prevalence, Phenomenology, and Outcome / Juvenile Maladaptive Aggression: A Review of Prevention, Treatment, and Service Configuration and a Proposed Research Agenda

Mario Maj, Raffaele Pirozzi, Lorenza Magliano, Andrea Fiorillo, and Luca Bartoli/Daniel F. Connor, Gabrielle A. Carlson, Kiki D. Chang, Peter T. Daniolos, Reuven Ferziger, Robert L. Findling, Janice G. Hutchinson, Richard P. Malone, Jeffrey M. Halperin, Belinda Plattner, Robert M. Post, Diane L. Reynolds, Kenneth M. Rogers, Kirti Saxena, and Hans Steiner, for the Stanford/Howard/AACAP Workgroup on Juvenile Impulsivity and Aggression

Activity | Published: 5/15/2006 | Keywords: depression, None, None, None, None, None

+Managing Nonadherence in Schizophrenia: The Role of Long-Acting Agents [Series Home Page]

John M. Kane, MD (Chair)

Journal Supplement

Managing Nonadherence in Schizophrenia: The Role of Long-Acting Agents

John M. Kane, MD (Chair) et al.

Activity | Published: 5/15/2006 | Keywords: None, None, None, None, None, None

Read this Supplement to become familiar with risk factors for nonadherence and learn about long-acting injectable antipsychotics and psychosocial interventions to improve your patients’ treatment outcomes.

+Distance Rounds [Series Home Page]

James W. Jefferson, MD

Distance Rounds

Bipolar Disorder: Therapeutic Options

James W. Jefferson, MD

Activity | Published: 5/15/2006 | Keywords: None, None, None, None, None, None

What factors influence the treatment of bipolar disorder? What pharmacologic and psychosocial interventions are effective in treating patients with this condition? In this Distance Rounds, you can learn strategies to optimize treatment for your patients with bipolar disorder.

Roger G. Kathol, MD

Distance Rounds

Psychopharmacology in Primary Care: Basic Principles

Roger G. Kathol, MD

Activity | Published: 4/15/2006 | Keywords: None, None, None, None, None, None

Almost 60% of patients with mental illness do not get psychiatric treatment. In this Distance Rounds, learn how to manage common psychiatric conditions, such as depression and anxiety, in primary care settings.

James Ellison, MD, MPH

Distance Rounds

Model Psychopharmacology Curriculum: Evidence-Based Medicine in Mental Health

James Ellison, MD, MPH

Activity | Published: 12/15/2005 | Keywords: None, None, None, None, None, None

Anecdotal experiences may be misleading, but evidence-based research can improve treatment strategies. In this Distance Rounds, find out how to translate evidence-based data into useful clinical information.

+Identifying and Managing Depression in the Medical Patient [Series Home Page]

David A. Fishbain, MD

E-View

Relationship Between Physical Symptoms and Depression Treatment Response in Patients With Comorbid Medical Conditions

David A. Fishbain, MD

Activity | Published: 5/15/2006 | Keywords: None, None, None, None, None, None

Participate in this E-View to update your knowledge of the impact of and available treatment options for pain and depression to improve outcomes for your patients.

Larry Culpepper, MD, MPH

E-View

Identifying, Evaluating, and Monitoring Depression in Patients With Medical Conditions

Larry Culpepper, MD, MPH

Activity | Published: 5/15/2006 | Keywords: None, None, None, None, None, None

Participate in this online lecture to find out why depression is often underrecognized and undertreated in patients with somatic symptoms and how you can better identify depression in this population.

Maurizio Fava, MD

E-View

Prevalence and Burden of Depression in the Medically Ill

Maurizio Fava, MD

Activity | Published: 4/15/2006 | Keywords: None, None, None, None, None, None

Participate in this online lecture to find out why depression is often underrecognized and undertreated in medically ill patients and learn how you can better identify and manage depression in this population.

James M. Martinez, MD

E-View

Review of the Efficacy and Safety of Available Antidepressants in the Treatment of Depression in Patients With Comorbid Medical Illness

James M. Martinez, MD

Activity | Published: 2/15/2006 | Keywords: None, None, None, None, None, None

Learn treatments for depression and comorbid cancer, HIV/AIDS, and other medical conditions.

+Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials [Series Home Page]

JCP CME

Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials/Psychiatric Comorbidity in Binge-Eating Disorder as a Function of Smoking History

Roy H. Perlis, Jeffrey A. Welge, Lana A. Vornik, Robert M. A. Hirschfeld, and Paul E. Keck, Jr./Marney A. White and Carlos M. Grilo

Activity | Published: 4/15/2006 | Keywords: bipolar disorder, eating disorders, None, None, None, None

+Review of the Pharmacologic Management of Depression [Series Home Page]

Michael E. Thase, MD (Chair)

PCC CME

The State of Knowledge of Chronic Depression/Academic Highlights: Managing Depression in Primary Care: Achieving Remission

Michael E. Thase, MD (Chair) et al.

Activity | Published: 4/15/2006 | Keywords: depression, None, None, None, None, None

Review diagnostic and treatment strategies for depression and its common comorbidities.

Michael E. Thase, MD (Chair)

JCP CME

Sociodemographic Characteristics and Cardiovascular Risk Factors in Patients With Severe Mental Disorders Compared With the General Population/ Academic Highlights: Review of the Pharmacologic Management of Depression

Astrid B. Birkenaes, Anne J. Søgaard, John A. Engh, Halldora Jonsdottir, P. Andreas Ringen, Anja Vaskinn, Svein Friis, Kjetil Sundet, Stein Opjordsmoen, and Ole A. Andreassen/Michael E. Thase, MD (Chair) et al.

Activity | Published: 3/15/2006 | Keywords: mental illness, medical conditions, None, None, None, None

Learn about current antidepressant medication profiles, which adjunctive medications complement them, and which medications may be best for your patients with depression.

+Bipolar Reports [Series Home Page]

Cheryl A. Chessick, MD

Pubweb

Treating Suicidality in Bipolar Disorder

Cheryl A. Chessick, MD; Introduction: Gary S. Sachs, MD

Activity | Published: 3/15/2006 | Keywords: None, None, None, None, None, None

Participate in this PubWeb to review 3 case reports that illustrate common presentations of suicidality, and receive recommendations for acute and maintenance interventions to manage your patients with bipolar disorder who are suicidal.

Terence A. Ketter, MD

Pubweb

Enhancing Diagnostic Accuracy for Bipolar Disorder

Terence A. Ketter, MD; Introduction: Gary S. Sachs, MD

Activity | Published: 12/15/2005 | Keywords: None, None, None, None, None, None

Almost 70% of people with bipolar disorder are initially misdiagnosed. Participate in this PubWeb to learn how to use measures such as the Mood Disorder Questionnaire and the Bipolarity Index to accurately diagnose bipolar disorder in your patients.

Pubweb

Bipolar Disorder in Primary Care

Larry Culpepper, MD, MPH; Introduction: Gary S. Sachs, MD

Activity | Published: 7/15/2005 | Keywords: None, None, None, None, None, None

Pubweb

Current Concepts in Diagnosing and Treating Rapid-Cycling Bipolar Disorder

Christopher D. Schneck, MD; Introduction: Gary S.Sachs, MD

Activity | Published: 5/15/2005 | Keywords: None, None, None, None, None, None

Pubweb

Treatment of Bipolar Depression

Andrew A. Nierenberg, MD; Introduction: Gary S. Sachs, MD

Activity | Published: 2/15/2005 | Keywords: None, None, None, None, None, None

Pubweb

Long-Term Management of Bipolar Disorder

Charles L. Bowden, MD; Introduction: Gary S. Sachs, MD

Activity | Published: 10/15/2004 | Keywords: None, None, None, None, None, None

+The Alzheimer's Disease Continuum: From Neuropathology to Clinical Practice [Series Home Page]

Pierre N. Tariot, MD (Chair)

Journal Supplement

The Alzheimer's Disease Continuum: From Neuropathology to Clinical Practice

Pierre N. Tariot, MD (Chair) et al.

Activity | Published: 1/15/2006 | Keywords: None, None, None, None, None, None

In the U.S., the rate of Alzheimer's disease is expected to triple over the next 50 years. Read this Supplement to learn how to detect and manage this disorder in your patients.

+The Impact of Disasters and Their Aftermath on Mental Health [Series Home Page]

Robert J. Ursano, MD (Chair)

PCC CME

Commentary: The Impact of Disasters and Their Aftermath on Mental Health

Robert J. Ursano, MD (Chair), et al.

Activity | Published: 2/15/2006 | Keywords: mental illness, None, None, None, None, None

Disasters can impact every aspect of people's lives, from grief over a lost loved one to health care and medication access. Find out from the experts how you can help your patients cope with tragedy and adversity.

+After the Tsunami: Mental Health Challenges to the Community for Today and Tomorrow [Series Home Page]

Jonathan R. T. Davidson, MD (Chair)

Journal Supplement

After the Tsunami: Mental Health Challenges to the Community for Today and Tomorrow

Jonathan R. T. Davidson, MD (Chair) et al.

Activity | Published: 2/15/2006 | Keywords: None, None, None, None, None, None

Catastrophic events seriously impact the mental health of survivors. Learn about assessing, diagnosing, and treating patients with trauma-related mental disorders.

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

Sonia Ancoli-Israel, PhD

E-View

Sleep and Aging: Prevalence of Disturbed Sleep and Treatment Considerations in Older Adults

Sonia Ancoli-Israel, PhD

Activity | Published: 2/15/2006 | Keywords: None, None, None, None, None, None

Watch this presentation to review the prevalence of and factors that contribute to sleep disturbances in older adults, and learn what you can do to treat your elderly patients with sleep disorders.

Roland R. Griffiths, PhD

E-View

Relative Abuse Liability of Hypnotic Drugs: Implications for Treating Insomnia

Roland R. Griffiths, PhD

Activity | Published: 1/15/2006 | Keywords: None, None, None, None, None, None

Participate in this E-View to find out about the recreational abuse and chronic quasi-therapeutic use of hypnotic drugs, and learn how you can assess your patients’ abuse liability when prescribing these agents.

Larry Culpepper, MD, MPH

E-View

Insomnia: A Primary Care Perspective

Larry Culpepper, MD, MPH

Activity | Published: 1/15/2006 | Keywords: None, None, None, None, None, None

Insomnia affects 10% to 15% of the general population. Watch this E-View to find out how insomnia may present in primary care settings and learn how you can effectively assess and treat this sleep disorder in your patients.

Milton K. Erman, MD

E-View

Therapeutic Options for the Treatment of Insomnia

Milton K. Erman, MD

Activity | Published: 11/15/2005 | Keywords: None, None, None, None, None, None

Participate in this online lecture to find out about the long-term benefits of pharmacologic and behavioral therapies for sleep disorders and learn how to select the most appropriate treatments for your patients with insomnia.

Gary S. Richardson, MD

E-View

The Human Circadian System in Normal and Disordered Sleep

Gary S. Richardson, MD

Activity | Published: 11/15/2005 | Keywords: None, None, None, None, None, None

How many of your patients have sleep disorders? Sit in on this lecture to learn about the physiology of the circadian clock and how it may be involved in the pathogenesis of circadian rhythm sleep disorders and insomnia in your patients.

E-View

Prevalence, Associated Risks, and Treatment Patterns of Insomnia

Thomas Roth, PhD (Chair)

Activity | Published: 8/15/2005 | Keywords: None, None, None, None, None, None

+The Recognition and Management of Bipolar Disorder With Comorbid Anxiety [Series Home Page]

Robert M. A. Hirschfeld, MD (Chair)

Journal Supplement

The Recognition and Management of Bipolar Disorder With Comorbid Anxiety

Robert M. A. Hirschfeld, MD (Chair) et al.

Activity | Published: 1/15/2006 | Keywords: None, None, None, None, None, None

Patients with bipolar disorder often present with comorbid anxiety. In this Supplement, find out how to recognize symptoms of anxiety and effectively treat your patients with this comorbidity.

+Focus on Bipolar Disorder Treatment [Series Home Page]

Bowden and Thase

Online Insight

Long-Term Treatment and Psychosocial Management

Charles L. Bowden, MD (Chair), and Michael E. Thase, MD

Activity | Published: 12/15/2005 | Keywords: None, None, None, None, None, None

In this Online Insight, learn maintenance therapy strategies to treat patients with bipolar disorder.

Ketter and Sachs

Online Insight

Treatment of Acute Mania and Bipolar Depression

Terence A. Ketter, MD, and Gary S. Sachs, MD

Activity | Published: 11/15/2005 | Keywords: None, None, None, None, None, None

Sit in on this online lecture to compare the safety and efficacy profiles of mood stabilizers, anticonvulsants, atypical antipsychotics, and antidepressants to effectively treat the different episodes of bipolar disorder.

Brief Report

Psychosocial Management of Bipolar Disorder

Michael E. Thase, MD

Activity | Published: 7/15/2005 | Keywords: None, None, None, None, None, None

Brief Report

Long-Term Treatment

Charles L. Bowden, MD

Activity | Published: 7/15/2005 | Keywords: None, None, None, None, None, None

Brief Report

Treatment of Bipolar Depression

Gary S. Sachs, MD

Activity | Published: 6/15/2005 | Keywords: None, None, None, None, None, None

Brief Report

Treatment of Acute Mania

Terence A. Ketter, MD

Activity | Published: 6/15/2005 | Keywords: None, None, None, None, None, None

+Management of Autism and Its Related Disorders [Series Home Page]

Robert L. Findling, MD (Chair)

Journal Supplement

The Management of Autism and Its Related Disorders

Robert L. Findling, MD (Chair) et al.

Activity | Published: 12/15/2005 | Keywords: None, None, None, None, None, None

Read this Supplement to review the epidemiology and neurochemistry of autism spectrum disorders. Then, find out how to diagnose these disorders and formulate effective treatment plans for your patients.

Michael G. Aman, PhD

E-View

Treatment Planning for Patients With Autism Spectrum Disorders

Michael G. Aman, PhD

Activity | Published: 10/15/2005 | Keywords: None, None, None, None, None, None

Sit in on this online lecture to update your understanding of the management of autism spectrum disorders, find out about treatment planning, and learn how to develop a therapeutic alliance with your patients’ parents.

Robert L. Findling, MD

E-View

Pharmacologic Treatment of Behavioral Symptoms in Autism and Pervasive Developmental Disorders

Robert L. Findling, MD

Activity | Published: 9/15/2005 | Keywords: None, None, None, None, None, None

In this E-View, learn about the role of stimulants, antidepressants, mood stabilizers, and antipsychotics in the treatment autism and other PDDs.

E-View

Neurochemistry in the Pathophysiology of Autism

Christopher J. McDougle, MD

Activity | Published: 6/15/2005 | Keywords: None, None, None, None, None, None

E-View

Assessment of Pervasive Developmental Disorders

Lawrence Scahill, MSN, PhD

Activity | Published: 6/15/2005 | Keywords: None, None, None, None, None, None

E-View

Epidemiology of Autism and Pervasive Developmental Disorders

Eric Fombonne, MD, FRCPsych

Activity | Published: 5/15/2005 | Keywords: None, None, None, None, None, None

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

Thomas Roth, PhD (Chair)

Journal Supplement

Sleep: New Frontiers in Psychiatry and Primary Care

Thomas Roth, PhD (Chair) et al.

Activity | Published: 12/15/2005 | Keywords: None, None, None, None, None, None

As the most common sleep problem, insomnia may cause impaired functioning and a diminished quality of life. In this Supplement, learn about treatments for insomnia, including the abuse liability of hypnotic agents.

+New Therapies for Treatment-Resistant Depression and Anxiety [Series Home Page]

Charles B. Nemeroff, MD, PhD (Chair)

Journal Supplement

New Therapies for Treatment-Resistant Depression and Anxiety

Charles B. Nemeroff, MD, PhD (Chair) et al.

Activity | Published: 11/15/2005 | Keywords: None, None, None, None, None, None

Read this Supplement to learn about pharmacologic and nonpharmacologic strategies that may help your patients with treatment-resistant depression, including those with comorbid anxiety, achieve response and remission.

+Safety Issues With Drug Therapies for Autism Spectrum Disorders [Series Home Page]

James T. McCracken, MD

E-View

Safety Issues With Drug Therapies for Autism Spectrum Disorders

James T. McCracken, MD

Activity | Published: 8/15/2005 | Keywords: None, None, None, None, None, None

Participate in this E-View to learn about safety and management tactics for administering antidepressants, stimulants, neuroleptics, and alpha agonists to children and adolescents with these disorders.

+New Insights Into the Nature and Treatment of Panic Disorder [Series Home Page]

Journal Supplement

New Insights Into the Nature and Treatment of Panic Disorder

Activity | Published: 4/15/2005 | Keywords: None, None, None, None, None, None

+The Role of Atypical Antipsychotics in the Treatment of Bipolar Disorder [Series Home Page]

Robert M. A. Hirschfeld, et al

Journal Supplement

The Role of Atypical Antipsychotics in the Treatment of Bipolar Disorder

Robert M. A. Hirschfeld, et al

Activity | Published: 3/15/2005 | Keywords: None, None, None, None, None, None

+Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion [Series Home Page]

Rosenbaum, et al

Journal Supplement

Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion

Rosenbaum, et al

Activity | Published: 2/15/2005 | Keywords: None, None, None, None, None, None

+New Perspectives in Treating Bipolar Disorder [Series Home Page]

Bowden, et al

Journal Supplement

New Perspectives in Treating Bipolar Disorder

Charles L. Bowden, et al

Activity | Published: 2/15/2005 | Keywords: None, None, None, None, None, None

+The Need for Better Management of Treatment-Resistant Depression [Series Home Page]

+Differential Diagnosis and Management of Daytime Sleepiness and Nighttime Wakefulness [Series Home Page]

Siegel, et al

Journal Supplement

Differential Diagnosis and Management of Daytime Sleepiness and Nighttime Wakefulness

Jerome M. Siegel, et al

Activity | Published: 12/15/2004 | Keywords: None, None, None, None, None, None

+Beyond Refractory Obsessions and Anxiety States: Toward Remission [Series Home Page]

Hollander, et al

Journal Supplement

Beyond Refractory Obsessions and Anxiety States: Toward Remission

Eric Hollander, et al

Activity | Published: 11/15/2004 | Keywords: None, None, None, None, None, None

+New Perspectives for Treating Generalized Anxiety Disorder [Series Home Page]

Stein et al

Journal Supplement

New Perspectives for Treating Generalized Anxiety Disorder

Murray B. Stein, et al

Activity | Published: 9/15/2004 | Keywords: None, None, None, None, None, None

+Recognizing the Physical Symptoms of Depression [Series Home Page]

Schatzberg er al

Journal Supplement

Recognizing the Physical Symptoms of Depression

Alan F. Schatzberg, et al

Activity | Published: 8/15/2004 | Keywords: None, None, None, None, None, None

Slides to Go

Recognizing the Physical Symptoms of Depression

Activity | Published: 8/1/2004 | Keywords: None, None, None, None, None, None

Schatzberg et al

Slides to Go

Recent Developments in Achieving Depression Remission

Alan F. Schatzberg, et al

Activity | Published: 9/15/2003 | Keywords: None, None, None, None, None, None

+Clinical Effectiveness of Atypical Antipsychotics in Dementia [Series Home Page]

Tariot et al

Journal Supplement

Clinical Effectiveness of Atypical Antipsychotics in Dementia

Pierre N. Tariot, et al

Activity | Published: 7/15/2004 | Keywords: None, None, None, None, None, None

+Managing Bipolar Depression [Series Home Page]

Bowden et al

Journal Supplement

Managing Bipolar Depression

Charles L. Bowden, et al

Activity | Published: 6/15/2004 | Keywords: None, None, None, None, None, None

+Drug-Induced Movement Disorders [Series Home Page]

Friedman et al

Journal Supplement

Drug-Induced Movement Disorders

Joseph H. Friedman, et al

Activity | Published: 5/15/2004 | Keywords: None, None, None, None, None, None

+Using Atypical Antipsychotics in Primary Care [Series Home Page]

Miller et al

Journal Supplement

Using Atypical Antipsychotics in Primary Care, 3: Safety Considerations

Del D. Miller, et al

Activity | Published: 4/15/2004 | Keywords: None, None, None, None, None, None

Lieberman et al

Journal Supplement

Using Atypical Antipsychotics in Primary Care, 2: Special Populations

Joseph A. Lieberman III, et al

Activity | Published: 9/15/2003 | Keywords: None, None, None, None, None, None

Lieberman et al

Journal Supplement

Using Atypical Antipsychotics in Primary Care, 1: Evidence and Clinical Strategies

Joseph A. Lieberman III, et al

Activity | Published: 5/15/2003 | Keywords: None, None, None, None, None, None

Culpepper et al

Journal: PCC

Using Atypical Antipsychotics in Primary Care

Larry Culpepper, et al

Activity | Published: 3/15/2003 | Keywords: None, None, None, None, None, None

+Revisiting the Use of High-Potency Benzodiazepines [Series Home Page]

Rosenbaum et al

Journal Supplement

Revisiting the Use of High-Potency Benzodiazepines

Jerrold F. Rosenbaum, et al

Activity | Published: 3/15/2004 | Keywords: None, None, None, None, None, None

+Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder in Adults [Series Home Page]

Biederman et al

Journal Supplement

Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder in Adults

Joseph Biederman, et al

Activity | Published: 3/15/2004 | Keywords: None, None, None, None, None, None

+New Treatments for Depression Characterized by Physical Symptoms [Series Home Page]

Manning et al

Journal Supplement

New Treatments for Depression Characterized by Physical Symptoms

J Sloan Manning, et al

Activity | Published: 2/15/2004 | Keywords: None, None, None, None, None, None

+The Expert Consensus Guideline Series: Using Antipsychotic Agents in Older Patients [Series Home Page]

Alexopoulos et al

Journal Supplement

The Expert Consensus Guideline Series: Using Antipsychotic Agents in Older Patients

George S. Alexopoulos, Joel Streim, Daniel Carpenter, and John P. Docherty

Activity | Published: 1/15/2004 | Keywords: None, None, None, None, None, None

+Treating Aggressive Behavior in the Elderly [Series Home Page]

Newsletter: CME Infopack

Treating Aggressive Behavior in the Elderly

Activity | Published: 6/15/2003 | Keywords: None, None, None, None, None, None

+Treating Depression: New Choices for a Chronic Problem [Series Home Page]

Thase et al

Journal Supplement

Treating Depression: New Choices for a Chronic Problem

Michael E. Thase, et al

Activity | Published: 12/15/2003 | Keywords: None, None, None, None, None, None

+Partial Compliance: The Need for Long-Acting Atypical Antipsychotics [Series Home Page]

Marder et al

Journal Supplement

Partial Compliance: The Need for Long-Acting Atypical Antipsychotics

Stephen R. Marder, et al

Activity | Published: 11/15/2003 | Keywords: None, None, None, None, None, None

+Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction [Series Home Page]

Stahl et al

Journal Supplement

Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction

Stephen M. Stahl, et al

Activity | Published: 11/15/2003 | Keywords: None, None, None, None, None, None

+The Expert Consensus Guideline Series: Optimizing Pharmacologic Treatment of Psychotic Disorders [Series Home Page]

Kane et al

Journal Supplement

The Expert Consensus Guideline Series: Optimizing Pharmacologic Treatment of Psychotic Disorders

John M. Kane, Stefan Leucht, Daniel Carpenter, and John P. Docherty

Activity | Published: 9/15/2003 | Keywords: None, None, None, None, None, None

+Long-Term Safety of Methylphenidate in the Treatment of ADHD: Dispelling the Myths and Misconceptions About Stimulant Therapy Abuse [Series Home Page]

Biederman et al

Journal Supplement

Long-Term Safety of Methylphenidate in the Treatment of ADHD: Dispelling the Myths and Misconceptions About Stimulant Therapy Abuse

Joseph Biederman, et al

Activity | Published: 8/15/2003 | Keywords: None, None, None, None, None, None

+Noncholinergic Treatments for Alzheimer’s Disease [Series Home Page]

Grossberg et al

Journal Supplement

Noncholinergic Treatments for Alzheimer’s Disease

George T. Grossberg, et al

Activity | Published: 8/15/2003 | Keywords: None, None, None, None, None, None

+Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders [Series Home Page]

Chengappa et al

Journal Supplement

Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders

K. N. Roy Chengappa, et al

Activity | Published: 7/15/2003 | Keywords: None, None, None, None, None, None

+Physical Symptoms of Depression and Their Impact on Patients and Society [Series Home Page]

Sartorius et al

Journal Supplement

Physical Symptoms of Depression and Their Impact on Patients and Society

Norman Sartorius, et al

Activity | Published: 5/15/2003 | Keywords: None, None, None, None, None, None

+Achieving Success in the Management of Bipolar Disorder: Is Lithium Sufficient? [Series Home Page]

Gray et al

Journal Supplement

Achieving Success in the Management of Bipolar Disorder: Is Lithium Sufficient?

Neil A. Gray, et al

Activity | Published: 5/15/2003 | Keywords: None, None, None, None, None, None

+Management of Aggression Across the Life Cycle [Series Home Page]

Alderfer et al

Journal Supplement

Management of Aggression Across the Life Cycle

Benjamin S. Alderfer, et al

Activity | Published: 4/15/2003 | Keywords: None, None, None, None, None, None

+The Role of GABA in Neuropsychiatric Disorders: A Review of GABA Agents [Series Home Page]

Nemeroff et al

Journal Supplement

The Role of GABA in Neuropsychiatric Disorders: A Review of GABA Agents

Charles B. Nemeroff, et al

Activity | Published: 3/15/2003 | Keywords: None, None, None, None, None, None

+Treating Depression and Anxiety to Remission: Use of Algorithms [Series Home Page]

Thase et al

Journal Supplement

Treating Depression and Anxiety to Remission: Use of Algorithms

Michael E. Thase, et al

Activity | Published: 2/15/2003 | Keywords: None, None, None, None, None, None

+New Approaches to Managing Difficult-to-Treat Depressions [Series Home Page]

Thase et al

Journal Supplement

New Approaches to Managing Difficult-to-Treat Depressions

Michael E. Thase, et al

Activity | Published: 2/15/2003 | Keywords: None, None, None, None, None, None

+Anxiety: New Treatment Perspectives [Series Home Page]

Rickels et al

Journal Supplement

Anxiety: New Treatment Perspectives

Karl Rickels, et al

Activity | Published: 1/15/2002 | Keywords: None, None, None, None, None, None